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ABSTRACT 
 
 Bioprocesses for therapeutic protein production typically require significant 
resources to be invested in their development. This development could be 
improved with technologies that can elucidate the physicochemical properties of 
process stream components with small sample volumes in a rapid and readily 
performed manner. This is especially true in early phase development when 
material and established analytical methods are limiting. 
This thesis has investigated various process materials but was focussed 
mainly on those existing in an ApolipoproteinA-IM (ApoA-IM) process, produced 
using an Eschericia coli (E. coli) host.  
Using a mass spectrometric technique this project began by monitoring the 
product and contaminant during the ApoA-IM process and how this analytical 
approach compares to traditional analytical methods such as high performance 
liquid chromatography (HPLC).  Results showed that, unlike many other analytical 
methods, surface enhanced laser desorption ionisation mass spectrometry (SELDI-
MS) can handle early process samples that contain complex mixtures of biological 
molecules with limited sample pre-treatment and thereby provide meaningful 
process-relevant information.  
The change in material during the flocculation/centrifugation stage of the 
process was then examined. When only a change in cellular debris was observed an 
existing methodology developed at University College London (UCL) was 
implemented to maximise cellular debris removal. The predictive scale down 
methodology enabled rapid optimization of the operating conditions for a 
flocculation followed with a centrifugation step using only small volumes (20mL) of 
a high solids (~20% w/w) E. coli heat extract. These experiments suggested that 
adding a higher level of a cationic polymer could substantially increase the strength 
of the flocculated particles produced, thereby enhancing overall clarification 
performance in a large scale centrifuge. This was subsequently validated at pilot 
scale. 
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  The proteins remaining from this flocculation/centrifugation stage were 
then compared using the mass spectrometric technique to calculate the difficulty of 
removing each protein contaminant from the ApoA-IM product and suggested 
conditions for future sorbent scouting runs. 
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CHAPTER 1 INTRODUCTION 
 
1.1 Protein production processes 
 
There are many different routes in the biopharmaceutical industry for 
recovering and purifying protein products. Whether the protein is produced 
extracellular or intracellular is critical to the route chosen (Figure 1.1). Extracellular 
proteins are generally easier to purify because they can be separated from whole 
cells without the need for cell breakage. This avoids the release of many host cell 
proteins that would be additional impurities to remove downstream. Methods for 
separation include centrifugation, microfiltration or expanded bed adsorption 
(EBA). Intracellular proteins require cell disruption to be released which could 
involve lysis or homogenisation (Table 1.1). 
 
Figure 1.1 Typical protein bioprocess options (Lienqueo and Asenjo,2000). 
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Table 1.1 Separation principles and unit operations used in downstream 
processing (Lienqueo and Asenjo,2000). 
 
One of the notable difficulties with process development is the inherent 
complexity caused by interactions between unit operations. Optimization of 
biopharmaceutical processes tend to be based on yield or product quality (Groep et 
al. 1997). Biopharmaceutical processing steps are highly interactive and optimising 
individual steps is unlikely to lead to an optimal process (Dyr and 
Suttnar,1997;Groep et al. 1997). Groep et al. demonstrated this by varying 
conditions in the aerobic fermentation and homogenization for an alcohol 
dehydrogenase (ADH) production process grown intracellularly in Saccharomyces 
cerevisiae (Groep et al. 1997). An interaction was demonstrated between growth 
conditions, cell strength and cell disruption. 
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1.1.1 Protein recovery 
 
There are many varied operations for protein recovery but this thesis will 
focus on flocculation and centrifugation.  Flocculation allows cellular debris to form 
strong, stable aggregates which can then be removed from the liquid using a single 
unit operation such as centrifugation. 
 
1.1.1.1 Flocculation 
 
Flocculation describes the aggregation of individual particles in a suspension 
due to the addition of a flocculating agent. Early work in 1969 by McGregor et al. 
highlighted the factors that affect the flocculation of homogenous cultures. These 
were (i) bacteria genus; (ii) suspending media; (iii) temperature; (iv) physiological 
age; (v) flocculating agent (type, concentration & rate of addition); (vi) surface 
shear (McGregor and Finn,1969). Most of these variables were shown to be related 
to the release of proteins, polysaccharides, or nucleic acids.  
Flocculation with natural polymers from micro-organisms, mineral 
flocculating agents such as aluminium sulphate or synthetic polymers are 
traditionally used in waste water treatment to remove microorganisms from the 
effluent of activated sludge (McGregor and Finn,1969). Additives such as aluminium 
sulphate have also been found to aid protein recovery from pure cultures such as 
those in the biopharmaceutical industry (Richardson et al. 1990). Gasner et al. 
found that strong polyelectrolytes as well as mineral hydrocolloids were the most 
effective (Gasner and Wang,1970). These mineral flocculating agents however tend 
to form low mechanical strength flocs rendering these agents useless for 
centrifugation (Shan et al. 1996). 
Synthetic flocculating agents, such as the one used in this thesis consist of 
long polymeric chains that adsorb different particles in a suspension, aiding their 
aggregation. These carry various charged groups that cause adsorption of the 
particles. Once adsorbed the particles either bridge together or their charges are 
neutralised. The polymer used in this thesis was cationic, binding to negatively 
charged cellular debris to form flocs.  
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Dosing of these agents is very important and there is usually an optimum 
level of addition where the maximum amount of flocculation occurs. If insufficient 
agent is added only some of the particles will flocculate. An over dose of flocculant, 
however means many of the particles are coated with flocculant, causing the 
particles to have the same charge, leading to particle repulsions and preventing 
flocculation.  
Floc particle strength is heavily influenced by surface shear during its 
formation. During floc formation a steady-state between floc growth and breakage 
is achieved. Mixing increases floc growth by increasing collision frequency but also 
breaks down the large floc particles due to shear force effects (Kim et al. 2001). 
The main downside of adding a flocculating agent to a bioprocess is that 
regulators such as the FDA require evidence that the flocculant has been removed 
downstream prior to drug formulation. Theoretically, if the flocculation is carried 
out correctly most of the flocculant will be removed with the flocs during 
clarification. However, undoubtedly some flocculant will remain in the product 
stream and analytical strategies have to be devised to demonstrate its removal. 
 
1.1.1.2 Centrifugation 
 
Centrifugation uses centrifugal force to separate mixtures such as 
flocculated process material. It’s frequently used in biopharmaceutical processes 
mainly due to its operational robustness and low running costs. Separation is 
achieved by density differences between heavy components (flocs) and lighter 
components (liquor) in the process material. Centrifuge designs include multi-
chamber, tubular bowl and disc-stack. Disc-stack centrifuges have particular 
benefits as they allow intermittent solids discharge removing the need for manual 
dismantling of the centrifuge bowl to remove solids. 
 
1.1.2 Protein purification 
 
Purification typically defines the profitability of a process consuming around 
60-70% of the total process operating costs (Dyr and Suttnar,1997). The extent of 
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purification in a biopharmaceutical process is ultimately dictated by the product 
and its end use. An injectable drug will necessitate a great deal more purification 
than a food product. This is reflected in their respective manufacturing costs, which 
ultimately dictate their selling price. Hence, a biopharmaceutical company is 
constantly trying to meet drug purity requirements while minimising costs. This 
results in a constant trade-off between resolution, capacity and speed. Product will 
be lost at each step of the process so it is important to limit the number of steps to 
keep the overall yield high (Bonnerjea et al. 1986). The route with the least steps to 
give a higher yield is rarely found and non-optimal conditions are chosen in favour 
of increased speed to market (Dyr and Suttnar,1997). 
Limited knowledge of the molecular properties of process material and how 
to handle such data has made the creation of a rational method to separate target 
proteins from impurities difficult (Asenjo and Andrews,2004). There are many 
factors involved in the decision on which combination of techniques (Figure 1.2) to 
purify a target protein including the properties of the process material (Table 1.2). 
Chromatography techniques are frequently used due to their high purification 
power and relatively low cost.  
 
Figure 1.2 Operational sequence selection for protein purification (Asenjo and 
Andrews,2004). 
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 Usually a chromatography sequence is designed so that minimal treatment 
is required between chromatography steps. For example, during ion-exchange the 
target protein is usually eluted in high salt conditions. It makes sense therefore to 
have a hydrophobic column following this step since binding in these columns also 
occurs with high salt concentrations.  
Chromatography resins now exist that allow mixed-mode separation. These 
resins have both hydrophobic and electrostatic properties, allowing hydrophobic 
binding and electrostatic elution. This reduces the number of steps in a process by 
having a single step that can take the place of both hydrophobic interaction and 
ion-exchange chromatography.  
 
Sample and target protein 
properties  
Influence on purification strategy 
Temperature stability  Need to work rapidly at lowered temperature  
pH stability  Selection of buffers for extraction ad purification.  
Selection of conditions for ion exchange, affinity or reversed 
phase chromatography  
Organic solvents stability  Selection of conditions for reversed phase chromatography  
Detergent requirement  Consider effects on chromatographic steps and the need for 
detergent removal. Consider choice of detergent.  
Salt (ionic strength)  Selection of conditions for precipitation techniques, ion 
exchange and hydrophobic interaction chromatography  
Co-factors for stability or activity  Selection of additives, pH, salts, buffers  
Protease sensitivity  Need for fast removal of proteases or addition of inhibitors  
Sensitivity to metal ions  Need to add EDTA or EGTA to buffers  
Redox sensitivity  Need to add reducing agents  
Molecular weight  Selection of gel filtration media  
Charge  Selection of ion exchange conditions  
Biospecific affinity  Selection of ligand for affinity medium  
Post-translational modifications  Selection of group-specific affinity medium  
Hydrophobicity  Selection of medium for hydrophobic interaction 
chromatography  
Table 1.2 Influence of protein stability on its purification (GE protein 
purification,2003). 
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1.1.2.1 Chromatography 
 
Chromatography exploits differences in the physicochemical properties of 
molecules present in process feeds. The three most common types of 
chromatography utilise differences in charge (ion-exchange chromatography), 
hydrophobicity (hydrophobic interaction chromatography) and size (size exclusion 
chromatography). The choice of which type to use and at which stage of the 
process in dependant on a number of factors some of which are highlighted in 
Table 1.3. 
 
Technique  Main features  Capture  Intermediate  Polish  Sample start 
condition  
Sample end 
condition  
IEX  High resolution 
High capacity  
High speed  
   
Low ionic 
strength  
Sample volume  
Not limiting  
High ionic 
strength or 
pH change  
concentrated  
HIC  High resolution  
High capacity  
High speed  
   
High ionic 
strength  
Sample volume 
not limiting  
Low ionic 
strength  
concentrated  
SEC  High resolution   
  
Limited sample 
volume (<5% 
total column 
volume) and 
flow rate range  
Buffer 
exchanged  
(if required)  
Diluted  
Table 1.3 Comparing chromatography techniques (GE protein purification,2003).  
 
1.1.2.1.1 Ion-exchange 
 
Ion-exchange (IEX) chromatography is potentially a very high resolution 
separation that has a high sample loading capacity (GE protein purification,2003). 
The separation is based on the reversible adsorption of a charged protein onto an 
oppositely charged chromatographic medium. Proteins are loaded onto a column 
and then conditions are altered so that bound substances are eluted differentially. 
This elution is usually performed by increases in salt concentration or changes in 
pH. Changes are made stepwise or with a continuous gradient. Most commonly, 
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samples are eluted with salt (NaCl), using a gradient elution. Target proteins are 
concentrated during adsorption and collected in a purified, concentrated form. 
The net surface charge of proteins varies according to the surrounding pH. 
When above its isoelectric point (pI) a protein will bind to an anion-exchanger, 
when below its pI a protein will bind to a cation-exchanger. Typically, IEX 
chromatography is used to adsorb the target molecule, but can also be used to bind 
impurities. IEX chromatography can be repeated at different pH values to separate 
several proteins which have distinctly different charge properties. 
 
1.1.2.1.2 Hydrophobic interaction 
 
Protein binding in hydrophobic interaction chromatography (HIC) is 
promoted by moderately high concentrations of anti-chaotropic salts, which also 
have a stabilizing influence on protein structure (Figure 1.3). Elution can be 
achieved by a linear or stepwise decrease in the salt concentration of the mobile 
phase. 
 HIC works well in combination with ion-exchange and size exclusion 
chromatography because its principle of protein adsorption is complementary. 
Since it requires a minimum of sample pre-treatment steps it can also be well 
utilised in processes with preceding precipitation steps. Its sensitivity is exhibited by 
the fact that even non-polar groups deep within the tertiary structure of a molecule 
can interact if they are incorrectly folded or damaged. This is particularly valuable 
when it is necessary to purify the native form of a molecule from close derivatives. 
Early developed adsorbents appeared to show a mixed mode of 
hydrophobic and ionic interaction but these were later improved by removing 
charged groups present in the sorbents allowing high binding of neutral proteins at 
high salt concentrations to be seen. Elution was also as expected by using a salt-free 
buffer or by decreasing the polarity of the eluent.  
HIC sorbents are usually composed of cellulose, dextran, or cross-linked 
agarose. Sorbents on the market include Phenyl and Octyl Sepharose fast flow, 
Protein mass spectrometry for bioprocess development & monitoring 
 
24 
 
Sepharose high performance and Superose. These meet various demands on 
chromatographic productivity, selectivity and efficiency. 
 
Possible theories for hydrophobic interaction: 
1. A “salting-out” effect in hydrophobic adsorption with the driving force 
being the entropy gained from structure changes in the water surrounding 
the interacting hydrophobic groups. The displacement of the ordered 
water molecules surrounding the hydrophobic ligands and the proteins 
leads to an increase in entropy (S) resulting in a negative value for the 
change in free energy (G) of the system. This implies that the 
hydrophobic ligand-protein interaction is thermodynamically favourable 
(Figure 1.3). 
2. The increase in surface tension of the water arising from the structure – 
forming salts dissolved in it. 
3. Van der Waals attraction forces between protein and ligand increase as 
the ordered structure of water increases in the presence of salting out 
salts.  
 
 
Figure 1.3 A theoretical mechanism for hydrophobic interactions. 
Close to the surface of the hydrophobic ligand and solute (L and H), the water 
molecules are more highly ordered than in the bulk water and appear to “shield off” 
the hydrophobic ligand and solute molecules. Added salt interacts strongly with the 
water molecules leaving less water available for the “shielding off” effect, which is 
H S 
L H S L 
W 
P=Polymer Matrix 
S=Solute Ligand 
L=Ligand attached to polymer matrix 
H=Hydrophobic patch on surface of solute molecule 
W=Water molecules in the bulk solution 
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the driving force for L and H to interact with each other (GE HIC principle and 
methods,2003). 
 
1.1.2.1.3 Immobilised metal affinity 
 
Immobilized metal affinity is when amino acids covalently bind to 
immobilised metals ions. An amino acid that does this readily is histidine. In a 
chromatography format the immobilised metal affinity sorbent is first charged with 
metal ions such as nickel (Ni2+) and copper (Cu2+). Proteins with an affinity for these 
ions interact with them and are retained by the sorbent while proteins with low 
affinity flow through. Changes in pH or competitive molecules like imidazole can 
then elute these proteins from the sorbent. 
Proteins that do not possess an affinity for metal ions can be engineered 
using recombinant DNA techniques in order to acquire this property. The DNA 
coding the protein of interest is inserted in a vector adjacent to a polyhistidine 
coding DNA sequence. During translation, a polyhistidine tag is therefore added to 
the C-terminal or N-terminal or the protein of interest giving it an affinity for metal 
ions. 
 
1.1.2.1.4 Size exclusion 
 
Size exclusion (SE) chromatography separates molecules according to 
differences in molecular weight (MW) (Figure 1.4) (GE gel filtration principles and 
methods,2003). Size exclusion is ideal for bio-molecules that maybe sensitive to pH, 
metal ion or co-factor concentration, and harsh environmental conditions. In 
contrast to IEX and HIC, there is no adsorption between molecules and the media, 
so buffer composition does not affect resolution. This means SE can be used for 
buffer exchange and separations can be performed in the presence of essential 
ions, cofactors, detergents, urea, guanidine hydrochloride, under variable ionic 
strengths and temperatures. 
The media for size exclusion are porous spherical particles selected for their 
physicochemical stability, and inertness. 
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A major disadvantage of using size exclusion chromatography in a process is 
that only the small volumes can be loaded, typically less than 10%, meaning larger 
volumes of resin/buffers and longer operating times are required. For this reason, 
SEC is usually only used as a final step in a process.  
 
Figure 1.4 The theory behind gel filtration (GE gel filtration principles and 
methods,2003). 
Equilibration is carried out with buffer which fills the inter- and intra-particle spaces. 
Intra-particle fluid (stationary phase) is in equilibrium with inter-particle fluid 
(mobile phase). Samples are eluted isocratically (constant buffer composition). 
 
1.2 Ultra scale-down (USD) technologies to aid process development 
 
USD technologies are beneficial as they can simulate large scale equipment 
while only requiring millilitre volumes of material. Thus, predictive performance of 
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large scale operations can be obtained at a fraction of the time and volume of 
material required compared with conventional approaches (Boychyn et al. 
2004;Boychyn et al. 2000;Neal et al. 2003;Reynolds et al. 2003;Willoughby et al. 
2004). USD technologies are particularly beneficial in early development when 
typically only small quantities of material are available.  
The USD approach for determining the sensitivity of the flocculated 
suspensions used in this thesis was a rotating disc device developed at UCL. The 
USD technology used for determining physicochemical properties of proteins used 
in this thesis was surface enhanced laser desorption ionisation mass spectroscopy 
(SELDI-MS). 
 
1.2.1 Determining the shear sensitivity of process material 
 
Biopharmaceutical processes typically exert a lot of stress on process 
particulates which can lead to cell breakage or protein aggregation (Cromwell et al. 
2006). Determining the shear sensitivity of these particulates can guide equipment 
selection and the conditions used during process development. Shear cells are 
ultra-scale down devices that can determine shear sensitivity (Biddlecombe et al. 
2007;Boychyn et al. 2001;Boychyn et al. 2004;Boychyn et al. 2000;Hutchinson et al. 
2006;Maybury et al. 2000;Salte et al. 2005;Tustian et al. 2007). The bioprocess 
material is placed in the shear device and exposed to different levels of shear. The 
amount of particulate damage is then analysed using techniques such as UV 
spectroscopy. This can then be modelled in the pilot scale.  
A pilot scale centrifuge can be modelled in the laboratory by using a shear 
device to simulate the shear experienced by particulates as they enter the pilot 
scale centrifuge feed zone followed by their separation with a laboratory 
centrifuge. 
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1.2.2 Determining the physicochemical properties of proteins 
 
It has been the aim of many researchers to predict the physicochemical 
properties of protein populations (Wall et al. 2002;Xu and Glatz,2009). Typical 
properties investigated are size, charge and hydrophobicity (Figure 1.5). 
 
Figure 1.5 Mapping the physicochemical properties of proteins (Wall et al. 2002).  
The common properties are charge, molecular weight and hydrophobicity measured 
respectively as the pI, MW and the percentage of acetonitrile required to elute each 
protein from an RP-HPLC column. The relative shades of the data points are related 
to electrospray ionisation-time of flight-mass spectrometry (ESI-TOF-MS) intensity. 
ESI-TOF-MS can give relative quantification between peaks in different samples. 
 
There are many techniques for determining physicochemical properties of 
proteins (table 1.4). 
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Method Derived Throughput Material 
required 
per run 
Impurity ID Cost per 
run 
Reproducibility 
Structure  
models 
Theoretically High N/A Yes Low N/A 
SELDI  Empirically High Low Yes High Medium 
Gel 
Techniques 
Empirically Low Medium Yes (low 
resolution)  
Medium Medium 
Microwell 
/Resin 
Empirically Medium Medium No Medium Medium 
Packed  
Column 
Empirically Low High No Low High 
Table 1.4 Techniques for determining physicochemical properties. 
 
1.2.2.1 Theoretically derived 
 
Many groups are working on linking a proteins known structure with its 
physicochemical properties. In 2002, Berggren et al., investigated the link between 
the number and type of surface exposed amino acids in a protein with its 
partitioning in an aqueous two-phase system (Berggren et al. 2002). The 
partitioning was between two EO30PO70-dextran aqueous phases of varying 
concentration. It was found that aromatic amino acids had the biggest effect, 
moving to the upper EO30PO70 phase and charged proteins tended to move into 
the lower dextran phase. 
Cramer et al. have looked at quantitative structure property relationship 
(QSPR) models (Chen et al. 2007;Chen et al. 2008;Chen and Cramer,2007;Cramer 
and Jayaraman,1993;Ladiwala et al. 2005;Ladiwala et al. 2006;Yang et al. 
2007a;Yang et al. 2007b). This approach uses non-linear support vector machine 
(SVM) techniques to correlate experimental data with physicochemical attributes. 
This method has had some success in predicting the retention of proteins in linear 
gradient hydrophobic interaction chromatography (Chen et al. 2008) and high salt 
binding on ion exchange resins (Yang et al. 2007a). The technique generates 
descriptors of a protein by its three dimensional structure. These descriptors are 
then grouped and ranked on their ability to predict experimental data for a training 
set of proteins.  A priori predictions are then made based on these descriptors for a 
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test set of proteins not included in the models. A group at GE Healthcare has also 
used QSPR to predict retention times (Malmquist et al. 2006). 
Asenjo et al. used structural data to predict the empirical protein retention 
time (Equation 1.1) for hydrophobic interaction chromatography (Lienqueo et al. 
2002;Lienqueo et al. 2003;Lienqueo et al. 2006;Lienqueo et al. 2007;Mahn et al. 
2004;Mahn et al. 2005;Mahn et al. 2007;Mahn and Asenjo,2005;Salgado et al. 
2005a;Salgado et al. 2005b;Salgado et al. 2006a;Salgado et al. 2006b;Salgado et al. 
2008). 
 
𝐷𝑅𝑇 =
𝑡𝑟 − 𝑡0
𝑡𝑓 − 𝑡0
 
Equation 1.1 Empirical dimensionless retention time (DRT). 
tr is the time corresponding to the retention time of the target protein; t0 is the time 
corresponding to the start of the elution gradient; tf is the time corresponding to the 
end of the salt gradient. If a protein is not retained by the resin, DRT is equal to 0, 
and if a protein elutes only after the gradient has been completed, its DRT is equal 
to 1. 
 
They calculated various surface hydrophobicity measurements based on the 
three dimensional structure and the hydrophobicity of the exposed amino acid 
residues to predict the dimensionless retention time (DRT). Depending on the 
information available and the hydrophobicity distribution, different models were 
used for calculating theoretical DRT (Figure 1.6). An example of one of the formulas 
used is shown in Equation 1.2. 
Protein mass spectrometry for bioprocess development & monitoring 
 
31 
 
Figure 1.6 Predicting dimensionless retention time (Lienqueo et al. 2007).  
The different methodologies for computational experiments to determine the 
suitable purification of a target protein.Where LH is local hydrophobicity; HCA is 
hydrophobic contact area; HI is hydrophobic imbalance; DRT III is the linear 
estimation of the amino acid surface composition. 
 
 
Equation 1.2 Theoretical dimensionless retention time (DRT) (Lienqueo et al. 
2007).   
Where Φsurface is the average surface hydrophobicity value; saai is the solvent 
accessible area occupied by amino acid ‘i’; φaai is the hydrophobicity value for amino 
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acid ‘i’; sp is the total solvent accessible area of the protein; A, B and C are constants 
for each set of operating conditions (e.g. varying resins). 
 
1.2.2.2 Empirically derived 
 
Techniques to derive physicochemical properties experimentally include 
aqueous biphasic systems (ABS), two dimensional-polyacrylamide gel 
electrophoresis (2D-PAGE) and reverse phase (RP) HPLC. 
 
1.2.2.2.1 Aqueous Biphasic Systems 
 
Aqueous biphasic systems are produced when two polymers, one polymer 
and a kosmotropic salt, or a chaotrope and kosmotrope are mixed together at an 
appropriate concentration or temperature. The proteins to be separated are then 
added. The greater a proteins hydrophobicity, the greater it’s abundance in the 
more hydrophobic phase and hence the greater its partition coefficient, K (Equation 
1.3). Unlike non-polar organic phase systems these two immiscible phases are 
water based and avoid the introduction of volatile organic compounds which can 
damage and denature biological molecules. Aqueous systems maintain protein 
stability; can partition individual proteins in mixtures; and give hydrophobic 
information (Gu and Glatz,2007). 
 
𝐾𝑖 =
𝐶𝑖
𝑡𝑜𝑝
𝐶𝑖
𝑏𝑜𝑡𝑡𝑜𝑚  
Equation 1.3 Empirical partition coefficients, Ki.. 
Where C is the concentration of protein i in the top and bottom phases. Relatively 
hydrophobic proteins have Log(K)>0. 
 
Glatz et al. used these systems to determine hydrophobic descriptors for a 
number of proteins (Xu and Glatz,2009). The upper phase they used was formed by 
polyethylene glycol (PEG) which was more hydrophobic than their lower phase 
solution of sodium sulphate and sodium chloride.  
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1.2.2.2.2 Two dimensional gel electrophoresis 
 
Glatz et al., used 2D-PAGE (an example of a 2D-PAGE gel is shown in Figure 
1.7) to determine the MW and pI of proteins. This information along with aqueous 
biphasic hydrophobicity data was used to construct a three dimensional property 
map of all the proteins in a corn extract sample. 
Typically, SDS-PAGE alone can resolve about one hundred distinct proteins 
but with the addition of a second dimension (charge) many more proteins can be 
observed. One of the main advantages of 2D-PAGE analysis is its ability to resolve 
proteins in very complex materials (Figure 1.7). 
The 2D-PAGE approach relies on proteins first undergoing isoelectric 
focussing using a tube or strip gel with a pH gradient to deduce the first dimension 
of pI. This gel is then laid horizontally next to an SDS slab gel and an electric current 
applied to get the second dimension of MW.     
 
Figure 1.7 A two dimensional polyacrylamide gel (Ou et al. 2001). 
The 2D-PAGE gel shows the protein complexity of a human hepatocellular 
carcinoma cell line. 
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1.2.2.2.3 RP-HPLC 
 
The elution time for proteins in RP-HPLC is related to their hydrophobicity. 
The percent acetonitrile at time of elution is related to the ratio of. non-polar to 
polar amino acids (Wall et al. 2002).  
 
1.2.3 Sorbent screening 
 
Instead of determining physicochemical properties to predict 
chromatography behaviour, proteins can be run directly on a variety of sorbents 
and conditions using USD methods. This can be done using micro-batch adsorption 
or micro-pipette columns (Table 1.5). 
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Table 1.5 Chromatography mode selection based on new proteomic techniques or 
conventional chromatography (Wenger et al. 2007). 
 
1.2.3.1 Micro-batch adsorption 
 
Companies use many different sorbents and comparison studies are timely 
due to the running of many columns, analysis of many fractions and the cost of the 
sorbents used (Weinberger et al. 2002a). Filter plates can be filled with various 
sorbents and mixed with the sample under various binding and elution conditions 
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(Figure 1.8) (Guerrier et al. 2007;Rege et al. 2006). Flow-throughs, washes and 
eluates can be extracted through the filter using a vacuum or centrifuge and then 
analysed using UV spectroscopy or HPLC (Weinberger et al. 2002a). 
 
 
Figure 1.8 Experimental procedure for micro-batch adsorption. 
 
1.2.3.2 Micro-pipette column 
 
Small scale columns (less than 1mL) are available that can improve the 
throughput of sorbent scouting while maintaining dynamic conditions. An 
adaptation of this technique includes pipette tips packed with sorbent (PhyTipsTM) 
(Figure 1.9). Using these tips in conjunction with a robotic device, Wenger et al., 
achieved a 10-fold increase in throughput (Wenger et al. 2007).  
 
Figure 1.9 A micro-pipette column (Wenger et al. 2007). 
 
A driving force for this 1000-fold reduction in scale was to increase 
throughput and reduce labour. Conditions in a Saccharomyces cerevisiae 
fermentation for a recombinant human papillomavirus vaccine were altered and a 
96 Well Plate 
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& 
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Orbital  
Mixing 
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following cation exchange chromatography step carried out in a laboratory column 
and micro-pipette tip format. The elution fractions were analysed and fermentation 
productivity was expressed as the total protein recovered after chromatography 
per input of cell weight. There was a good correlation for productivity between the 
laboratory column and the micro-pipette tips (Figure 1.10).   
 
Figure 1.10 Comparison of different chromatography scales (Wenger et al. 2007). 
Cation exchange purification was used with an automated micro-scale and a 
laboratory purification to assess the fermentation productivity (total protein 
recovery after chromatography per cell weight input) across a wide range of cell 
growth and induction conditions. 
 
1.3 SELDI-MS 
 
Surface enhanced laser desorption/ionisation time of flight mass 
spectroscopy (SELDI-TOF-MS) is a new high throughput analytical method 
developed by Hutchens and Yip (Hutchens and Yip,1993). It promotes the 
revolutionary concept of derivatizing the mass spectrometric probe surface with 
functional groups to allow surface enhanced affinity capture (SEAC) of components 
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in a sample (Merchant and Weinberger,2000). These retained components are then 
analysed using mass spectrometry. This allows a simple all-in-one platform for 
reactions along with a highly sensitive identifiable detection (Caputo et al. 2003). 
 
1.3.1 Surface enhanced affinity capture 
 
The probe surface plays an active role in the extraction, presentation, 
structural modification, and/or amplification of components in the sample 
(Merchant and Weinberger,2000). Biomolecules bind to these surfaces due to 
hydrophobic, electrostatic, coordinate covalent bond or Lewis-acid/base 
interactions (Merchant and Weinberger,2000). Creation of specific biochemical 
surfaces is possible for SEAC, including antibodies, receptors, enzymes, DNA, small 
molecules, ligands and lectins (Merchant and Weinberger,2000). This allows 
compounds with shared physicochemical properties to be retained; thus, the 
various analytes are likely to have a more equal probability of becoming 
incorporated in the matrix crystal, which in turn reduces analyte signal suppression 
(Merchant and Weinberger,2000). Each ProteinChip has several of these active 
surfaces, all possessing the same functional group (Barzaghi et al. 2004;Weinberger 
et al. 2002a). ProteinChips can mimic chromatography media by altering their 
selectivity using different binding buffers for application and washing (Figure 1.11).  
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Figure 1.11 SELDI selective ProteinChip preparation.  
Four ProteinChip arrays, each with distinct affinity capture properties are aligned 
side by side. Each array has eight specific regions or “spots” with defined surface 
chemistry allowing eight different experimental conditions. Different proteins 
(shapes) are retained on different arrays due to the specific surface chemistries. 
Different adsorption conditions (e.g. pH and/or [NaCl]) influence selectivity on a 
given array (Merchant and Weinberger,2000). 
 
The SELDI ProteinChip arrays are produced by Bio-Rad Laboratories Inc. 
(Hercules, CA, U.S.A.) and consist of thin pieces of stainless steel with chemically 
active 1mm diameter spots (Figure 1.12). Cation-exchange (CM10, a carboxy methyl 
surface), anion-exchange (Q10, a quaternary amine surface), hydrophobic (H50) 
and immobilised metal affinity (IMAC10) are known as selective ProteinChips and 
the normal phase (NP20) as non-selective. The normal phase (NP20) arrays have a 
silicon oxide surface that hydrophilic and charged protein residues can bind to by 
direct pipetting of the sample to the surface (Favre-Kontula et al. 2008). The 
selective ProteinChips are prepared by exposing them to the sample in a 
bioprocessor (Figure 1.12). 
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Figure 1.12 Using the SELDI bioprocessor. 
Selective ProteinChips are inserted into a plastic cassette. A bottomless plastic 96 
well reservoir is then placed over the top that fits neatly over each spot on the 
ProteinChip. An aluminium frame clips the whole assembly into place. This complete 
unit is called a bioprocessor and it allows the isolation of each spot for the 
application of different binding buffers. 
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Washing steps on the ProteinChip allow the removal of unbound or weakly 
bound molecules and salts that can interfere with ProteinChip analysis. Once the 
ProteinChips have undergone washing they can be air-dried ready for the addition 
of the energy absorbing molecule (EAM). The EAM is added in excess to the 
ProteinChips and causes crystallization of proteins present allowing better protein 
ionisation during the laser desorption/ionisation (LDI) stage.  
Selection of the EAM depends on the sample under investigation but it is 
commonly sinapinic acid (SPA) dissolved in trifluoracetic (TFA) acid and acetonitrile 
(ACN). The application of EAM allows better protein ionisation, enhances signal 
sensitivity, reproducibility and quantification (Weinberger et al. 2002a).  
Work by Cordingley et al. looked at the effects of factors involved in EAM 
addition in a fractional factorial design of experiments approach on several 
developed metrics reflecting SELDI trace quality and reproducibility (Cordingley et 
al. 2003). This allowed them to investigate each factor and the interactions 
between factors in order to select the optimised level of each for the best possible 
traces. The factors chosen are shown in Table 1.6 
 
Table 1.6 Factors in SPA formulation and application (Cordingley et al. 2003). 
   
They found that the best conditions for SPA addition were increased time 
between last wash and SPA application, TFA/ACN mixture made just prior to 
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application, high precision pipetting, and two applications of a relatively low 
volume of SPA. The age of the SPA did not seem to have a significant effect. 
 
1.3.2 Laser desorption/ionisation 
 
LDI analysis has been around since the 1960s. Initially it was used to study 
small inorganic salts and organic molecules but was later extended to large 
biopolymers with the arrival of matrix assisted LDI (MALDI) (Merchant and 
Weinberger,2000;Tang et al. 2004;Weinberger et al. 2002b;Weinberger et al. 
2002a;Weinberger et al. 2002c). Unlike SELDI, the sample probe used with MALDI is 
passive, its sole purpose is to facilitate presentation of all of the molecules in the 
sample to the mass spectrometer (Merchant and Weinberger,2000).  
LDI occurs when the sample directly absorbs energy from the laser and 
heats up via direct or secondary thermal changes, thus producing desorbed gaseous 
ions (Merchant and Weinberger,2000).  Energy is typically provided for desorption 
as a pulsed UV laser (Merchant and Weinberger,2000). Commonly a nitrogen laser 
(lambda – 337nm) is used, due to a simple footprint and relatively low cost 
(Merchant and Weinberger,2000). An optical attenuator controls laser fluence, and 
an optical beam splitter is used to divert some of the laser beam to a high speed 
photodetector that is used to trigger time of flight (TOF) measurement (Merchant 
and Weinberger,2000). 
A ProteinChip spot is divided into pixels and these are grouped into 
partitions. Typically the spot is divided into four of these partitions allowing 
different acquisition settings to be used for each. This means, for the first partition 
the laser fires at every fourth pixel starting with the first and for the second 
partition the laser fires at every fourth pixel starting with the second and so on. The 
advantage of partitioning is that four different acquisition settings can be used to 
get four data sets representative of the whole spot surface. For instance, two 
partitions can be used with different laser strengths to get low and high m/z data 
leaving two partitions for other acquisition settings if deemed necessary.  
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1.3.3 Time of flight mass spectrometry 
 
The SELDI ProteinChip reader used in this thesis is shown in Figure 1.13 
along with schematics on its operation (Figure 1.14 & Figure 1.15). Once the laser 
has generated the gaseous ions they enter an acceleration stage (Figure 1.15). This 
acceleration stage consists of an ion acceleration region containing an ion optic 
assembly, and an ion-free flight region comprised of an ion drift tube (Merchant 
and Weinberger,2000). Two different ions with respective masses, m1 and m2 
(m2>m1) are created at the same time and location with the same charge, z 
(Merchant and Weinberger,2000). The repeller is raised to some potential V while 
the ground aperture is held at ground potential (Merchant and Weinberger,2000). 
If m1 and m2 are cations then the repeller plate is raised to a positive potential and 
a negative potential if they are anions (Merchant and Weinberger,2000). In this 
regard, only a single polarity of ions can be analysed at any one time (Merchant and 
Weinberger,2000). Due to the creation of this electric field, ions are accelerated to 
a constant final energy along distance s, through the opening in the ground 
aperture, and out into the drift tube region of the mass spectrometer (Merchant 
and Weinberger,2000). Ions continue to travel through free flight distance x prior to 
striking the system’s detector (Merchant and Weinberger,2000). 
 
 
Figure 1.13 The SELDI ProteinChip Reader 
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Figure 1.14 The SELDI mass spectrometer (Merchant and Weinberger,2000). 
 
Figure 1.15 Time of flight in a mass spectrometer (Merchant and 
Weinberger,2000). 
 
Signal processing is promoted by a high-speed analog-to-digital converter 
(A/D) typically linked to a personal computer running a system control and data 
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reduction software program (Merchant and Weinberger,2000). Detected analyte is 
displayed as a peak whose amplitude or area is proportional to abundance. Time of 
flight (TOF) is related to the ion analyte mass-to-charge ratio (m/z) (Merchant and 
Weinberger,2000). The individual mass spectral peaks generated correspond to the 
molecular weights of components retained on each spot; the effective molecular 
mass range of the instrument is 1-500kDa (Weinberger et al. 2002a). 
Calibration is achieved by correlating the flight time for a number of well-
characterized analytes with their established m/z values (Merchant and 
Weinberger,2000). A least-squares fit algorithm is applied to determine slope and 
intercept values for the linear relationship between m/z and the square of total 
flight time (Merchant and Weinberger,2000). A calibration expression similar to 
that of Equation 1.4 is subsequently used to determine the m/z for all unknown 
samples. 
 
bat
z
m
t  /
2
 
Equation 1.4 Time of flight mass spectrometer calibration. 
Where m is the mass of the ion; z is the ion charge; t is the time of flight; a and b are 
calibration constants. 
 
Two calibration strategies are typically employed: internal and external 
standard calibration (Merchant and Weinberger,2000). For internal calibration, the 
sample of interest is spiked with at least one calibrant and the sample of interest is 
simultaneously analysed with the added calibrants in a single experiment 
(Merchant and Weinberger,2000). The resultant spectrum from this measurement 
is calibrated using known m/z values for each calibrant, allowing a highly accurate 
m/z determination for the unknown (Merchant and Weinberger,2000). During 
external calibration, calibrants and unknowns are analyzed in independent 
experiments (Merchant and Weinberger,2000). The calibration function derived 
during the calibration experiment is applied to the unknown spectrum to provide 
an accurate determination of m/z (Merchant and Weinberger,2000). Due to finite 
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differences in ion acceleration potential, sample location, and free flight 
differences, internal calibration generally provides an error of less than 100ppm 
compared to an error of 500-1000ppm with the external calibration(Merchant and 
Weinberger,2000). 
 
1.3.4 Potential uses 
 
The majority of SELDI-MS publications are related to biomarker discovery 
but there is also literature on its use in fermentation/cell-culture optimization (Park 
et al. 2006); purification development (Merchant and Weinberger,2000); process 
monitoring (Kumar et al. 2008) and product analysis (Woolley and Al Rubeai,2009) 
including on-chip digestion (Caputo et al. 2003;Lodish et al. 1999). 
 
1.3.4.1 Fermentation/cell culture optimisation 
 
SELDI-MS has been used to measure the production of an anti-botulinum 
neurotoxin antibody fragment (bt-Fab) during its fermentation (Park et al. 2006). 
Linked with a statistical experimental design IMAC (Ni2+) ProteinChips could be used 
to find fermentation conditions that could improve bt-Fab production. An immuno-
affinity assay corroborated these conclusions. SELDI-MS has also been used to 
select the best strategy for the optimal expression of a recombinant S-LAT mouse 
protein and were able to discriminate between a 23.9 and a 24.1 kDa -N and -C 
terminal construct of the protein (Brenac et al. 2006). 
 
1.3.4.2 Process monitoring and product analysis 
 
SELDI-MS can be used for analysis of proteins in process liquid streams 
(Weinberger et al. 2002a). Normal phase ProteinChips have silicate surfaces that 
retain proteins through hydrogen bonding and/or Van der Waals forces 
(Weinberger et al. 2002a). During a process, SELDI-MS gives a highly sensitive 
analysis of process components and can also reveal important information about 
protein integrity (e.g. proteolytic degradation, glycosylation) that can be exploited 
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for the purpose of process optimisation, lot acceptance criteria, or product 
specifications (Weinberger et al. 2002a). 
One group has investigated using SELDI-MS in parallel with SDS-PAGE to 
analyze fractions in order to optimize chromatography runs (Brenac, V et al. 2008). 
In this work it was possible to track both the target protein and host cell proteins 
(Brenac, V et al. 2008;Weinberger et al. 2002a). Other groups have also used SELDI-
MS to evaluate purification steps (Fortis et al. 2006;Guerrier et al. 2005;Guerrier et 
al. 2007;Wierling et al. 2007). 
 
1.3.4.3 Purification development 
 
Adsorption to SELDI surfaces may reveal the biochemical property of the 
analyte, including chemical properties such as hydrophobicity, total charge, pI, 
phosphorylation, glycosylation, and primary composition (Merchant and 
Weinberger,2000). In situ clean-up diminishes sample loss by eliminating non-
specific binding and dilutions inherent with traditional column chromatography 
(Merchant and Weinberger,2000). SELDI-MS also eliminates fractional analysis 
present with conventional chromatography due to proteins on the ProteinChips 
being selected and analysed directly (Weinberger et al. 2002a). 
Chromatography mode decisions can be made and scaled up to 
commercially available sorbents with similar chemical properties as the 
ProteinChips (Weinberger et al. 2002a). A study by Weinberger et al, used SELDI 
ProteinChips to predict the chromatography step for endostatin purification from 
Pichia pastoris (Weinberger et al. 2002a). They predicted that cation exchange 
chromatography at pH 5 promoted optimal binding of endostatin and full 
desorption occurred at greater or equal to 300mM of NaCl. Scale up of these 
conditions to a lab-scale column with CM HyperZ sorbent showed that endostatin 
purity was increased from less than 10% in the initial feedstock to greater than 90% 
after the column (Weinberger et al. 2002a). They also found polishing conditions 
with an IMAC (Cu2+) array that could reduce the small molecular weight 
components that were still present after cation exchange (Weinberger et al. 2002a). 
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1.3.5 Advantages 
 
Historically, protein analysis has been carried out with 2D-PAGE. However 
2D-PAGE lacks reproducibility, fails to resolve most proteins outside 5-100kDa and 
the molecular weight measurement is typically only accurate to -/+5%. Many 
protein spots need further analysis with MS and the technique has difficulty in 
separating membrane proteins. 
The advantage of using SELDI over other mass spectrometry techniques 
such as MALDI is selectivity. This allows easy wash removal of salts, detergent, 
buffer, and  organics so interference common with MALDI is reduced with minimal 
lose of sample (Caputo et al. 2003). This also means that samples incompatible with 
MALDI can still be used with SELDI with very little sample modification (Caputo et 
al. 2003;Favre-Kontula et al. 2008;Weinberger et al. 2002a).  
The energy absorbing molecule (EAM) is applied to the proteins already 
homogenously presented on the ProteinChips surface (Weinberger et al. 2002a). 
MALDI however mixes the EAM with the sample before sample application to an 
inert surface, this inherently causes non-homogeneity of the sample (Weinberger et 
al. 2002a). This results in less efficient desorption and consequently makes 
reproducible detection, identification and quantification of the proteins in complex 
mixtures difficult (Weinberger et al. 2002a). SELDI-MS is sensitive enough for 
detection and quantification of proteins in the range of 1-50 femtomoles per 
protein with remarkably fine molecular weight based resolution (Weinberger et al. 
2002a). 
SELDI-MS data acquisition and analysis can be as little as 30 minutes, 
providing an analytical technique that can match high throughput sorbent screening 
reducing the time for chromatography sorbent evaluation (Brenac, V et al. 2008). 
Weinberger et al., took less than 5 days and 10mL of sample to screen 200 sorbents 
some of which showed target protein or impurity capture (Weinberger et al. 
2002a). 
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1.3.6 Limitations 
 
Ion suppression, sample matrix, coeluting compounds, and cross-talk can all 
affect the quantitative performance of a mass detector (Annesley,2003). Ion 
suppression is caused by non-volatile material such as salts, ion-pairing agents, 
endogenous compounds and drugs/metabolites. These materials change the 
efficiency of droplet formation and/or surface ionization. Consequently, this affects 
the amount of charged ions in the gas phase that ultimately reach the detector. 
Only relative quantification with SELDI-MS can be achieved unless the 
ProteinChip is spiked with known concentrations of the protein under investigation. 
 
1.4 Host organism 
 
The recombinant host used in this thesis was Escherichia coli (E.coli). E.coli is 
gram negative, motile and rod-shaped belonging to the Enterobacteriaceae family. 
The bacterium is a well established host within the pharmaceutical industry and has 
become one of the most comprehensively studied free-living, single celled 
organisms. E.coli is used as the host for many bioprocesses due to it being less 
complex and easier to grow and maintain in minimal media compared to other cells 
such as those derived from mammals.   
An E.coli population can double in less than an hour allowing rapid 
population growth. As a bacterium, E.coli has an additional segment of DNA known 
as plasmid DNA that complements the main segment of DNA and is found in the 
cytoplasm. A desired gene can be inserted into the plasmid to enable E.coli to 
produce recombinant proteins.  
 
1.5 Process materials 
 
A variety of different protein solutions were used in this thesis including 
single protein solutions, hen egg white, a fab lysate and ApoA-IM process samples. 
The latter two materials were produced in E.coli. 
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1.5.1 Hen egg white 
 
Lysozyme is important in the pharmaceutical and food industry due to its 
effective anti-microbial properties (Vachier et al. 1995). Ovotransferrin is an iron 
transport glycoprotein which exhibits anti-microbial activity (Vachier et al. 1995). 
Ovalbumin is a glycoprotein that is the main cause of egg white gelling and has 
nutritional value as a protein supplement (Vachier et al. 1995). The abundance of 
the four main proteins in HEW, along with their pI and MW are shown in Table 1.7. 
  
Table 1.7 The four main proteins in hen egg white (Vachier et al. 1995). 
 
Laboratory techniques to purify these proteins include precipitation by salts 
or solvents, ionic strength reduction or chromatography (Vachier et al. 1995). 
Chromatography particularly with ion-exchange has been the most promising due 
to other techniques results in protein denaturation and low purities (Vachier et al. 
1995). 
 
1.5.2 Antibody fragment process material 
 
An antibody fragment (fab’) was produced in a high cell density batch/fed-
batch industrial fermentation of a recombinant E.coli strain W3110. The E.coli was 
harvested from the fermentation broth by centrifugation before undergoing an 
alkali heat lysis step to extract the fab’ from the periplasm. The cells were then 
removed by centrifugation and the remaining periplasmic extract purified using ion- 
exchange chromatography (Figure 1.16). 
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Figure 1.16 Fab’ production process.  
 
1.5.3 ApolipoproteinA-IM dimer process material 
 
ApolipoproteinA-IM (ApoA-IM) is a naturally occurring variant of ApoA-I that 
appears to confer protection against cardiovascular disease to those that carry the 
mutated gene (Suurkuusk and Hallen,1999). Apolipoprotein A-I (ApoA-I) is a 28 kDa 
protein present in human plasma in low concentration. The native form of the 
protein is a 56 kDa covalent dimer. ApoA-I is the major protein component of high 
density lipoprotein, which serves to maintain cholesterol homoeostasis and 
eliminate excess cholesterol. The mutation results in an arginine residue at position 
173 being substituted with cysteine (Vitello and Scanu,1976).  Figure 1.17 & Figure 
1.18 show the amino acid sequence of ApoA-IM and the structure of ApoA-I 
respectively. The cysteine substitution in the mutated form (ApoA-IM) allows a 
disulphide bond to be formed between two monomers to create an ApoA-IM 
dimer. This can be prevented during certain stages of production using a reducing 
agent such as DTT. A “simplified” process diagram for ApoA-IM dimer generation is 
shown in Figure 1.19. 
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Figure 1.17 ApoA-IM amino acid sequence.  
ApoA-IM is the naturally occurring variant of ApoA-I comprising of 243 amino acids 
with a cysteine substitution for arginine at position 173. The monomer & dimer have 
respective molecular weights of 28 & 56 kDas. The pI of ApoA-IM is between 5.1 and 
5.3. 
 
Figure 1.18 The structure of truncated human apolipoproteinA-I (ApoA-I) (Borhani 
et al. 1997) 
ApoA-IM is a major protein component of high density lipoprotein (HDL). The 
molecule consists of a pseudo-continuous alpha-helix with kinks at regularly spaced 
proline residues. It forms a horseshoe shape with dimensions (125 x 80 x 40 Å). Four 
molecules in an asymmetric unit associate via their hydrophobic faces to form an 
anti-parallel four helix bundle with an elliptical ring shape.  
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Figure 1.19 ApoA-IM dimer production process.  
After the E.coli cells are ready for harvesting they are heat lysed to release ApoA-IM 
into solution. Reducing conditions are then introduced to keep ApoA-IM in its 
monomer form. The remaining cellular debris is flocculated ready to be removed by 
centrifugation. Diluting the material at this stage improves the yield of ApoA-IM 
during centrifugation. After centrifugation the ApoA-IM containing supernatant 
passes through a series of chromatography columns to reduce impurity levels and 
any non-reducible forms of ApoA-IM. The ordering of the columns is a common 
example of IEX being followed with a HIC column due to the IEX elution and HIC 
loading occurring with salt. After three columns ApoA-IM is oxidised to its dimer 
form and non-oxidisable ApoA-IM levels lowered with the Q column before final 
fill/finish steps. 
 
1.6 Project objectives 
 
In the demanding world of biopharmaceutical manufacture it is highly 
advantageous for a company to be able to rapidly develop well performing and cost 
effective processes with minimal resource requirements. This thesis investigates 
the use of ultra-scale down (USD) technologies for this purpose. 
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1.6.1 Objective 1: Develop the use of a mass spectrometry technology for 
bioprocess materials 
 
In order to gain a greater insight into processes during and after their 
development improved analytical techniques are required. Protein mass 
spectrometry can now be carried out in a rapid and cost-effective manner and has 
varied application. Chapter two will apply a protein mass spectrometry technique 
to the bioprocess materials used in this thesis and investigate ways to improve their 
quality. 
 
1.6.2 Objective 2: Application of the approach to an industrial process in 
conjunction with a USD device 
 
To validate the use of the mass spectrometric technique for this project it 
will be used alongside traditional assays to analyse process streams in an existing 
process. Chapter three attempts to validate the mass spectrometry approach by 
applying it as an analytical technique for process monitoring of ApoA-IM dimer 
process development. Comparisons between the different approaches can then be 
drawn. The mass spectrometric technique will then be used to monitor the 
flocculation/centrifugation stage of the ApoA-IM process.  
In chapter four another ultra-scale down technique for improving the 
flocculation/centrifugation in terms of cellular debris removal will also be applied. 
 
1.6.3 Objective 3: Develop novel approaches for acquisition and analysis of 
mass spectra to expedite bioprocess development and monitoring 
 
Further expansion on the mass spectrometry approach is necessary to gain 
further insights into proteins that exist in process streams. The aim is to develop a 
platform that can expedite data treatment while adding increased flexibility on data 
handling to improve bioprocess development.  
Chapter five investigates the mass spectrometry protocols that will be used 
to characterise the relationship between product and contaminant proteins present 
in the ApoA-IM material after flocculation/centrifugation. 
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Chapter six describes the generation of the platform to handle the large 
volume of mass spectrometry data that was produced in chapter five. The Matlab 
code used is included as an appendix to this thesis. 
Chapter seven introduces a novel method for using the mass spectrometry 
data produced in chapter five to elucidate some of the physicochemical properties 
of the proteins present in process materials and how the information can be used 
for process development. 
 
The overall conclusions and future work for this research are summarized in 
chapter eight.  
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CHAPTER 2 CONFIGURATION OF A PROTEIN MASS SPECTROMETER 
FOR BIOPROCESS MATERIALS 
 
2.1 Introduction 
 
This engineering doctorate (EngD) was focussed at using surface enhanced 
laser desorption ionisation - time of flight - mass spectrometry (SELDI-TOF-MS) as a 
process monitoring tool and to aid purification decisions. Before this could be done, 
it was necessary to address the many issues inherent with this chosen experimental 
approach. 
This chapter seeks to investigate how spectra resolution is affected by 
sample type, sample concentration, and laser strength. This is to give the SELDI-MS 
user the necessary awareness and knowledge to control these input variables in 
order to produce high resolution mass spectra peaks. This chapter will also evaluate 
the use of the mass spectrometry approach for later work in this EngD project as 
well as highlight some of the issues that will need to be addressed in later chapters. 
 
Summary of chapter aims: 
 
 Provide information about SELDI-MS spectra characteristics that can be used in 
future chapters. 
 Provide guidelines for using the mass spectrometry technique for future 
chapters.  
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2.2 Materials & Methods 
 
All chemicals, unless specified otherwise, were obtained from Sigma 
Chemical Co. Ltd. (St. Louis, MO, U.S.A.) and were of analytical grade.  
 
2.2.1 Protein samples 
 
Various protein samples were used in this EngD project. Single purified 
proteins were selected to get mass accuracy for the mass spectrometer and for 
initial case studies. Hen egg white (HEW) was chosen as a relatively simple mixture 
of a few abundant proteins making it ideal for deciding upon initial data treatment 
routines. A clarified E.coli heat lysate containing fab’ produced at UCL and samples 
from a E.coli ApoA-IM dimer process used at Pfizer provided the industrially realistic 
feed materials to further develop the data treatment routines.  
 
2.2.1.1 Single purified proteins 
 
Purified cytochrome c horse, lysozyme, soy bean trypsin inhibitor, bovine 
serum albumin, and ovalbumin were used in this thesis. They were each dissolved 
in 10mM PBS, pH 7.4. 
 
2.2.1.2 Hen egg white 
 
HEW consists mainly of four proteins (Table 1.7) (Vachier et al. 1995). HEW 
was diluted with 2 volumes of 50mM Tris at pH 8 and stirred for 1 hour at 4oC. Any 
precipitate was removed by centrifugation at 27,000g for 15 minutes. The 
remaining supernatant aliquots were frozen at -20oC ready for use. 
 
2.2.1.3 Fab’ lysate  
 
The humanised fab’ lysate was produced by batch fermentation of E.coli 
W3310 transformed with the plasmid pAGP-4 (Bowering et al. 2002). The strain and 
plasmid were kindly provided by Celltech R&D Ltd., Slough, U.K.. For periplasmic 
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extraction, fermentation cell broth was centrifuged in a CARR Powerfuge and cell 
paste heat lysed to release periplasmic proteins into supernatant (Figure 1.16). Cells 
were removed using a Beckman centrifuge at 166.7rps for 1h 40 min at 4oC. 
 
2.2.1.4 ApoA-IM dimer process samples 
 
Samples were collected during different stages of Pfizer’s (Chesterfield, MO, 
U.S.A.) ApoA-IM dimer process (Figure 3.1). After collection, the samples were 
immediately frozen at -20oC. When required for use, the samples were defrosted at 
room temperature and used immediately. All work was carried out at Pfizer 
(Chesterfield, MO, U.S.A.). 
 
2.2.2 Mass spectrometry 
 
All reagents and equipment specific to SELDI-MS except acetonitrile (ACN) 
and trifluoroacetic (TFA) acid were supplied by Bio-Rad Laboratories Inc. (Hercules, 
CA, U.S.A.). 
 
2.2.2.1 Energy absorbing molecule preparation 
 
The energy absorbing molecule (EAM) used was sinapinic acid (SPA). It was 
prepared by reconstitution with 200µl of 1% TFA in ultrapure water and 200µl of 
pure acetonitrile into a pre-supplied SPA vial. The vial was vortexed until dissolved 
for 10 mins and centrifuged at 220rps for 5 mins to pellet any undissolved SPA. 
 
2.2.2.2 Non-Selective ProteinChip preparation 
 
All samples were diluted ten-fold with 10mM PBS, pH 7.4 before deposition 
of 5L onto the NP20 (normal phase) ProteinChip surface. After air drying for 20 
minutes the spots were washed three times with 5L of deionised water to 
eliminate non-adsorbed proteins. After 20 minutes from the last wash being 
removed, the spots were dry and 1L of the SPA was applied. After 5 minutes the 
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EAM application was repeated before a final 5 minute dry step prior to ProteinChip 
analysis. 
 
2.2.2.3 Selective ProteinChip preparation 
 
The selective ProteinChips used in this chapter (CM10 & Q10) were 
prepared following identical protocols. Spots were equilibrated three times with 
150L of equilibration buffer for 5 minutes under shaking (8.3rps). The spots were 
then loaded with 150L of the sample previously diluted in equilibration buffer. The 
sample was incubated with the spot surface for 30 minutes while being shaken 
(8.3rps). Each spot was then washed three times with 150L of the equilibration 
buffer for 5 minutes under shaking (8.3rps) to eliminate non-adsorbed proteins. 
This was followed by a quick rinse of water to remove any salts and then the spots 
were left to dry at room temperature. 
After 20 minutes the spots were dry and 1L of the EAM is applied. After 5 
minutes the EAM application was repeated before a final 5 minute dry step prior to 
ProteinChip analysis. 
 
2.2.2.4 Data acquisition 
 
All arrays were analyzed using a PCS4000 Reader (Figure 1.13) in a positive 
ion mode, with a source voltage of 25kV. The m/z range investigated was 
dependent on the sample. Focus mass was set to the m/z of the ApoA-IM monomer 
(28.1kDa/e). Each spot was divided into four partitions allowing the possibility of 
four different acquisition protocols to be carried out for each spot. Laser strength 
responsible for the desorption-ionization of proteins on the spot surface was 
adjusted based on the mass spectra intensity observed for each sample. Adsorption 
of sample proteins on arrays appeared as a signal at the appropriate molecular 
masses. 
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2.2.2.5 Data treatment  
 
SELDI-MS data in this chapter was treated with Ciphergen Express 3.0 
software using settings in Table 2.1. 
 
Analysis 
setting tab 
Options Description Value set 
Baseline 
 
Calculates 
electrical and 
chemical 
(EAM) noise. 
Smooth before 
fitting baseline 
Can improve baseline accuracy by fitting data 
to moving average before baseline calculation 
On 
 
Window  Specifies width of the moving average filter 
used to smooth baseline 
25 points 
Width Selecting automatic assigns the automatic 
fitting width 
Auto 
Filtering 
 
 
Filtering 
parameters 
Removes high frequency noise to improve 
signal to noise ratio.  
On 
Average 
Width Excessive filter widths can distort peaks and 
reduce resolution 
0.2 times 
expected 
width 
Noise 
 
Calculates 
noise as 
variation in 
signal, not 
signal itself. 
Start measuring 
noise from: 
Sets lower mass limit for noise calculation. 
Typically matrix m/z excluded. 
Minimum 
m/z 
Measure noise 
to: 
Sets upper mass limit for noise calculation. 
End at end is maximum mass in spectrum. 
End at end 
Spot 
Correction 
On/Off Corrects for slight systematic shifts in TOF 
data when spectra are collected from 
different spots on same array. 
Off 
Table 2.1 Settings used when processing data with Ciphergen Express 3.0 
 
2.3 Results 
 
2.3.1 Sample analysis with mass spectrometry 
 
Throughout this EngD different samples have been analyzed using SELDI-MS. 
One of the goals of this project was to create a framework that could be used for a 
variety of different samples including those realistic to bioprocess streams. It was 
therefore important to evaluate how the SELDI mass spectra would look for these 
different materials (Figure 2.1). From previous knowledge of our samples, small and 
large m/z regions were defined respectively as any peak less than or equal to 
22.5kDa/e and any peak greater than 22.5kDa/e. The laser strength used was 
Protein mass spectrometry for bioprocess development & monitoring 
 
61 
 
higher for the large m/z region because these proteins required more energy to 
ionise.  
The mass spectra of the samples presented in Figure 2.1 are clearly very 
different. They are shown in ascending order of expected complexity. Hen egg 
white (HEW) the least complex, exhibiting relatively few peaks compared to the fab’ 
and ApoA-IM samples.  
One of the novelties of using SELDI-MS was the ability to identify an array of 
proteins in the mixtures tested as opposed to total protein and specific protein 
assays for the product, which are the common analytical techniques used for 
microwell and chromatography experiments.  
 
Figure 2.1 Representative mass spectra for adsorbed protein samples. 
The samples investigated were hen egg white (HEW), and two clarified E.coli heat 
lysates; one containing an antibody fragment (fab’) produced at UCL and the other 
containing ApoA-IM produced at Pfizer. The ProteinChips used in this study were 
normal phase (NP20) arrays which have a silicon oxide surface to bind hydrophilic 
and charged protein residues (Favre-Kontula et al. 2008). 
 
Lysozyme, ovomucoid, ovalbumin, & conalbumin are four of the most 
abundant proteins in HEW and they have respective molecular weights (MW) of 
14.3, 28, 44.5 and 77.7kDa (Vachier et al. 1995). In Figure 2.1, peaks corresponding 
to these MWs can be seen in the HEW mass spectra, although ovalbumin was 
14.3kDa/e 
44.5kDa/e 
77.7kDa/e 
47.5kDa/e 
28.15kDa/e 
56.3kDa/e 
28kDa/e 
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observed as a relatively small peak. These MWs were confirmed by using purified 
forms of the three proteins. The broadness of the peaks is due to the highly 
glycosylated nature of hen proteins compared to the unglycosylated proteins in 
E.coli (Mine,1995). 
Figure 2.1 highlights the issues faced with using SELDI-MS to quantify 
proteins. It is noticeable in the HEW spectra that lysozyme (14.3kDa/e) was the 
largest peak, followed by conalbumin (77.7kDa/e) and lastly a very small peak for 
ovalbumin (44.5kDa/e). This is the opposite expected based on the naturally 
occurring v/v quantities of these proteins in HEW. Typically lysozyme, ovalbumin, & 
conalbumin constitute 3, 13 & 54% (v/v) of HEW respectively (Vachier et al. 1995).  
Fab’ has a MW of 47.5kDa and ApoA-IM exists as a monomer at 28.15kDa 
and a dimer at 56.3kDa, these can also be seen in their respective spectra (Figure 
2.1). Some of the other peaks in these three spectra maybe multi-charged versions 
of the proteins present. Ciphergen Express 3.0 software (BioRad, Hercules, U.S.A.) 
has a peak wizard tool that may reduce these mistakes but since only a few samples 
will be used in this thesis it should be possible to manually select only true peaks. 
 
2.3.2 Width of mass spectra peaks 
 
As mentioned in the previous section, the peaks in the HEW spectra are 
significantly broader than in other samples and that is due to them being heavily 
glycosylated. It is harder to observe with this sample but as the other two samples 
show there is a drop in resolution at higher masses due to a proportional increase 
in peak width (Figure 2.1) (Dijkstra et al. 2006). This indicates that peak area rather 
than peak height maybe more accurate at measuring the amount of protein 
adsorbed. 
At the time of this study it was reported by Ciphergen and the literature that 
peak accuracy was typically +/-0.3% of m/z (Brozkova et al. 2008;Panicker et al. 
2009). This suggests that peak width typically increased by 0.6% of m/z. This value 
could be very useful for calculating peak area. ApoA-IM post centrifuge supernatant 
was chosen to validate this number due to the large number of detectable peaks.  
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Figure 2.2 shows the effect of m/z on peak width at half peak height using 
the ApoA-IM post centrifuge supernatant proteins (Figure 3.1) bound to a CM10 
ProteinChip using 20mM sodium citrate, pH 3, 0M NaCl. This condition was chosen 
because it showed high levels of adsorption. Figure 2.2 shows a linear relationship 
from 10-30kDa/e. From this relationship we were able to derive Equation 2.1. 
 
 
Figure 2.2 Relationship between m/z and peak width.  
ApoA-IM post centrifuge supernatant was incubated on the CM10 ProteinChip with 
20mM sodium citrate, pH 3, 0M NaCl. The total protein concentration incubated 
with the surface was 0.05mg/mL. Peaks were detected using the Ciphergen peak 
detection wizard at a setting of 3 times S/N ratio. Peak widths were recorded as 
peak width at half peak height. A laser strength of 1750nJ was used. 
 
 
𝑤ℎ  ≈ 0.006𝑚/𝑧 
Equation 2.1 Width of mass spectra peaks. 
Where wh is peak width at half peak height; m is mass; and z is charge 
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2.3.3 Alignment of mass spectra peaks 
 
The Ciphergen Express software comes with a number of tools to align 
corresponding peaks that can have percentage deviations of up to 0.3% due to 
different ProteinChip readers, aging of the readers or slight variations during 
acquisition (Jeffries,2005). Due to the need to selectively bind different proteins 
under different conditions it would be impractical to use these tools due to there 
being no single protein existing in all spectra to align others. It was therefore 
necessary to measure what effect alignment has on reproducibility. To do this, 
peaks where automatically selected from ApoA-IM post centrifuge supernatant 
proteins adsorbed to a Q10 ProteinChip at pH 8.0, 0M NaCl using the Ciphergen 
peak detection wizard. This adsorption condition was chosen because it bound a 
large number of proteins over a wide range of m/z values. Peaks were determined 
as those with a signal to noise (s/n) greater than 3. The coefficient of variation 
(%CV) was then calculated for the peaks across 3 out of 4 partitions on a spot 
before and after manual alignment. 
Figure 2.3 shows that there was a slight difference before and after 
alignment which was magnified at the low masses. From this result it was believed 
that calculating an area under the peak rather than peak intensity may improve 
reproducibility between aligned and unaligned peaks. The benefit of using peak 
area to improve reproducibility will be shown later in Figure 6.9 & Figure 6.10. 
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Figure 2.3 The effect of peak alignment on partition reproducibility. 
 (○) before manual peak alignment of automatically selected peaks, (●) after 
manual peak alignment of automatically selected peaks. The ApoA-IM post 
centrifuge supernatant proteins were adsorbed onto a Q10 ProteinChip with 50mM 
Tris, pH 8, 0M NaCl. Peaks were found using the Ciphergen peak detection wizard at 
a setting of 3 times S/N ratio. A laser strength of 1750nJ was used on 3 out of 4 
partitions. 
 
2.3.4 The effect of protein concentration and laser strength on mass spectra 
peak resolution and intensity 
 
From an experimental standpoint it was now of interest to find the 
sensitivity limits of the mass spectrometer and investigate what effect protein 
concentration and laser strength had on resolution. 
 
 
ApoA-IM monomer (28.1kDa/e) 
ApoA-IM dimer (56.3kDa/e) 
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2.3.4.1 Protein concentration 
 
As shown previously with the HEW sample in Figure 2.1 it would be 
impossible to achieve absolute quantification using SELDI-MS without spiking 
samples with known standards. This would not be feasible in this thesis due to the 
complex nature of binding that will be experienced under the varying conditions 
used and the limited prior knowledge of which proteins are present in the samples 
examined. Even if it were possible to do this, it would no longer make this method 
high throughput which is one of the main advantages of using SELDI-MS over other 
techniques. 
It was decided that to understand further the effect protein size has on peak 
intensity a predefined sample was required. The sample chosen for this was a 
mixture of five proteins; cytochrome c horse, lysozyme, soy bean trypsin inhibitor, 
bovine serum albumin, & conalbumin. This mixture was made by creating 1 mg/mL 
solutions of each protein in 10mM PBS, pH 7.4 and then combining all five in equal 
volume. This produced a clearly defined stock solution of proteins that covered a 
wide range of MWs from cytochrome c horse (12.43kDa) to conalbumin (77.7kDa). 
The stock solution was diluted to give eight different concentrations and these 
were then analyzed by spotting directly onto an NP20 ProteinChip. It was now 
possible to quantify the effect MW had on peak intensity. 
Figure 2.4 shows that even when proteins are in equal proportions peak 
intensity is higher at lower masses. At higher masses intensity drops significantly. 
The biggest shift is observed between the two smallest proteins; cytochrome c 
(12.4kDa/e) and lysozyme (14.3kDa/e) and the remaining proteins. This suggests 
that different acquisition settings are required for smaller proteins. 
The reason that smaller proteins have higher peak intensities is thought to 
be due to the relative ease at which smaller proteins ionize to form smaller ion 
clouds increasing their chance of hitting the ion detector (Dijkstra et al. 2007). This 
combined with a noticeable drop in resolution again supports the use of peak area 
rather than peak height for quantifying proteins. This observation will be used later 
in chapter six. 
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It can also be seen from Figure 2.4 that all the proteins have sigmoidal 
profiles with an approximate linear region between 5–100fM. This supports 
BioRads and others observations that the mass spectrometer is sensitive to 
femtomole (fM) quantities (Brenac, V et al. 2008;Weinberger et al. 2002a). All of 
these proteins are detectable above 1fM but to get strong signals the operator 
should use concentrations greater than 10fM.    
 
 
Figure 2.4 The effect of protein concentration on peak intensity. 
A mixture of five proteins was used: (●) cytochrome c horse (cyt), 12.4kDa; (○) 
lysozyme (lys), 14.3kDa; (▼) soy bean trypsin inhibitor (sbti), 19.7kDa; (□) bovine 
serum albumin (bsa), 66.8kDa; (■) conalbumin (con), 77.7kDa. There is an 
Protein mass spectrometry for bioprocess development & monitoring 
 
68 
 
approximate linear range between 1-102 fM for all five proteins. Analysis was 
carried out directly on an NP20 ProteinChip with a laser strength of 2000nJ. 
 
2.3.4.2 Laser strength 
 
It was clear during analysis that the strength of the nitrogen laser used to 
ionize the proteins from the ProteinChip surface had a clear impact on peak 
intensity and resolution. Therefore the same five protein mixture was bound to one 
spot on an NP20 ProteinChip and the four partitions each analyzed with different 
laser strengths.  
Figure 2.5 shows a hyperbolic relationship between laser strength and peak 
intensity. It would now be necessary to see what combinations of protein 
concentration and laser strength would give high peak resolutions. 
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Figure 2.5 The effect of laser strength on peak intensity. 
A mixture of five standard proteins was used: (●) cytochrome c horse (cyt), 12.4kDa; 
(○) lysozyme (lys), 14.3kDa; (▼) soy bean trypsin inhibitor (sbti), 19.7kDa; (□) 
bovine serum albumin (bsa), 66.8kDa; (■) conalbumin (con), 77.7kDa. The stock 
solution was diluted to 0.01mg/mL in 10mM PBS, pH 7.4 prior to NP20 ProteinChip 
application. 
 
2.3.4.3 Optimising protein concentration and laser strength 
 
Some proteins of interest in this thesis are fairly large (ApoA-IM dimer, 
56.3kDa/e). These large proteins have been shown previously to have lower peak 
resolution (Figure 2.2). Effort was therefore made to reduce the impact that protein 
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concentration and laser strength would have on peak resolution particularly with 
these large proteins (Figure 2.6). 
 
 
Figure 2.6 The effect of protein concentration and laser strength on resolution. 
(A) cytochrome C horse and (B) conalbumin were adsorbed to an NP20 ProteinChip. 
Peak resolution values were taken manually from Ciphergen Express for each 
condition. Lighter areas indicate improved resolution. 
 
For a small protein such as cytochrome c horse (12.4kDa/e) increasing 
concentration clearly improved peak resolution although laser strength had less of 
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an effect. For a large protein such as conalbumin (77.7kDa/e) less protein was 
required and more laser strength needed to get good peak resolution. 
Figure 2.6 shows that for optimal resolution greater than 100fM should be 
loaded for small proteins and approximately 10fM should be loaded for large 
proteins. BioRad recommends loading between 0.1 and 0.3mg/mL of total protein 
to gain good reproducibility. The concentration of ApoA-IM monomer in the post 
centrifuge supernatant (Figure 3.1, sample E) was 1.6mg/mL. This meant a trade-off 
in future NP20 ProteinChip experiments as ApoA-IM post centrifuge supernatant 
would need to be diluted ten-fold to 0.16mg/mL (5.7fM of ApoA-IM monomer) in 
order to get reasonable resolution while diluting enough to allow adequate buffer 
exchange without the need for de-salting or dialysis. Based on Figure 2.6 a decision 
was also made to use a low laser strength (<6000nJ) for small proteins (≤22.5kDa/e) 
and a high laser strength (>6000nJ) for large proteins (>22.5kDa/e) although this 
may change depending on the sample used. 
 
2.4 Summary 
 
This chapter has looked at the artefacts common with mass spectrometry 
particularly those associated with SELDI-MS. This should give the reader some 
guidelines on which conditions to use to get quality data along with examples of the 
data that is achievable using this approach.  
 
Review of chapter aims: 
 
 Provide information about SELDI-MS spectra characteristics that can be used in 
future chapters. 
 Investigated differences between the samples used in this thesis. 
 Peak width typically increases by 0.6% of m/z value. 
 Peak alignment shows some improvement in reproducibility but doesn’t 
seem to be critical to this work. 
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 Provide guidelines for acquiring mass spectrometry data for future chapters.  
 ApoA-IM post centrifuge supernatant sample should be diluted ten-fold to 
0.16mg/mL ApoA-IM monomer before application to an NP20 ProteinChip. 
 If sample concentration is unknown then a range of concentrations should 
be applied to the ProteinChip. The concentration chosen should be high 
enough to give a strong signal e.g. greater than 100amps for masses 
around 5kDa/e at a laser strength of 1500nJ but low enough that it does not 
saturate the detector. Peaks that saturate the detector are marked by red 
ticks on Ciphergen Express 3.0. 
 Small and large proteins are defined respectively as any peak less than or 
equal to 22.5kDa/e and any peak greater than 22.5kDa/e. 
 A low laser strength (<6000nJ) should be used for small proteins and a high 
laser strength (>6000nJ) for large proteins although this may change 
depending on the sample used.  
 
 We are now able to proceed to the next chapter which aims to validate this 
technique by using it as a process monitoring tool. 
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CHAPTER 3 PROTEIN MASS SPECTROMETRY FOR MONITORING THE 
APOLIPOPROTEINA-IM PROCESS 
 
3.1 Introduction 
 
Currently a great deal of attention is being focused on quality by design 
(QbD) and process analytical technologies (PAT) in order to guide and accelerate 
robust bioprocess development for biologics such as therapeutic proteins (Garcia et 
al. 2008). Both are driven by a requirement to readily determine critical product 
attributes; such methods must not require large sample volumes and complicated 
sample preparation.  This is especially important in early phase development when 
little is known about the target protein and process impurities, and well-developed 
quantitative analytical methods such as various forms of high pressure liquid 
chromatography (HPLC) and immunoassays are still to be established. 
Information such as relative quantity & size (molecular weight) of the 
biological compounds in solution would be useful to gauge the effect of a process 
step with respect to yield and purity. Gel electrophoresis techniques have this 
capability but with limited mass range (5-100 kDa), require optimisation and have 
relatively low resolution and sensitivity (Caputo et al. 2003;Jenkins and 
Pennington,2001). Surface enhanced laser/desorption ionization time of flight mass 
spectroscopy (SELDI-MS) could be an alternative method to address these issues 
(Woolley and Al Rubeai,2009). 
The ProteinChips used in this study are normal phase (NP20) arrays which 
have a silicon oxide surface for the binding of hydrophilic and charged protein 
residues (Favre-Kontula et al. 2008).  Analytical results from more traditional assays 
such as various forms of HPLC were used as appropriate to compare with the SELDI-
MS results. 
A “simplified” process diagram for ApoA-IM dimer generation is shown in 
Figure 3.1 along with locations within the process where samples were taken for 
analysis. The product exists as a monomer under reducing conditions (samples E – 
J) and a dimer under oxidising conditions (samples K – N). 
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Figure 3.1 ApoA-IM dimer production process samples. 
Solid and dashed arrows indicate bioprocess streams and sampling points 
respectively. Sampling points are denoted by letters for easier reference to 
analytical data. 
 
Summary of chapter aims: 
 
 Validate that the mass spectrometry technique is comparable to conventional 
analytical techniques such as HPLC and ELISA by using SELDI-MS to monitor in-
process samples during the production of ApoA-IM Dimer Intermediate (ADI). 
 Examine the protein profiles during the flocculation process in the hope that 
conditions can be changed to improve the yield and/or purity of ApoA-IM.  
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3.2 Materials & Methods 
 
Unless specified otherwise the materials & methods are unchanged from 
section 2.2. 
 
3.2.1 Protein samples 
 
ApoA-IM process samples were collected during its operation and frozen at -
20oC ready for use (Figure 3.1). These samples were diluted tenfold in 10mM PBS, 
pH 7.4 before their application to the NP20 ProteinChip surface. 
 
3.2.2 Mass spectrometry 
 
3.2.2.1 Data acquisition 
 
The molecular weight range investigated was 1 to 90 kDa. Focus mass was 
set to 28.1kDa. Laser strength responsible for the desorption/ionization of proteins 
on the spot surface was set at 1750 nJ for 1-30 kDa range and 3000 nJ for 5-90 kDa 
range. 
 
3.2.2.2 Data treatment 
 
SELDI-MS data in this chapter was treated with Matlab using settings from 
(Coombes et al. 2005). This included a wavelet threshold of 10 and to isolate noise, 
and a threshold of 6 times the mean absolute deviation (MAD) of the wavelet 
coefficients.  
Peaks (Table 3.1) were manually selected based on a signal/noise ratio > 5 
and from prior SELDI-MS analysis of the samples. HCPs are representative of a 
number of unidentified peaks that were present between 5 - 13kDa/e.  
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Peak Mass/Charge (kDa/e) 
Host Cell Proteins 6.86, 7.27, 7.85, 8.83, 9.28, 11.16, 
12.22, 12.41, 12.66 
Possible Truncation 26.2 
Monomer 28.15 
Dimer 56.3 
Possible Aggregate 84.5 
Table 3.1 Peaks manually detected in mass spectra. 
 
From the data collected in chapter 2 it was known that peak width was 
proportional to 0.6% m/z. In order to reduce the bias of smaller proteins having 
increased peak height and narrower widths (Figure 2.4) summed peak intensities 
were therefore used instead of peak intensity using a Matlab function, assuming a 
peak width of 0.3% m/z. Figure 3.2 shows the method used to convert peak 
intensities into summed peak intensities based on this value. 
 
Figure 3.2 Calculation of summed peak intensity. 
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3.2.3 Reversed Phase HPLC 
 
The Reverse Phase (RP) HPLC (Agilent Technologies Inc., Santa Clara, CA, 
U.S.A.) method was carried out by the analytical group at Pfizer Global Research & 
Development (St. Louis, MO, U.S.A). It was run under reducing conditions and 
utilized for in-process testing to determine the titre of ApoA-IM monomer species 
and several product-related impurities such as truncated species. An Agilent 1100 
series chromatography system (Agilent Technologies Inc., Santa Clara, CA, U.S.A.) 
was used comprising solvent pump, degasser, injector, and fixed wavelength UV 
detector. The eluate was monitored for 280nm absorbance and peaks were 
integrated using the Agilent HPLC software. Component concentrations were based 
on the total integrated area of respective peaks. 
 
3.2.4 Size Exclusion HPLC 
 
The SDS Size Exclusion (SE) HPLC (Agilent Technologies Inc., Santa Clara, CA, 
U.S.A.) method was carried out by the analytical group at Pfizer Global Research & 
Development (St. Louis, MO, U.S.A). It was used to measure ApoA-IM monomer, 
dimer, high molecular weight, and monomer-related species in process samples.  
SDS was present in the mobile phase to dissociate non-covalent aggregates.  
 
3.2.5 Host cell protein analysis 
 
The Enzyme-linked immunosorbent assay (ELISA) method was carried out by 
the analytical group at Pfizer Global Research & Development (St. Louis, MO, U.S.A). 
It was used to determine the amount of host cell protein impurities in ADI and in-
process samples.  Samples to be assayed for host cell protein (HCP) impurities are 
applied to a micro-titre plate which has been coated with capture antibodies and 
blocked to prevent non-specific binding.  The plate is then probed with secondary 
antibody (conjugated with biotin) and then with streptavidin horseradish 
peroxidase conjugate.  The presence of HCP is monitored indirectly by the reaction 
of peroxidase with tetramethylbenzidine (TMB).  The intensity of colour, measured 
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spectrophotometrically, is proportional to the amount of HCP present.  Standards 
are analyzed in each assay and sample results calculated by interpolation from the 
standard curve.  Assay range is 1 – 32 ng HCP/mg ApoA-IM. 
 
3.3 Results 
 
3.3.1 Initial capture chromatography     
 
Spectra in Figure 3.3 show that the capture column performs as expected in 
retaining the ApoA-IM in the post centrifuge supernatant (sample E) and removes 
some lower molecular weight host cell proteins, which can be seen in the flow 
through (sample F). The capture pool (sample G) contains ApoA-IM mostly in the 
monomer form with a significant amount of host cell protein contaminants left.  In 
Table 3.2, the RP-HPLC method shows ApoA-IM monomer at 1.6 mg/mL in the post 
centrifuge supernatant prior to column loading (sample E), increasing to 2.1 mg/mL 
in the capture pool (sample G). This corresponds to 7.6 and 18.3mA for the 
monomer peaks in the respective SELDI-MS spectra. By initial observation it seems 
that there is a discrepancy between the RP-HPLC and SELDI-MS results for these 
two samples but by comparing these two methods under reducing conditions (pre-
oxidation samples, E-J) it seems that there is a linear relationship between the two 
techniques with an R2 value of 0.93 (Figure 3.4). A linear relationship is also 
observed when measuring truncated species (Table 3.2) suggesting that both 
techniques could be measuring the same truncation at 26.2 kDa/e. The reason for 
SELDI-MS and RP-HPLC results not being comparable post-oxidation (samples K-N) 
is because SELDI-MS involves minimal sample pre-treatment whereas the RP-HPLC 
assay reduced all of the samples prior to analysis. 
Due to the complexity of the capture pool solution, it was not possible to 
make SE-HPLC measurements to determine the relative amounts of monomer and 
dimer in that sample.  SELDI-MS results shown in Table 3.3, however, show that 
there is significantly higher level of monomer relative to dimer for the capture pool 
(sample G), which is consistent with the reducing conditions present at this stage of 
the process.  HCP levels measured with the ELISA method (Table 3.4) show HCP 
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reduction from over 10,000 ng/mg in the post centrifuge supernatant (sample E) to 
1,500 ng/mg for the capture pool (sample G). A reduction in HCP levels is also 
shown by SELDI-MS but due to HCPs being recorded as a summation of different 
low molecular weight peak intensities (Table 3.1) that ionize by varying amounts 
the comparison appears to be more relative rather than absolute quantitation 
(Table 3.4). 
 
 
Figure 3.3 Mass spectra for ApoA-IM dimer production process samples.  
(E) post centrifuge supernatant; (F) Capture flow-through; (G) Capture pool; (H) IEX 
pool; (I) UF/DF 1; (J) UF/DF 2; (K) Oxidation pool; (L) Q pool; (M) UF/DF 3; (N) ADI. 
The low mass/charge (1-30 kDa/e) and high mass/charge (5-90 kDa/e) regions were 
acquired at 1750 and 3000nJ respectively. The y-axis scale used for each mass to 
charge range is shown in the top spectra. The same scale is used for all samples. 
56.3+H kDa/e 
28.1+H kDa/e 
28.1+2H kDa/e 
84.5+H kDa/e 
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PROCESS STEP RP-HPLC SELDI-MS 
 Reduced 
r-ApoA-IM 
(mg/mL) 
Truncated 
Species 
(%) 
Monomer 
Summed 
Peak 
Intensity 
(mA) 
Truncated 
Species 
(%) 
E POST CENTRIFUGE 
SUPERNATANT 
1.6 14.7 7.6 7.2 
G CAPTURE POOL 2.1 14.3 18.3 7.7 
H IEX POOL 8.8 7.8 52.1 3.9 
I UF/DF 1 9.5 7.1 53.1 3.5 
J UF/DF 2 6.2 0 27.4 0.1 
K OXIDATION POOL 1.3 n.d. 7.8 0.2 
L Q POOL 5.7 0.2 1.0 0.5 
M UF/DF 3 15.1 0.1 0.6 0.1 
N ADI 19.0 n.d. 1.4 7.2 
Table 3.2 Quantification of monomer and truncated species using mass 
spectrometry and RP-HPLC.  
Samples E-J are from the reduction stage of the process, whereas K-N are from the 
oxidisation stage. All HPLC samples are analysed under reducing conditions. All 
SELDI-MS samples are analysed under similar conditions to that existing in the 
process. The SELDI-MS low mass (1-30 kDa) and high mass (5-90 kDa) regions were 
acquired at 1750 and 3000nJ respectively. Samples not analysed, are indicated as 
not determined (n.d.). 
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Figure 3.4 ApoA-IM monomer quantification using mass spectrometry and RP-
HPLC. 
Comparison between quantification using RP-HPLC and SELDI-MS for the ApoA-IM 
protein in samples prior to oxidation (samples E-J). The line of best fit shown has an 
R2 value of 0.93 
 
Due to the complexity of the capture pool solution, it was not possible to 
make SE-HPLC measurements to determine the relative amounts of monomer and 
dimer in that sample.  SELDI-MS results shown in Table 3.3, however, show that 
there is significantly higher level of monomer relative to dimer for the capture pool 
(sample G), which is consistent with the reducing conditions present at this stage of 
the process.  HCP levels measured with the ELISA method (Table 3.4) show HCP 
reduction from over 10,000 ng/mg in the post centrifuge supernatant (sample E) to 
1,500 ng/mg for the capture pool (sample G). A reduction in HCP levels is also 
shown by SELDI-MS but due to HCPs being recorded as a summation of different 
low molecular weight peak intensities (Table 3.1) that ionize by varying amounts 
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the comparison appears to be more relative rather than absolutely quantitative 
(Table 3.4). 
 
PROCESS STEP SE-HPLC SELDI-MS 
Monomer 
(%) 
Dimer 
(%) 
Aggregates 
(%) 
Monomer 
(%) 
Dimer 
(%) 
Aggregates 
(%) 
E POST 
CENTRIFUGE 
SUPERNATANT 
n.d. n.d. n.d. 60.7 10.3 1.4 
G CAPTURE POOL n.d. n.d. n.d. 50.9 32.7 12.1 
H IEX POOL n.d. n.d. n.d. 66.1 22.7 9.3 
I UF/DF 1 n.d. n.d. n.d. 63.7 23.9 10.6 
J UF/DF 2 >95 <5 0 64.3 25.9 8.0 
K OX POOL 25 72 2.2 16.4 70.5 10.3 
L Q POOL <1 99 0 4.6 91.8 1.3 
M UF/DF 3 n.d. n.d. n.d. 3.3 90.1 5.5 
N ADI 0.3 99 0.4 3.9 89.9 5.0 
Table 3.3 Quantification of monomer, dimer and aggregates using mass 
spectrometry and SE-HPLC.  
Samples E-J are from the reduction stage of the process, whereas K-N are from the 
oxidisation stage. All samples are analysed under similar conditions to that existing 
in the process. The SELDI-MS low mass/charge (1-30 kDa/e) and high mass (5-90 
kDa/e) regions were acquired at 1750 and 3000nJ respectively. Samples not 
analysed, are indicated as not determined (n.d.). 
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PROCESS STEP ELISA SELDI-MS 
HCP 
(ng/mg ApoA-IM) 
HCP 
(%) 
E POST CENTRIFUGE 
SUPERNATANT 
>10,000 27.7 
G CAPTURE POOL 1500 4.3 
H IEX POOL 100 to 200 1.9 
I UF/DF 1 n.d. 1.8 
J UF/DF 2 ~10 1.8 
K OX POOL n.d. 2.9 
L Q POOL 1 to 2 2.3 
M UF/DF 3 n.d. 1.1 
N ADI <2 1.2 
Table 3.4 Quantification of host cell proteins using mass spectrometry and ELISA.  
ELISA measurement is based on all HCPs present whereas SELDI-MS based on a 
predetermined sample of HCPs in the range of 5 to 13 kDa/e. Peaks in the range of 
13-15 kDa/e were ignored as possible multi-charged forms of monomer and its 
truncation. Samples E-J are from the reduction stage of the process, whereas K-N 
are from the oxidisation stage. All samples are analysed under similar conditions to 
that existing in the process. Samples not analysed, are indicated as not determined 
(n.d.). 
 
3.3.2 Ion-exchange chromatography 
 
The RP-HPLC method shows that the concentration of monomer quadruples 
across the ion-exchange chromatography column (samples G & H), which is 
similarly shown with the SELDI-MS comparison (Table 3.2). There is also a 
concomitant two-fold reduction of truncated species and a reduction in the dimer 
and aggregate relative to the monomer that can be observed with both techniques 
(Table 3.2 & Table 3.3). The ion-exchange pool spectrum (sample H) in Figure 3.3 
shows clearly that this column removed most of the host cell proteins (the group of 
peaks less than 2 kDa). Separate host cell protein analysis (Table 3.4) shows that 
HCP levels in the UF/DF 1 sample (sample I) are 100-200 ng/mg, dropping from over 
1,500 ng/mg in the capture pool sample.  HCPs are also seen to drop somewhat in 
the SELDI-MS results (Table 3.4) but do not reflect the one order of magnitude 
reduction found with the standard ELISA method.  This represents a major 
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weakness of the SELDI-MS method used in this study for analyzing highly purified 
samples where accurate detection of trace impurities becomes critical in guiding 
process development effort.  To overcome this, it may be necessary in future work 
to use ProteinChip conditions that select for these HCPs over the more abundant 
target protein in order to increase HCP detection. 
 
3.3.3 Oxidation 
 
The oxidation pool spectrum (sample K) shows that the size of the monomer 
peak drops significantly with dimer formation, as expected (Figure 3.3, sample K). 
For the oxidation pool and the samples that follow (samples K-N), it is no longer 
reasonable to compare the RP-HPLC with the SELDI-MS results due to the now 
oxidised proteins being reduced prior to RP-HPLC analysis, the expected mismatch 
for these samples can be observed (Table 3.2). This highlights a main advantage of 
SELDI-MS in that it requires limited sample pre-treatment and hence analyses 
material in the conformation present during process operation. 
The comparison for monomer and dimer post oxidation between the SELDI-
MS and SE-HPLC results is similar although not exact (Table 3.3). The reason for this 
could be due to an underestimation of the amount of dimer by SELDI-MS. The 
dimer being twice as large has a much larger time of flight, allowing its ion cloud to 
have more time to expand from same charge repulsions and hence more of the 
protein missing the detector (Dijkstra et al. 2007). This results in broader, shorter 
peaks. For more quantitative assessment with the SELDI-MS method, monomer and 
dimer should therefore be calibrated separately.  
 
3.3.4 Anion-exchange chromatography & final step 
 
Figure 3.3 shows the spectra for samples prior to and post the Q column 
(samples K & L respectively) along with the final purified ApoA-IM dimer (ADI) 
sample (sample N). Qualitatively, the dimer content increases substantially across 
the Q column, consistent with HPLC analysis shown in Table 3.3.  However, only 
91.8% is dimer in the Q pool and 89.9% in the ADI sample based on SELDI-MS 
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intensity values (Table 3.3), lower than the 99% dimer measured by the HPLC 
method. 
 
3.3.5 Host cell protein removal 
 
It is of interest to investigate the ability of SELDI-MS analysis to monitor HCP 
reduction across each step in the manufacturing process. The biggest change in 
impurities levels during the process was between 5 and 13 kDa/e and so it was 
assumed that this was the location for many of the HCPs. There was also typically 
more noise within this range perhaps due to multi-charged ionisation or proteolysis 
of large molecular weight proteins. Efforts were made to limit potential proteolysis 
by using samples directly after defrosting. Where possible, information from 
literature and knowledge obtained from earlier research in Chapter 2 was used to 
improve spectra quality including the reduction in multi-charged ionisations 
(Cordingley et al. 2003).    
By assigning the peaks in the range of 5 to 13 kDa as host cell proteins (Table 
3.1, peaks between 13 and 15 kDa could be multi-charged forms of monomer and 
its truncated species and so were not included), the total intensities of those peaks 
at different points in the process could reflect the relative amounts of HCP (Table 
3.4). As expected, there is a general trend downward as the protein solution 
becomes purer. Table 3.4 shows the actual HCP values measured for some of the 
samples by the ELISA method as measured relative to the product. Qualitatively, 
there is order-of-magnitude agreement between HCPs measured with ELISA and 
SELDI-MS, especially in the early stages of the process.  As the solution becomes 
cleaner, SELDI-MS analysis appears to overestimate the level of HCPs left. This could 
be due to smaller proteins including the HCPs shown in this work having much 
smaller times of flight relative to larger molecules such as the monomer. This 
results in the HCPs having less time for their ion clouds to expand, increasing the 
likelihood of their ions colliding with the ion detector (Dijkstra et al. 2007). This 
would lead to a higher than expected HCP signals for the SELDI-MS data. This would 
be further exaggerated as impurities including larger proteins (>13kDa/e) are 
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removed. Further development of the SELDI-MS method may give scope to 
circumvent such short comings. 
There was a desire to identify HCPs found within this dataset with existing 
E.coli protein databases. It is known that many proteins share similar native masses 
so although matches were found based on native mass, the level of certainty was 
limited. To increase confidence each of these HCPs would have needed to be 
isolated and proteolysed to produce the unique peptide maps that could then be 
compared with relevant databases. Unfortunately, with other work that needed to 
be completed, this was too large a task to be carried out within the timeframe of 
this study and hence this has been left to future work (section 8.3).   
 
3.3.6 Mass spectrometry analysis during flocculation process 
 
Figure 3.5 shows a series of SELDI-MS spectra obtained for samples during 
an ultra scale down mimic of the flocculation process (Berrill et al. 2008); the top 
spectrum is for the heat extracted lysate (sample A), followed by the addition of 
DTT to the lysate to reduce covalently linked ApoA-IM molecules (sample B), then 
with addition of the flocculating reagent to precipitate impurities and cell debris 
(sample C), and finally with water dilution prior to centrifugation (sample D).  These 
samples represent the sequential treatment of the cell broth for extracting ApoA-
IM from the cell periplasm then clarifying the resultant cell lysate. On the vertical 
axis is the relative intensity of each peak, an indication of the amount of that 
particular species in the solution.  The horizontal axis shows the mass over number 
of charges for each peak; the value shown in the plot is equivalent to kDa over 
number of electronic charges.  For most cases, e is equal to 1 however peaks at ~ 
14.1kDa in these spectra are likely monomer with 2 electronic charges. The peak at 
about 28.2kDa is the ApoA-IM monomer and the small peak at 56.3kDa its dimer 
form.  Interestingly, the addition of DTT to the heat extracted cell lysate (sample B) 
appears to release into solution ApoA-IM monomer, which is likely associated with 
the cell membrane.  The release of ApoA-IM into solution seems to further increase 
with the addition of the flocculating reagent (sample C).   
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Also shown in Figure 3.5 is the large number of protein contaminants in the 
molecular weight range from 1 to 10 kDa, some of them are seen to be reduced 
post flocculation & centrifugation (Figure 3.3, sample E). This contaminant profile 
information obtained with these crude samples demonstrates a particular power of 
the SELDI-MS method.  For these crude samples SE-HPLC does not work effectively 
and the more quantitative RP-HPLC analysis is limited to the quantification of ApoA-
IM amount and relative amounts of some product related impurities such as 
truncated species (Table 3.2). 
 
 
Figure 3.5 Mass spectra of USD flocculation samples.  
SELDI-MS analyses of heat extract samples before and during an ultra scale down 
mimic of the flocculation process. Samples were centrifuged at 216.7 rps for 5 
minutes prior to analysis. (A) heat extract; (B) sample A with DTT addition; (C) 
sample B with flocculating agent addition (D) sample C with water addition, also 
known as centrifuge feed supernatant. The low mass/charge (1-30 kDa/e) and high 
mass/charge (5-90 kDa/e) regions were acquired at 1750 and 3000nJ respectively. 
The y-axis scale used for each mass to charge range is shown in the top spectra. The 
same scale is used for all samples. 
 
 
 
 
 
56.3+H kDa/e 28.1+H kDa/e 28.1+2H kDa/e 
84.5+H kDa/e 
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PROCESS STEP RP-HPLC 
Reduced 
r-ApoA-IM (mg/mL) 
Truncated 
Species (%) 
A HEAT EXTRACT  1.6 15.6 
D CENTRIFUGE  
FEED 
1.7 15.5 
Table 3.5 RP-HPLC analysis before and after the pilot scale flocculation. 
 
It was observed that flocculation conditions had less of an impact on protein 
profile than on cellular debris removal. For this reason the next chapter will focus 
on using an ultra scale-down model to improve cellular debris clearance rather than 
protein contaminant removal. 
 
3.4 Summary 
 
Review of chapter aims: 
 
 Validate that mass spectrometry technique is comparable to conventional 
analytical techniques such as HPLC and ELISA by using SELDI-MS to monitor in-
process samples in the production of ApoA-IM Dimer Intermediate (ADI). 
 The SELDI-MS method offers an effective analytical tool for monitoring in-
process samples during early-stage process development when little is 
known about the protein and impurities, and well developed quantitative 
analytical methods are not yet in place.  
 The normal phase ProteinChip (NP20) provides a broad spectrum 
adsorption surface that enables detection of product and contaminant 
proteins not readily measured with any other single analytical technique. 
For these crude samples SE-HPLC does not work effectively and the more 
quantitative RP-HPLC analysis is limited to the quantification of ApoA-IM 
and relative amounts of some product related impurities such as truncated 
species. 
 Intensity values of the observed peaks along with their molecular weights 
provide rapid assessment with respect to the relative abundance and 
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functional “identity” of those peaks, i.e., ApoA-IM monomer, dimer, and 
host cell proteins.  
 Near the end of the process, when the protein solution becomes very pure, 
the SELDI-MS method as implemented has reduced value since the 
obtained spectra are dominated by the target protein whereas interest at 
that stage focuses more on minor impurities such as host cell proteins and 
product-related species. A possible solution to this problem could be the 
use of surfaces with increased selectivity for contaminant capture while 
reduced binding of the product protein.  
 
 Examine the protein profiles during the flocculation process in the hope that 
conditions can be changed to improve the yield and/or purity of ApoA-IM. 
 The addition of DTT to ApoA-IM heat extract appears to release into solution 
substantial amount ApoA-IM monomer, which is likely associated with the 
cell membrane.   
 The release of ApoA-IM into solution seems to further increase with the 
addition of the flocculating agent.   
 Some protein contaminants in the molecular weight range from 1 to 10kDa, 
seem to be reduced post flocculation. 
 There is a much greater change in cellular debris removal than protein 
profiles at this stage so the decision was made to concentrate on improving 
cellular debris removal. 
 
The next chapter will now address cellular debris removal during the 
flocculation/centrifugation stage of the ApoA-IM process using another USD device. 
ApoA-IM post centrifuge supernatant material produced from this stage will be 
used for purification development in chapters five through to seven. 
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CHAPTER 4 DEFINING & IMPROVING THE FLOCULATION & 
CENTRIFUGATION STAGE OF THE APOLIPOPROTEINA-IM PROCESS 
USING A USD DEVICE 
 
4.1 Introduction 
 
Due to increased titres and fermentation volumes, the size of 
chromatography columns and the volumes of buffers to be used with them are 
being pushed ever higher (Thommes and Etzel,2007). For this reason there is a 
desire to find methods to lower the burden on the chromatographic steps in a 
process.  
Flocculation combined with a preceding centrifugation step is one method 
to reduce the contaminants that can have disastrous effects on subsequent steps 
that usually include chromatography. The flocculating agent causes these 
contaminants, usually cellular debris to form larger aggregates which are then 
easier to remove by centrifugation. 
The required floc characteristics depend on the subsequent separation 
operation. In a disc stack centrifuge there are typically relatively high levels of shear 
in the feed zone so there is a demand for floc particles to be strong and dense 
enough to prevent breakup. The more resistant the particles are to shear the higher 
the speed the centrifuge can be operated at. This in turn allows higher flow rates to 
be used through the centrifuge without sacrificing clarification or yield capabilities. 
If the floc particles are shear sensitive and the targets for clarification are 
not achieved then it is necessary at laboratory scale to investigate what factors 
during the flocculation process enable the production of stronger flocs. 
The USD method to measure the shear sensitivity of floc particles expands 
on previous work carried out at University College London. The concept is to mimic 
the pilot scale centrifuge in the laboratory, by finding the shear that is similar to 
that experienced in the feed zone of a pilot centrifuge. This is carried out by 
exposing the feed material to different levels of shear in the laboratory and then 
measuring the ease of clarification in a laboratory scale centrifuge compared to 
pilot scale. The theory and method of mimicking entry shear has been thoroughly 
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described in the literature (Boychyn et al. 2001;Boychyn et al. 2004;Boychyn et al. 
2000). 
 
Summary of chapter aims: 
 Demonstrate how a mimic for centrifugal clarification can be applied to a 
flocculated E.coli extract and give insight into the interaction between 
flocculation and centrifugation.  
 
4.2 Materials & Methods 
 
Unless specified otherwise the materials & methods are unchanged from 
section 2.2. 
The process material used in this study was a flocculated ApoA-IM heat 
extract (Figure 3.1, sample A) provided by Pfizer (Chesterfield, MO, U.S.A.). Material 
was collected and used directly from the process within an hour of it being made.  
The initial solid concentration of the feed stream was determined by centrifuging 
the feed in 50 mL graduated centrifuge tubes in an Sorvall RC6 centrifuge (Thermo 
Electron Corp., Asheville, NC, U.S.A.), rotor SLA-600TC (N=166.7rps, t=0.5 h). The 
feed was found to vary slightly between flocculation batches but averaged at ~20% 
(w/w) solids, packed volume basis. 
Multiple centrifugation runs were performed and each time duplicate 
measurements were taken with standard deviation used to estimate error. This 
error never exceeded +/- 5% in the laboratory or pilot centrifuge. Each run showed 
similar trends with figures showing data from a representative run. 
 
4.2.1 Bench-top studies 
 
4.2.1.1 Flocculation 
 
E.coli cells were heat lysed before exposure to a 1% w/v solution of 
flocculating agent in ultrapure water. The flocculant used is proprietary and cannot 
be identified other than it being a cationic polymer but the same flocculant grade 
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and quality was used for both bench-top and pilot studies. A R1312 Turbine stirrer 
(IKA Works Inc., Wilmington, NC, U.S.A.) was used to mix 400 mL of E.coli extract at 
6.66 s-1. Flocculating agent was added at 3 g/kg, 5 g/kg, and 7 g/kg relative to E.coli 
extract. The material was mixed for 15 minutes before water was added prior to 
centrifugation. Water was added to make final weight ratio of 1.0 w/w (total 
additions including flocculating agent solution/heat extract) to improve product 
yield and centrifuge performance. 
 
4.2.1.2 Centrifugation 
 
E.coli flocs were diluted ten-fold to ~2.0% (w/w, packed volume basis) in 
50mM PBS, pH 7.4, to make a 1 L suspension. This was used to produce well spun 
supernatant, low shear (100 rps) exposed material, and high shear (300 rps) 
exposed material. Shear exposure was carried out for 20 s in a high-speed rotating-
disc device. The construction of this device has been described previously 
(Hutchinson et al. 2006). These two shear conditions were used prior to 
centrifugation to mimic the impact of high-shear regions in the inlet of centrifuges, 
leading to potential cell disruption and carry-over of solids contaminants. The 
remaining suspension was kept as a no shear control condition. The optical density 
at 600nm was measured for both the sheared and the non-sheared feed 
suspensions (ODf) to generate data to calculate % clarification from Equation 4.1.  
 
100% 



rf
sf
ODOD
ODOD
C  
Equation 4.1 % clarification for centrifugation. 
Where ODf, ODs and ODr are the optical density of the feed, the sample supernatant 
and the supernatant of the reference sample, respectively (Boychyn et al. 2004). 
 
Clarification was mimicked by taking 1.5 mL samples of non-sheared and 
sheared material and placing these in 2.2 mL Eppendorf tubes. The tubes were spun 
in an Eppendorf 5810R centrifuge, rotor T-60-11 (Eppendorf North America Inc., 
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New York; N = 25 to 208.3 rps, lab = 0.009 to 0.617 m
2, tlab = 0.2 h). The 
supernatant was removed by pipetting and the OD600 of the supernatant was 
measured (ODs). The well-spun material (N=208.3 rps, tref=0.5 h) was prepared for 
the purpose of a clarification reference sample with OD600 measured (ODr). Where 
necessary this material was also used to dilute samples in order to operate in the 
linear optical range of the spectrophotometer. 50mM PBS, pH 7.4 was used as a 
blank. 
The hindered settling correction factor was calculated on the % solids of the 
material just prior to laboratory centrifugation. 
 
4.2.2 Pilot plant studies 
 
4.2.2.1 Flocculation 
 
E.coli cells were heat lysed before exposure to a 1% w/v solution of 
flocculating agent in water for injection (WFI). The amount of flocculating agent 
added was changed from 3 g/kg to 4.5 g/kg as well as the addition rate of the 
flocculating agent from 9 L/min to 4.5 L/min. The material was mixed for 15 
minutes before water was added prior to centrifugation. Water was added to make 
final weight ratio of 1.0 w/w (total additions including flocculating agent 
solution/heat extract) to improve product yield and centrifuge performance. 
 
4.2.2.2 Centrifugation 
 
Flocculated material was clarified with a CSA-8 disk-stack centrifuge 
(Westfalia Separator AG, Oelde, Germany) at a flowrate of 120 L/hr. For one run 
additional flowrates of 180 and 270 L/hr were used to verify the pilot clarification 
with the laboratory scale. The optical density of the supernatant (ODS) was 
measured at 600nm. Temperature was maintained at ~10oC using glycol cooling 
circulating at -4oC. Solids were discharged immediately upon the bowl reaching 
capacity (indicated by breakthrough of solids to supernatant). Equation 4.1 was also 
used to calculate measurements of % clarification for pilot scale. The well-spun 
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material (N=208.3 rps, tref=0.5 h) was prepared for the purpose of a clarification 
reference sample with OD600 measured (ODr). 
 
4.2.3 Microscope images 
 
Microscope images were taken on an Axioscope 2 plus microscope (Carl 
Zeiss MicroImaging Inc., Thornwood, NY, U.S.A.) at 10x and 100x magnification. 
 
4.3 Theoretical considerations 
 
4.3.1 Sigma theory 
 
Sigma theory, is a concept used to describe the solid-liquid separation 
performance of a centrifuge and can be used to determine the clarification time. 
The Sigma factor, also called equivalent settling area, is defined as the surface area 
of a gravity settling tank with equivalent settling performance. The derivation of the 
Sigma concept is described elsewhere (Ambler,1961). 
Each type of centrifuge design has a unique correlation for calculating a 
Sigma value. Equation 4.2 & 4.3 show the formulas for calculating the Sigma value 
for a laboratory and disc-stack centrifuge respectively. 
 








io
o
lab
lab
RR
R
g
V
2
ln2
2
 
Equation 4.2 Sigma for a swing-out laboratory centrifuge. 
Where lab is the equivalent settling area of the laboratory centrifuge (m
2), Vlab is 
the volume of process material in the centrifuge tube (m3), = 2N (rad.s-1), N is the 
rotational speed (rps), g is acceleration due to gravity (ms-2), Ri is the inner radius 
(m) (the distance between the centre of rotation and the top of the liquid), Ro is the 
outer radius (m) (the distance between the centre of rotation and the bottom of the 
tube) (Maybury et al. 1998). 
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 
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  
Equation 4.3 Sigma for a disc-stack centrifuge. 
Where ds is the equivalent settling area of a disk stack centrifuge (m
2), nd is the 
number of active discs, r1 and r2 are the inner and outer disc radius (m), θ is the half 
disc angle (degrees). 
 
The ease of broth clarification for any particular centrifuge is given by the 
ratio of the volumetric flow rate, Q, and settling area, . Therefore comparisons 
between different laboratory centrifuges, or the same centrifuge using different 
settings, can be performed using Equation 4.4. 
 
dsds
ds
lablab
lab
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Q
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Equation 4.4 Comparing two different centrifuges. 
Where Q is the flow rate (m3s-1), t is the residence time (s), and c is a correction 
factor to account for non-ideal fluid flow patterns, the value of which depends on 
centrifuge design. Subscripts lab and ds represent the laboratory and disk stack 
centrifuge respectively. The laboratory centrifuge is usually considered a reference, 
hence clab = 1.0 for this centrifuge. 
 
For high solids feed material there is a need to overcome the phenomenon 
of hindered settling in order to get a good comparison between the clarification in 
laboratory scale to that observed at pilot scale. 
 
4.3.2 Hindered settling 
 
Hindered settling starts to occur at high solid concentrations. As the solids 
concentration increases, the settling rate of particles decreases due to the increase 
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in interparticle forces. Particles settling slowest will be hindered by those 
underneath them. This is particularly noticeable in the confined spaced of a 
laboratory centrifuge. At very high solids what is known as “blanket” sedimentation 
can occur. This is when particles all settle at the same rate and form a large floc that 
sweeps up the fine particles in the liquid. This leads to an over prediction in the 
laboratory scale to that seen in the pilot scale continuous flow centrifuge. 
Due to the high shear in the feed zone and short residence time in the 
centrifuge bowl it is believed that flocs do not have enough time to reform and 
therefore hindered settling is not a main concern at pilot scale. This is not the case 
at laboratory scale where the length of time between shearing material and 
clarification may be enough to allow flocs to reform and cause hindered settling 
which consequently increases clarification performance in the laboratory scale 
compared to the pilot scale at an equivalent separation condition. In order to allow 
a more accurate comparison between the USD and pilot centrifuges, we dilute the 
floc for the USD experiments to such an extent that floc reformation is minimized. A 
correction to the USD data to allow for hindered settling at high solids 
concentration in the pilot centrifuge must then be applied in Equation 4.5. 
It has been shown in previous USD studies (Boychyn et al. 2001;Boychyn et 
al. 2004;Maybury et al. 2000) that diluting material to approximately 2% w/w may 
help reduce hindered settling, without greatly affecting the liquid viscosity. 
In 1954, Richardson & Zaki developed a mathematical relationship for 
hindered settling, shown in Equation 4.5 that can be used to predict the clarification 
of high solid density feeds in an industrial centrifuge from laboratory clarification 
data (Richardson and Zaki,1997). 
 
 
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Equation 4.5 Hindered settling correction factor 
Where φ is the cellular solids fraction and h is the hindered settling correction factor 
that equals to 1 for no hindered settling. 
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The derivation of the hindered settling correction factor concept is 
described elsewhere (Salte et al. 2005). 
 
4.4 Results 
 
4.4.1 Evaluation of shear 
 
To understand the size and morphology of the flocculated solids and how 
shear affects these parameters, microscope images were taken (Figure 4.1). It can 
be seen that particle size decreases with increasing shear represented here by the 
speed of the rotating disc in the shear device. Particle size was approximately 75m 
for the no and low shear condition and 25m for the high shear condition 
suggesting that as shear was increased, particles were being broken down. Data 
shown in Figure 4.2 supports these results of shear sensitivity by giving a 
quantitative measure of shear effects. In this figure and other figures like this 
centrifuge speed was changed to alter the equivalent settling area. An increase in 
the equivalent flow rate to equivalent settling area ratio corresponded to a 
decrease in centrifuge speed from 208.3 to 25 rps while maintaining the time for 
centrifugation constant at 12 minutes. There is clearly a difference in % clarification 
between the material before and after exposure to high shear at any particular 
equivalent flow rate to equivalent settling area ratio (Figure 4.2). Both Figure 4.1 & 
Figure 4.2 results determined that the flocculated particles were sensitive to the 
shear conditions they were exposed to, which were selected to be relevant to 
process scale centrifugation (Neal et al. 2003). 
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Pilot scale feed material Low sheared pilot scale 
feed material 
(100s-1) 
High sheared pilot scale 
feed material 
(300s-1) 
   
   
Figure 4.1 Microscope images of flocculated ApoA-IM material exposed to shear. 
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Figure 4.2 Developing a mimic of the ApoA-IM dimer recovery process  
Flocs were exposed to the following shear conditions in the shear device: (○) non-
sheared; (□) high sheared, 300s-1 (relates maximum energy dissipation rate of 2x106 
Protein mass spectrometry for bioprocess development & monitoring 
 
99 
 
W/kg) (◊) high sheared with hindered settling correction factor applied; (▲) pilot 
centrifuge. The x-axis is the ratio of equivalent flow rate to equivalent settling area. 
All laboratory samples were sheared for 20s. Data points are plotted on probability-
logarithmic axes indicate mean values with errors from duplicate runs. Solid lines 
represent the line of best fit for each data set. The hindered settling correction used 
(hlab) was calculated from Equation 4.5 as 0.57. The values of cds and clab were 0.4 
and 1 respectively. 
 
4.4.2 Adoption of a hindered settling correction factor 
 
The solids percentage in the pilot centrifuge feed of ~20% was far greater 
than the 2% threshold where this type of USD work has previously been carried out 
successfully without the hindered settling correction factor (Boychyn et al. 
2001;Boychyn et al. 2004;Maybury et al. 2000). For this reason, the pilot and USD 
data (USD feed material is diluted to 2% solids before centrifugation) consistently 
didn’t match one another by similar degrees each time. After a hindered settling 
correction factor of 0.57 was taken into account, the USD data was found to be in 
much greater agreement with the pilot data (Figure 4.2). The phenomenon for 
hindered settling is described in section 4.3.2. 
 
4.4.3 Comparing % clarification between pilot scale and USD mimic 
 
For one of the pilot plant runs, it was possible to operate the disc-stack 
centrifuge at three different flowrates. The objective was to investigate the effect 
of flowrate on % clarification and to get a better comparison between lab and pilot 
scale (Figure 4.3). A generally good agreement in trends can be seen between 
scales. 
 
Protein mass spectrometry for bioprocess development & monitoring 
 
100 
 
Q
ds
/c
ds
.
ds
or (V
lab
/c
lab
t
lab

lab
h
lab
(ms
-1
)
10-9 10-8 10-7 10-6
%
 C
la
ri
fi
c
a
ti
o
n
30
50
70
90
99
99.9
Lab centrifuge,
no shear
Lab centrifuge,
high shear
Pilot centrifuge
 
 
Figure 4.3 Comparing the USD % clarification with pilot scale 
Floc suspension was exposed to the following shear conditions in the shear device: 
(○) non-sheared; (□) high sheared, 300s-1; (▲) pilot centrifuge. The x-axis is the ratio 
of equivalent flow rate to equivalent settling area. All laboratory samples were 
sheared for 20s. Data points are plotted on probability-logarithmic axes and 
indicate mean values with errors from duplicate runs. Solid lines represent the line 
of best fit for each data set. The hindered settling correction used (hlab) was 
calculated as 0.57. The values of cds and clab were 0.4 and 1 respectively. 
 
4.4.4 Varying flocculating agent addition rate for both scales 
 
Two different addition rates were used in generating pilot scale flocculated 
material (Figure 4.4). The rates used where 4.5 L/min and 9 L/min. It was observed 
that the higher addition rate produced a higher variability in flocculated particle 
size by visual observation (results not shown). This high addition rate may reduce 
the chance of an even distribution of flocculating agent which would result in a 
more heterogeneous population of particle sizes.  
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It can be seen that for both addition rates at the low equivalent flow rate to 
equivalent settling area ratio (high centrifuge speed, 208.3rps) a greater than 99% 
clarification is achieved for both the no and high shear conditions (Figure 4.4). It 
seems that shear doesn’t seem to have a big affect at such high centrifugation 
speeds, probably due to even smaller particles being removed at such high speeds. 
Unfortunately we cannot feasible reach these conditions in the pilot centrifuge as 
the data point shown is already at the highest centrifugation speed possible. Such 
high solids concentration also requires the flowrate to be set in a very narrow 
range. Low flowrates result in clarifications taking too long, while high flowrates can 
cause the centrifuge to become overloaded with material, this can cause some flocs 
to overspill into the supernatant, resulting in inadequate clarification.  
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Figure 4.4 Varying flocculating agent addition rate at both scales. 
(A) Flocs prepared with a flocculating agent addition rate of 9 L/min (B) Flocs 
prepared with a flocculating agent addition rate of 4.5 L/min. Floc suspension 
exposed to the following shear conditions in the shear device: (○) non-sheared; (□) 
high sheared, 300s-1; (▲) pilot centrifuge. The x-axis is the ratio of equivalent flow 
rate to equivalent settling area. All laboratory samples were sheared for 20s. Data is 
corrected with a hindered settling correction factor. Data points are plotted on 
probability-logarithmic axes and indicate mean values with errors from duplicate 
runs. Solid lines represent the line of best fit for each data set. The hindered settling 
correction used (hlab) was calculated as 0.57. The values of cds and clab were 0.4 and 
1 respectively. 
(A) 
(B) 
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 For the high addition rate, clarification in both the no and high shear 
conditions drops more rapidly as the ratio of equivalent flow rate to equivalent 
settling area is increased (reducing centrifuge speed). This may be explained by the 
previous observation of increased particle size heterogeneity at the higher addition 
rate which would lead to the presence of smaller floc particles causing reduced 
clarification when compared to the lower addition rate.  
Another observation is that at the high addition rate, the difference in 
clarification between the no and high shear condition is greater than that for the 
low addition rate. At the 9 L/min addition rate and the highest equivalent settling 
area, the % clarification is 73 and 30%, more than two-fold drop, for the no and 
high shear rates respectively. Whereas for the 4.5 L/min addition rate the % 
clarification is 95 and 76% for the no and high shear rates respectively. This 
suggests that the particles at the high addition rate are more shear sensitive which 
could also be due to inadequate mixing causing the particles to be larger, more 
fragile and more heterogeneous than they were at the lower addition. The time for 
mixing and the flocculant addition rate are not independent from one another, 
using a lower flow rate not only results in a steadier and controlled flocculation but 
also gives the particles more time to age and hence increases their mechanical 
strength. Once the lower addition rate was introduced there was also a notable 
increase in the reproducibility of these USD experiments (results not shown).  Note 
that the pilot plant data points more closely align with high shear results in both 
runs. 
 
4.4.5 Varying flocculating agent addition ratio with USD mimic 
 
An experiment was carried out at laboratory scale to study the effect of 
flocculant levels on clarification. Three different flocculant amounts were used; 3, 5 
and 7 g/kg of heat extract. Figure 4.5 shows that the amount of recoverable solids 
increased as the amount of flocculating agent added was increased. The biggest 
shift observed was from 3 to 5 g/kg, which may indicate that the original amount of 
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flocculant added in the pilot plant of 3 g/kg may not be sufficiently flocculating all 
of the smaller cell debris. 
 
 
 
Figure 4.5 Using the USD mimic to study the effect of varying the ratio of 
flocculating agent addition on the laboratory centrifuge index. 
The laboratory centrifuge index was calculated as the % solids (w/w) in the floc after 
varying amounts of flocculating agent had been added. The solid pellet was created 
at 166.7 rps for 30 minutes in a Sorvall RC6 centrifuge. All laboratory samples were 
sheared under the high shear condition for 20s. Bars indicate mean values with 
errors from duplicate runs. 
 
At these three different flocculating agent addition levels, representative 
samples underwent two shear conditions, low shear (100s-1) and high shear (300s-
1). From the % solids the hindered settling correction factor was determined using 
Equation 4.5 for each of these six samples. Figure 4.6 shows that little change in 
clarification was observed for the material that was exposed to the low shear. 
However, Figure 4.2 shows that the high shear condition was the closest match to 
the shear experienced at pilot scale and Figure 4.6 shows that under this condition 
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there was an increase in % clarification from 88 to 99% as the level of flocculating 
agent was increased. This indicated that as the level of flocculating agent was 
increased, the floc particles produced were stronger and hence easier to clarify. 
 
 
 
Figure 4.6 Using the USD mimic to study the effect of varying the ratio of 
flocculating agent addition on the % clarification. 
USD conditions were chosen that matched the pilot plant and each condition was 
corrected for hindered settling using the laboratory centrifuge index (Equation 4.5). 
Flocculation suspension exposed to the following shear conditions in the shear 
device: (dotted bars) low shear (100s-1); (dashed bars) high shear (300s-1). The high 
shear condition was used as earlier results indicated that this was the closest match 
to the shear experienced at pilot scale. All laboratory samples were sheared for 20s. 
Bars indicate mean values with errors from duplicate runs. 
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4.4.6 Validation of USD flocculating agent addition ratio at pilot scale 
 
Based on laboratory data shown previously as well as Pfizer supporting data 
it was decided that the amount of flocculating agent added at pilot scale should be 
increased to 4.5 g flocculating agent/kg heat extract. 
Material produced in the pilot plant by flocculation with 4.5 g flocculant/kg 
heat extract was used in laboratory studies to look at how sensitive this new 
material was to shear and hence if the % clarification was improved over a range of 
centrifugation conditions. The USD data in Figure 4.7 shows that clarification was 
improved overall compared to the experiments carried out with material made with 
3 g/kg and the same addition rate.  
 
 
Figure 4.7 Validating at pilot scale the USD predictions on the effect of flocculating 
agent addition ratio. 
A new flocculation addition ratio of 4.5 g flocculating agent/kg heat extract was 
used unless stated otherwise while addition rate was kept constant at 4.5L/min. Floc 
suspension exposed to the following shear conditions in the shear device: (○) non-
sheared; (□) high sheared, 300s-1; (▲) pilot centrifuge, (♦) pilot centrifuge with 
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0.3kg flocculating agent/kg heat extract, (-- line) high sheared, 300s-1, with 3 g 
flocculating agent/kg heat extract. The x-axis is the ratio of equivalent flow rate to 
equivalent settling area. All laboratory samples were sheared for 20s. Data points 
are plotted on probability-logarithmic axes and indicate mean values with errors 
from duplicate runs. Solid lines represent the line of best fit for each data set. 
 
This improvement was more pronounced at the lowest centrifugation speed 
where, under high shear with 3g/kg, the % clarification obtained was 76% 
compared to the 88% at the new 4.5g/kg addition. Possibly, higher flocculant levels 
could lead to stronger particles. There could also be a greater number of smaller 
debris being flocculated, which improves the clarification. Laboratory % solids 
results support the latter assessment (Figure 4.5). 
 
4.5 Summary 
 
This chapter described the use of an ultra scale-down methodology for 
solid-liquid separation in industrial centrifuges for a flocculated feed material. 
 
Review of chapter aims: 
 
 Demonstrate how a mimic for centrifugal clarification can be applied to a 
flocculated E.coli extract and give an insight into the interaction between 
flocculation and centrifugation.  
 The feedstock is a high solids (20% solids) shear sensitive flocs.  
 The high solid content necessitated the inclusion of a dilution step and a 
hindered settling correction factor for the USD centrifugation.  
 Using this approach it was possible with small volumes (approx. 100 ml for 
full characterization) to rapidly investigate the interaction between 
flocculation and centrifugation conditions for this material.  
 The developed method was utilized to optimize the flocculation step at 
large-scale, which was shown to improve the overall clarification. 
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The next three chapters of this thesis will now investigate how to improve 
the purification of the material produced from this flocculation/centrifugation 
stage.
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CHAPTER 5 DEVELOPING AN EXPERIMENTAL METHODOLOGY TO 
DEFINE PRODUCT AND CONTAMINANT RELATIONSHIPS 
 
5.1 Introduction 
 
Cordingley et al., investigated some of the factors involved in SELDI sample 
preparation and application (Table 5.1). The response variables chosen were based 
on the number of peaks, mass range of detectable peaks and resolution 
parameters. 
 
Factor  Type Low level (-) Midpoint High level (+) 
Concentration and 
volume of sample  
Continuous 100L at 
1mg/mL 
40L at 
2.5mg/mL 
25L at 
4mg/mL 
Length of washes  Continuous 0 min 5 min 10 min 
Number of washes  Continuous 2 3 4 
Table 5.1 Factors in SELDI ProteinChip preparation. 
 
This group found that the best settings from those investigated were; 
minimal wash times and fewest number of washes. Volume and protein 
concentration of sample could be set as convenient. 
This work along with information supplied by BioRad gives a good 
background on some of the factors that have an effect on SELDI-MS. This chapter 
however investigates a couple of specific factors involved in the optimisation of the 
protocols for the selective binding of proteins to the ProteinChip surface, including 
decisions on which solutions to use.  
These adapted protocols for the selective ProteinChips will be used for later 
purification development work in chapter seven. 
 
Chapter aims: 
 Finalise SELDI protocols for later purification development study, including the 
selection of solutions A & B. 
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 Use protocols to generate adsorption data for the ApoA-IM material produced 
in the previous chapter for use in the remaining sections of this thesis. 
 
5.2 Materials & Methods 
 
Unless specified otherwise the materials & methods are unchanged from 
section 2.2. 
 
5.2.1 Reducing pH below the pI of the ApoA-IM monomer 
 
Due to ApoA-IM having a pI of approximately 5.4, it was necessary to add 
1% polysorbate 20 to the ApoA-IM post centrifuge supernatant (Figure 3.1, sample 
E) before dropping the pH to 3 to avoid protein precipitation. Once the polysorbate 
was added and the pH was reduced, the polysorbate 20 was removed using a 3mL 
slide-alyser cassette (Thermo Fisher Scientific Inc., IL, U.S.A.) with a 2.5kDa cut-off. 
 
5.2.2 Mass spectrometry 
 
5.2.2.1 Selective ProteinChip preparation 
 
Before ProteinChip equilibration, the H50 ProteinChips were activated by 
incubating twice with 50L of 50% Acetonitrile for 5 minutes and the IMAC10 
ProteinChips were activated by incubating twice with 50µL of 100mM nickel 
sulphate for 5 minutes. 
After this stage the selective ProteinChips (CM10, Q10, H50 & IMAC10) used 
in this chapter were prepared with identical protocols (Figure 5.1) but with buffers 
specific to their surface chemistry. Spots were equilibrated three times with 150L 
of solution A for 5 minutes under shaking (8.3 rps). The spots were then loaded 
with 150L of the sample previously diluted in solution A based on previous load 
optimisation results. The sample was incubated with the spot surface for 30 
minutes while being shaken (8.3 rps). Each spot was then washed three times with 
150L of solution A for 5 minutes under shaking (8.3 rps) to eliminate non-
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adsorbed proteins. This was followed by a quick rinse with 150L of solution B to 
reduce salt levels and then the spots were left to dry. 
After 20 minutes the spots were dry and 1L of the EAM was applied. After 
5 minutes the EAM application was repeated before a final 5 minute dry step prior 
to ProteinChip analysis. 
 
 
Figure 5.1 Steps for selective ProteinChip preparation. 
Solution A & B will vary depending on the experiments in later sections. 
 
Equilibration 
2 x 150L solution A 
5min 
 
Incubation 
1 x 150L solution A 
& sample 
30 min 
Initial wash 
3 x 150L solution A 
5 min 
 
Final wash 
1 x 150L solution B 
instantaneous rinse 
 
Remove excess liquid & air dry 
20 min 
Surface activation 
2 x 50L 50% ACN 
5 min 
 
 
 
EAM addition & air dry 
2 x 1L SPA, 
5 min 
 
Cation-exchange (CM10) 
& Anion-exchange  
(Q10) Preparation 
Immobilised metal 
affinity (IMAC10) 
Preparation 
Surface activation 
2 x 50L 100mM NiSO4 
5 min 
 
 
 
Hydrophobic  
(H50) Preparation 
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5.2.2.2 Data treatment 
 
SELDI-MS data in this chapter was treated with Matlab as described in 
section 3.2. 
 
5.3 Results 
 
Typical protocols for the preparation of the various ProteinChips are shown 
in Figure 5.1. This chapter will look at the selection of solution A and solution B. 
 
5.3.1 Selection of wash step solutions for hydrophobic ProteinChips 
 
The protocols supplied by BioRad (and previously Ciphergen) suggest using 
the H50 ProteinChips in a reverse phase mode, with acetonitrile (ACN) and 
triflouroacetic acid (TFA). These solvents have an advantage because of the absence 
of salt, removing the need for a final water wash and because they have been used 
previously with HPLC for elucidating the hydrophobic characteristics of proteins 
(Wall et al. 2002). The down side of using these solvents are their minimal use at 
larger scales and the possibility of unknown damaging effects on the proteins 
themselves. This damage is one of the reasons why aqueous biphasic systems are 
sometimes used to measure hydrophobicity.  
Along with investigating the use of these reverse phase solvents further we 
therefore also wanted to investigate ammonium sulphate buffers which are more 
commonly used at industrial scale and maybe less damaging to the proteins. 
 
5.3.1.1 Single Protein solutions 
 
In Figure 5.2, polar (1% TFA in ultrapure water) and non-polar (50% ACN in 
ultrapure water) solvents were used for binding BSA & Lysozyme on an H50 
ProteinChip following the protocol in Figure 5.1. As can be seen in Figure 5.2 there 
is no binding of lysozyme with the 1% TFA condition on the hydrophobic 
ProteinChip but considerable binding of BSA. However the opposite is observed 
with the use of 50% ACN. A possible reason for this is that hydrophobic proteins 
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have increased stability adsorbed to a hydrophobic surface when exposed to 
increased solvent polarity. A hydrophilic protein displays the opposite, being 
increasingly stable in solution with increased solvent polarity. The higher adsorption 
of BSA relative to lysozyme in the polar solvent suggests that BSA is a more 
hydrophobic protein. This observation is supported by conventional RP-HPLC where 
lysozyme elutes before BSA with an increasing percentage of non-polar solvent 
(Parris and Baginski,1991). 
 
 
Figure 5.2 Competitive adsorption of BSA and lysozyme to a hydrophobic 
ProteinChip using reverse phase solvents. 
Equal quantities of BSA and lysozyme were mixed in 10mM PBS, pH 7.4 to make 
0.1mg/mL total protein. The TFA solution was 1% TFA diluted in ultrapure water and 
the ACN solution was 50% ACN diluted in ultrapure water. The solutions were used 
for all steps in the ProteinChip preparation. The laser strength used was 2500 & 
1750nJ for BSA & lysozyme respectively. 
 
Due to the concerns raised with reverse phase solvents it was decided to 
compare TFA with ammonium sulphate solutions. Since BSA exhibited hydrophobic 
properties it was used in this study. Figure 5.3 shows that the two solvent systems 
show similar trends, with the binding of BSA dropping as the percentage of TFA or 
ammonium sulphate concentration was lowered. 
Protein mass spectrometry for bioprocess development & monitoring 
 
114 
 
 
Figure 5.3 Non-competitive adsorption of BSA to a hydrophobic ProteinChip using 
TFA or ammonium sulphate. 
A solution of 0.1mg/mL of BSA was made with 10mM PBS, pH 7.4. This solution was 
incubated with either (A) varying TFA concentration (used as solution A & B) in 
ultrapure water or (B)  50mM Tris, pH 7 with varying ammonium sulphate 
concentration (solution A) and a final wash with 50mM Tris, pH 7 with no 
ammonium sulphate (solution B). A laser strength of 6000nJ was used. 
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5.3.1.2 Complex mixtures 
 
To further aid the decision on whether to use ammonium sulphate or 
reverse phase solvents, a comparison of the two methods was carried out using a 
complex process material. The material chosen was the ApoA-IM post centrifuge 
supernatant produced from the previous chapter. 
Figure 5.4 shows that ammonium sulphate improved the adsorption of 
ApoA-IM post centrifuge supernatant proteins to the H50 ProteinChip in greater 
magnitude than ACN even though the ammonium sulphate spots had a final water 
wash which could have removed proteins.  
Precipitation may explain why the spectrum without ammonium sulphate 
has a higher signal intensity than the spectra with ammonium sulphate even though 
visually there was no apparent visual turbidity. The “salting-in” effect by 
ammonium sulphate may increase the surface charge of the proteins, reducing 
their adsorption to the non-polar surface (Arakawa and Timasheff,1984). 
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Figure 5.4 Competitive adsorption of ApoA-IM post centrifuge supernatant 
proteins to a hydrophobic ProteinChip with ACN or ammonium sulphate. 
A solution of 0.05mg/mL ApoA-IM post centrifuge supernatant was incubated with; 
(A) varying ACN concentration in ultrapure water (used for solutions A & B) or (B) 
50mM Tris, pH 7 with varying ammonium sulphate concentration (solution A) and a 
final wash with 50mM Tris, pH 7 with no ammonium sulphate (solution B). A laser 
strength of 2000 & 6000nJ was used for the low and high m/z regions respectively 
(regions separated by breaks on x-axis). For figure A the y-axis scale is 0 – 60µA and 
0 – 20µA for low and high m/z respectively. For figure B the y-axis scale is 0 – 
1000µA and 0 - 1200 µA for low and high m/z respectively. 
ApoA-IM 
monomer 
ApoA-IM 
monomer 
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5.3.2 Selection of final wash step solutions for all of the selective 
ProteinChips 
 
The final wash step to prepare the selective ProteinChips (CM10, Q10, H50 
& IMAC10) involves an instantaneous ultrapure water wash of the ProteinChips to 
remove salts that may interfere with laser desorption/ionisation (LDI) (Figure 5.1., 
solution B). Since later work required using the ProteinChips with an analogous 
method to that used with a chromatography column, it would be beneficial to 
remove this water wash step. It was also a concern that washing with water may 
remove or irreversible effect the proteins bound. This was a particular concern for 
the hydrophobic (H50) ProteinChips since proteins typically elute from hydrophobic 
surfaces in low salt conditions. 
The aim was to replace the water with a low molarity solution at the same 
pH as the buffer used in the preceding steps (Figure 5.1, solution A). It was 
hypothesized that if the molarity was low enough there would be negligible adverse 
effects on ionization particularly as the proteins already contribute their own ion 
suppression (Annesley,2003). 
 
5.3.2.1 Hydrophobic ProteinChips 
 
As shown previously, hydrophobic ProteinChips satisfactorily adsorbed 
proteins in the presence of ammonium sulphate. The only remaining foreseeable 
downside of using salt instead of reverse phase solvents was that the low salt 
concentrations during the final wash step would be very different to the high salt 
concentrations used during adsorption and hence proteins may desorb from the 
surface. 
To test this hypothesis, a hydrophobic ProteinChip was pre-incubated with 
BSA using 50mM Tris, pH 7 with either 1 or 2M ammonium sulphate (Figure 5.5). By 
varying the final water wash conditions for this ProteinChip it was possible to 
witness desorption. The result demonstrated that once BSA was adsorbed its 
desorption within a time frame of 9.5 minutes was gradual. This result was the 
same for both the 1 & 2M ammonium sulphate conditions. The desorption even 
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seemed to be less than a control spot that used 0.35% TFA in ultrapure water as a 
final wash condition, which was known to be a good adsorption condition from 
Figure 5.3 (A). 
 
Figure 5.5 Non-competitive adsorption of BSA to a hydrophobic ProteinChip by 
varying ammonium sulphate concentration and incubation time.  
A solution of 0.1mg/mL BSA was incubated with 50mM Tris, pH 7. In the legend for 
each spectrum, the top line is the ammonium sulphate concentration in 50mM Tris, 
pH 7 used for equilibration, sample incubation and wash; the middle line is the final 
wash solution and the bottom line is the time for the final wash step. A laser 
strength of 3000nJ was used. 
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5.3.2.2 Ion Exchange ProteinChips 
 
It now seems unlikely that adsorbed proteins are removed by water within 
the time frames of the protocols used. A change in pH from the equilibration, 
binding and wash solution to the final wash with water could still however affect 
the adsorption/desorption of the proteins. ApoA-IM post centrifuge supernatant 
was adsorbed to two spots on a anion exchange (Q10) ProteinChip using 50mM Tris 
at pH 8.0 as solution A. One of the spots had a final wash with water and the other 
had no final wash and was left to dry.  
Interestingly, as can be observed from Figure 5.6, a better response was 
observed for the ApoA-IM monomer (main 28.1kDa/e peak) without a water wash 
than with one although there is minimal effect on the contaminant levels. Overall, 
having 50mM Tris present didn’t seem to have a negative impact on the response 
observed. This shows that a lower concentration of Tris such as 10mM should be an 
adequate replacement for water while still possessing the buffering capabilities 
desired. 
 
Figure 5.6 Varying the final wash step for adsorbed ApoA-IM post centrifuge 
supernatant proteins. 
(A) 50mM Tris, pH 8.0 with no final water wash; (B) 50mM Tris, pH 8.0 with final 
water wash. Identical scales are used for axes with the y axis from 0 – 80amps. 
Laser strength used was 900 & 1250nJ for low & high m/z regions respectively. 
ApoA-IM 
monomer 
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5.3.3 Final decision on which buffers to use for selective ProteinChips 
 
After adapting the protocols in Figure 5.1 it was now necessary to decide 
which buffer species to use in later protein adsorption experiments. Proteins in the 
various samples have highly variable pI values so buffer selection was highly 
dependent on the sample used. Solutions were chosen so that they covered a pH 
range that was 2 pH units from the pI of the protein of interest depending on the 
surface being used. For instance, on a CM10 ProteinChip, buffers were selected that 
provided buffering capabilities covering at least 2 pH units below the pI and on a 
Q10 ProteinChip at least 2 pH units above the pI. The main aim during solution 
choice was to use the fewest number of buffer species to cover the largest pH 
range. This reduced the impact that varying solution species may have on 
adsorption. This lead to the selection of the buffers shown in Table 5.2. 
  
ProteinChip Buffer 
pH Equilibration species (solution A) Final wash species (solution B) 
CM10  
& Q10 
3.0-6.0 20mM Citrate, 0-1M NaCl 5mM Citrate, 0M NaCl 
6.1-6.9 50mM Bis-Tris, 0-1M NaCl 10mM Bis-Tris, 0M NaCl 
7.0-9.0 50mM Tris, 0-1M NaCl 10mM Tris, 0M NaCl 
H50 3.0-6.0 20mM Citrate,  0-2M (NH4)2SO4 5mM Citrate, 0M (NH4)2SO4 
6.1-6.9 50mM Bis-Tris, 0-2M (NH4)2SO4 10mM Bis-Tris, 0M (NH4)2SO4 
7.0-9.0 50mM Tris, 0-2M (NH4)2SO4 10mM Tris, 0M (NH4)2SO4 
IMAC10 7.4 10mM PBS, 0-0.2M imidazole 5mM PBS, 0M imidazole 
Table 5.2 Equilibration and final wash buffers for the selective ProteinChips. 
 
5.3.4 Selective adsorption profiles for the ApoA-IM post centrifuge 
supernatant proteins 
 
The ApoA-IM post centrifuge supernatant proteins were bound to the four 
different ProteinChips under varying pH and salt conditions (Figure 5.7) to explore 
the adsorption characteristics of the proteins present. 
 Solution A was used for equilibration, sample incubation, and wash in a 
single experiment using a single bioprocessor arranged as shown in Figure 5.7. The 
corresponding lower molarity buffer was used for the final wash buffer (solution B, 
Table 5.2). For example, when 20mM sodium citrate, 0M NaCl at pH 3 was used for 
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equilibration, sample incubation and wash, 5mM sodium citrate, 0M NaCl at pH 3 
was used as the final wash. 
 
 
Figure 5.7 Condition array for profiling post centrifuge supernatant 
Four different ProteinChip arrays, each with distinct affinity capture properties are 
aligned side by side. Each array has eight specific spots with defined surface 
chemistry allowing eight different experimental conditions. A specialised bottomless 
plastic 96 well reservoir is placed over these ProteinChips to isolate each of these 
spots. This allows separate exposure of each spot to 200L of buffer. Proteins are 
selectively retained due to the surface chemistry and buffer used. Each condition 
produces a single mass spectrum that displays the proteins retained on the surface 
under that condition. Well B represents an unused spot. 
 
During ProteinChip data acquisition, spots were divided into four partitions 
and two of these partitions were read using different laser strengths. A low laser 
strength (1750nJ) for the low m/z region (5-22.5kDa/e) and a high laser strength 
(3000nJ) for the high m/z region (22.5-60kDa/e). This resulted in two spectra for the 
same adsorption condition. The other two remaining partitions were not used in 
case acquisition needed to be repeated. The whole experiment took less than a day 
to complete and generated a vast array of data. 
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Figure 5.8 shows some of the mass spectra from this experiment at the pH 
that exhibited the best binding of our target protein for each surface. 
 
 
Figure 5.8 Mass spectra for adsorbed ApoA-IM post centrifuge supernatant 
proteins using conditions in Figure 5.7. 
(A) CM10 ProteinChip at pH 3 under varying NaCl concentration; (B) Q10 
ProteinChip at pH 8 under varying NaCl concentration; (C) H50 ProteinChip at pH 5.5 
under varying (NH4)2SO4 concentration; (D) IMAC10 ProteinChip at pH 7.4 under 
varying imidazole concentration. Laser strength of 1750 & 3000nJ was used for low 
and high mass respectively. 
 
It was observed that the CM10 ProteinChip at pH 3 bound more proteins in 
the ApoA-IM post centrifuge supernatant than any of the other conditions used and 
interestingly many impurities were bound when the ApoA-IM no longer adsorbed at 
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0.3M NaCl. It could be argued therefore that binding at 0.1M NaCl and eluting at 
0.3M NaCl could be a very good capture step on a cation exchange column at pH 3. 
The major downside to this is the extra sample preparation required in order to 
reduce the pH of solution past 4.8, the pI of ApoA-IM (section 5.2). The Q10 
ProteinChip also bound many of the proteins. 
The best adsorption conditions on the H50 ProteinChip were at pH 5.5 
which may be due to it being close to the pI of ApoA-IM. The ApoA-IM adsorption 
lessens as you lower ammonium sulphate but then binds the most at 0M, probably 
due to “salting in” as described previously (Arakawa and Timasheff,1984). It would 
have been very interesting to see if a good separation was achievable on the 
hydrophobic ProteinChip at pH 3 which may have validated further scouting of a 
cation exchange and a hydrophobic interaction chromatography sequence. Of 
course, this would be based on assuming that the hydrophobic ProteinChip could 
be related to real chromatography, which is still to be determined. 
 
5.4 Summary 
 
Review of chapter aims: 
 
 Finalise SELDI protocols for purification development 
 Hydrophobic ProteinChips can produce adsorption data with ammonium 
sulphate buffers so the use of reverse phase solvents and the consequent 
damage they may cause to the proteins can be avoided. 
 Water in the final wash step of ProteinChip preparation can be replaced 
with a low molarity buffer to maintain the same pH used during 
equilibration, sample incubation and washing. 
 Buffers selected that used minimal solution species while covering a large 
pH range in order to keep any impact from varying solution species to a 
minimum. 
 Buffer solutions chosen that cover at least plus and minus two pH units from 
the pI of the protein of interest for the Q10 and CM10 respectively.  
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 Use protocols to generate adsorption data for the remaining sections of this 
thesis. 
 Ninety three conditions were used to generate a large array of adsorption 
data for ApoA-IM post centrifuge supernatant proteins to be used in the 
following chapters. 
 
Due to the large volume of mass spectra data, the next chapter will address 
the creation of a flexible platform to expedite data handling with the ultimate aim 
of creating unique ways to aid purification development in chapter seven. 
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CHAPTER 6 DATABASE FOR HANDLING PROTEIN MASS SPECTRA 
 
6.1 Introduction 
 
Ciphergen Express is preinstalled in a computer linked to the Bio-Rad 
ProteinChip Reader. The platform has various functions for improving data quality. 
Although excellent software with an easy to use graphical user interface, extra 
programming flexibility would be beneficial to organize, treat and visualize mass 
spectra data within a single platform for purification development. 
Matlab (The Mathworks Inc., Natick, U.S.A.) was the platform of choice due 
to its common use in engineering research and because other groups had 
previously written programming code for various SELDI mass spectrometry 
treatment algorithms (Coombes et al. 2005).  
This chapter will discuss the elements required and the resultant functions 
created to produce a program within the Matlab environment to handle SELDI-MS 
data. Once the Matlab functions were in place they could then be compared with 
the Ciphergen platform based on the reproducibility of data sets processed using 
the two routines (Figure 6.1). All Matlab code created for this chapter is located in 
the appendix to this thesis. 
After elucidating issues associated with SELDI-MS data (chapter two) and 
modifying selective ProteinChip preparation to generate adsorption mass spectra 
(chapter five) it is now necessary to find a method to automate the organisation 
and treatment of the data for use in chapter seven.  
 
Chapter aims: 
 Create Matlab functions to organise data based on adsorption conditions used. 
 Apply Matlab functions to carry out typical mass spectra data treatment. 
 Compare Matlab with Ciphergen Express data treatment. 
 
 
Protein mass spectrometry for bioprocess development & monitoring 
 
126 
 
 
Figure 6.1 Options for mass spectra data treatment.  
 
6.2 Materials & Methods 
 
Unless specified otherwise the materials & methods are unchanged from 
section 2.2. 
 
6.2.1 Mass spectrometry 
 
6.2.1.1 Selective ProteinChip preparation 
 
 Two Q10 ProteinChips (16 spots in total) were equilibrated three times with 
150L of 50mM Tris, pH 8, 0M NaCl (solution A) for 5 minutes under shaking (8.3 
rps). The spots were then loaded with 150L of ApoA-IM post centrifuge 
supernatant previously diluted ten-fold in solution A. The sample was incubated 
with the spot surface for 30 minutes while being shaken (8.3 rps). Each spot was 
then washed three times with 150L of the solution A for 5 minutes under shaking 
(8.3 rps) to eliminate non-adsorbed proteins. Each spot then finally had 
instantaneous exposure to 10mM Tris, pH 8, 0M NaCl (solution B) to reduce salts 
while maintaining pH. After 20 minutes the spots were dry and 1L of SPA was 
Ciphergen processing 
Raw TOF data for low and high m/z regions 
Upload data into Matlab environment 
 
 
Matlab 
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Check peak reproducibility 
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applied. After 5 minutes the SPA application was repeated before a final 5 minute 
dry step prior to ProteinChip analysis. 
 
6.2.1.2 Data acquisition 
 
All arrays were analyzed using a PCS4000 Reader (Figure 1.13) in a positive 
ion mode, with a source voltage of 25kV. The m/z range investigated was from 5 to 
60kDa/e for all samples. All of the proteins of interest were within this range. Focus 
mass was set to the m/z of the target protein (28.1kDa) being investigated. All spots 
were divided into four partitions and one partition read with the same laser 
strength for all spots. One spot was chosen to have all four partitions read. Laser 
strength responsible for the desorption-ionization of proteins was 1850nJ for low 
and high m/z regions. Adsorption of sample proteins on arrays appeared as a signal 
at the appropriate molecular masses. 
 
6.2.2 Data treatment 
 
Ciphergen Express 3.0 & Matlab 7.5 were the two platforms used in this 
study. Ciphergen Express 3.0 and Matlab 7.5 were used as described in section 2.2 
and 3.2 respectively. 
 
6.3 Results 
 
To create a Matlab programming space for use in chapter 7 the following 
was required; a way of easily uploading and sorting the large volume of data from 
the Ciphergen Express software and then carrying out batch treatment of the data. 
 
6.3.1   Organisation & storage of mass spectrometry data 
 
Before any data treatment could be carried out on Matlab, it was necessary 
to import the data into the Matlab environment while maintaining information 
about its preparation. Data from the ProteinChip reader can be exported from 
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Ciphergen Express as comma separated value (.csv) files. Ciphergen Express names 
the files with the name given to the spectrum by the user during data acquisition. In 
order to keep a record of preparation parameters in Matlab, a short code was 
created to name each spectrum within Ciphergen Express before exporting them 
(Figure 6.2). A script could then be written in Matlab to de-code how the 
ProteinChip was prepared from the filename of each spectrum. The code created 
for each spectrum is based on the minimum number of characters necessary to 
describe the level used for each of the factors chosen. The four factors used were 
ProteinChip surface, pH, salt species, and salt concentration. Since there were two 
sets of data for each adsorption condition (low and high m/z data) Ciphergen 
Express automatically appends “_1” to the filename of one of the files to make the 
filenames unique.  
Raw data was exported and stored in a “Raw” folder in the Matlab 
environment (Figure 6.5). The same data processed with Ciphergen functions was 
exported into a “Processed” folder. Metadata was also exported with the processed 
data to keep a record of the acquisition parameters used.  
The process of organising and storing mass spectra data is summarised in 
Figure 6.3. 
 
Figure 6.2 Identification code for mass spectra files. 
Code created so each spectra in Matlab can be linked to the adsorption conditions 
used to generate them. 
x0000y0000m 
pH 
e.g. 0700 = 7.0 
Salt Concentration 
e.g. 1000 = 1M 
Salt Species 
e.g. y = 
s – NaCl 
a – (NH4)2SO4 
i – Imidazole 
m/z Region 
Presence or 
absence of “_1” 
signifies low or 
high m/z spectra 
ProteinChip Surface 
e.g. x = 
c - CM10 
q – Q10 
h – H50 
i – IMAC10 
n – NP20 
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Figure 6.3 Uploading mass spectra data into the Matlab environment. 
 
6.3.2 Program execution 
 
A “ReadRoot” program was created that when executed, opened the 
previously created “Processed” folder and read each of the .csv files individually to 
extract the m/z, intensity and metadata information. It then collated all this data 
into m/z and intensity matrices plus matrices for metadata and filenames. The 
program also clipped the “_1” from the ends of any filenames in the filenames 
matrix so that the low and high m/z data now had identical names. The spectra files 
in the “Raw” folder where then read based on the filenames matrix to make sure all 
the processed data had supporting raw data for later data treatment comparisons. 
 
6.3.3 Treatment of raw mass spectrometry data 
 
There were various options for the treatment of SELDI-MS data, many of 
which have been published (Coombes et al. 2005). Typically the initial data 
treatment involves noise reduction and baseline correction (Figure 6.4). Different 
treatment routines will later be compared based on peak reproducibility. 
 
Export raw .csv files into  
raw folder 
Export processed & meta .csv files into 
processed folder 
Extract conditions from identification code 
Process spectra 
Ciphergen Express 
Matlab 
Name spectra with identification code 
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Figure 6.4 Processing mass spectra data within the Matlab environment. 
 
6.3.3.1 Noise reduction 
 
Usually the first processing step used on raw mass spectrometry data 
(Figure 6.5) is denoising. The noise is believed to be caused by fluctuations in 
current output (Coombes et al. 2005).  
 
 
Noise reduction 
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Upload raw data into Matlab environment 
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Figure 6.5 Raw mass spectra for adsorbed ApoA-IM post centrifuge supernatant 
proteins. 
A solution of 0.05mg/mL ApoA-IM post centrifuge supernatant was bound to a Q10 
ProteinChip at pH 8.0, 0M NaCl. Each spectrum is from 1 of 4 partitions. The laser 
strength used was 1850nJ for the low and high m/z regions. 
 
After researching different denoising functions it was decided to use one 
publicized in a journal by a group at the University of Texas (Coombes et al. 2005). 
In their work they used an Undecimated Discrete Wavelet Transform (UDWT) that 
was shown to be very effective at denoising spectra. This transform uses small 
waves located at different times as the basis function. The transform is achieved by 
scaling and translation of a scaling function and wavelet function, meaning that the 
wavelet transform unlike other transforms (e.g. Fourier) is localised in both time 
and frequency.  
In this work the method involved transformation of the data from the initial 
time domain to the wavelet domain. The variability of the wavelet coefficients is 
then computed based on their median absolute deviations (MAD). Any coefficients 
below a chosen threshold (0.67xMAD) are then set to zero. The data is then 
transformed back to the original time domain.  Figure 6.6 & Figure 6.7 respectively 
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show the estimated noise and its subtraction from the raw spectra shown in Figure 
6.5. 
 
Figure 6.6 Mass spectra signal noise for adsorbed ApoA-IM post centrifuge 
supernatant proteins.  
A solution of 0.05mg/mL ApoA-IM post centrifuge supernatant proteins were bound 
to a Q10 ProteinChip at pH 8.0, 0M NaCl. Each spectrum is from 1 of 4 partitions. 
The laser strength used was 1850nJ for the low and high m/z regions. Signal noise 
was calculated using an undecimated discrete wavelet transform. 
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Figure 6.7 Denoised mass spectra for adsorbed ApoA-IM post centrifuge 
supernatant proteins.  
A solution of 0.05mg/mL ApoA-IM post centrifuge supernatant was bound to a Q10 
ProteinChip at pH 8.0, 0M NaCl. Each spectrum is from 1 of 4 partitions. The laser 
strength used was 1850nJ for the low and high m/z regions. 
 
6.3.3.2 Baseline correction 
 
After denoising, baseline correction is the next common step for treatment 
of mass spectra. The function used by Coombes et al. was a monotone minimum 
estimation. This served the purpose for their work but they did not recommend it 
for others to use. In this thesis, a baseline correction function (msbackadj) was used 
with default settings from the Matlab bioinformatics toolbox. This function 
estimates the baseline within multiple shifted windows of width 200 m/z and then 
regresses the varying baseline to the window points using a spline approximation. 
This function allowed increased flexibility due to the various methods of baseline 
adjustment that could be used. Figure 6.8 shows the removal of the baseline from 
the spectra in Figure 6.7 using the default settings for the Matlab function. 
 
Protein mass spectrometry for bioprocess development & monitoring 
 
134 
 
 
Figure 6.8 Denoised & baselined mass spectra for adsorbed ApoA-IM post 
centrifuge supernatant proteins.  
A solution of 0.05mg/mL ApoA-IM post centrifuge supernatant was bound to a Q10 
ProteinChip at pH 8.0, 0M NaCl. Each spectrum is from 1 of 4 partitions. The laser 
strength used was 1850nJ for the low and high m/z regions. 
 
6.3.3.3 Splicing low and high m/z spectra data 
 
After the raw spectra had been processed for both low and high m/z regions 
it would now be beneficial to splice the low and high m/z data together to get one 
spectrum for each condition instead of the original two. Since ‘_1’ had been 
removed from the ends of half of the filenames, the filenames matrix now had 
identical names for the low and high m/z data. This allowed the use of Matlabs 
“unique” function to find the pairs of filenames that were identical. Based on this 
the corresponding mass spectra data was then also paired. The low and high m/z 
data from each pair were then identified by comparing the ratio of their start and 
end m/z values. The data was then spliced together correctly and clipped at the 
extremes of m/z.  As can be seen from Figure 6.8 the values chosen for these 
spectra were; minimum m/z of 5kDa/e, intersect between low and high m/z data of 
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22.5 kDa/e and maximum m/z of 60kDa/e. Now each adsorption condition only had 
one spectrum created from the original low and high m/z spectra. 
 
6.3.3.4 Identifying peaks 
 
One of the biggest hurdles in biomarker discovery is finding an algorithm 
that can successfully and consistently locate real peaks. In biomarker discovery 
many samples are investigated with relatively few different adsorption conditions, 
in purification development the opposite is true. The advantage of this is that peak 
selection only needs to be done once on conditions where many peaks bind.  
After trialling many different peak selection algorithms it was decided that 
manual peak selection would be preferred in this work due to individual users being 
more inclined to select real peaks rather than artefacts of mass spectrometry. The 
next step in the data treatment routine involved summing peak intensities as 
described in section 3.2. 
 
6.3.4 Reproducibility 
 
6.3.4.1 Partitions within a spot 
 
To compare the Matlab and Ciphergen Express platforms, the coefficient of 
variation (%CV) was calculated for thirty manually selected peaks (also used in the 
next chapter) in ApoA-IM post centrifuge supernatant across four out of four 
partitions on a Q10 ProteinChip spot. Interestingly Figure 6.9 shows that de-noising 
raw spectra marginally improves peak reproducibility across partitions but baseline 
correction carried out with Ciphergen Express and Matlab actually reduces 
reproducibility compared to the raw spectra. Summed peak intensity also 
marginally improves peak reproducibility compared to peak intensity for all 
treatments including the raw data. 
Before final conclusions could be drawn on these different treatment 
methods, it was decided to see if similar observations were seen when investigating 
reproducibility across spots on different ProteinChips. 
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Figure 6.9 Peak reproducibility between spot partitions for adsorbed ApoA-IM 
post centrifuge supernatant proteins. 
A solution of 0.05mg/mL ApoA-IM post centrifuge supernatant was bound to a Q10 
ProteinChip at pH 8.0, 0M NaCl. Reproducibility is from 4 out of 4 partitions on one 
spot. The %CV was calculated for each manually selected peak across partitions. The 
average and standard deviation of the %CV for the thirty peaks was then plotted for 
each treatment method. DN and BC refer to de-noised and baseline corrected 
spectra respectively. The laser strength used was 1850nJ for the low and high m/z 
regions. 
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6.3.4.2 Partitions between spots 
 
Figure 6.10 shows that the % CV is higher when examined across spots and 
ProteinChips than within partitions, ranging from 20 to 40% depending on the 
treatment method used. Other groups have also reported coefficients of variation 
above 30 percent due to the multi-variable nature of the SELDI-MS technique 
(Panicker et al. 2009;Semmes et al. 2005).  
Apart from the % CV, the patterns seen between Figure 6.9 and Figure 6.10 
are similar. Figure 6.10 shows that denoising raw spectra marginally improves peak 
reproducibility across spots & ProteinChips but baseline correction carried out with 
Ciphergen Express and Matlab show a proportionally large deterioration in 
reproducibility compared to the raw and de-noised spectra. Summed peak intensity 
also marginally improves peak reproducibility compared to peak intensity for all 
treatments including the raw data. 
In the next chapter the method used for purification development will 
therefore de-noise the raw data but no baseline correction will be carried out. Also, 
summed peak intensity will be used. When deciding on data visualisation 
techniques in the next chapter, the approach chosen will incorporate a method to 
improve reproducibility further. 
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Figure 6.10 Peak reproducibility between ProteinChips for adsorbed ApoA-IM 
post centrifuge supernatant proteins. 
A solution of 0.05mg/mL ApoA-IM post centrifuge supernatant was bound to a Q10 
ProteinChip at pH 8.0, 0M NaCl. Reproducibility is from 1 out of 4 partitions on 
sixteen spots (two ProteinChips). The %CV was calculated for each manually 
selected peak across partitions. The average and standard deviation of the %CV for 
all thirty peaks was then plotted for each treatment method. DN and BC refer to de-
noised and baseline corrected spectra respectively. The laser strength used was 
1850nJ for the low and high m/z regions. 
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6.4 Summary 
 
Review of chapter aims: 
 
 Create Matlab functions to organise data based on adsorption conditions used. 
 Matlab functions created that can upload and interpret spectra files in order 
to sort the spectra data based on adsorption conditions used. 
 Functions allow the retention of meta data. 
 Spectra files for low and high m/z are spliced together to produce one 
spectrum for each adsorption condition.  
 
 Apply Matlab functions to carry out typical mass spectra data treatment. 
 Functions from the literature and the Matlab bioinformatics toolbox have 
been used to treat the data within the Matlab framework and those 
successful for improving reproducibility retained for use in the next chapter. 
 Baseline correction showed a drop in reproducibility hence Matlab will now 
only be used to treat the data using denoising and summed peak intensity 
calculations. 
 To reduce the variability of the mass spectrometry data further, the 
approach chosen in the next chapter for purification development will 
incorporate a method that uses peak normalisation. 
 
 Compare Matlab with Ciphergen Express data treatment. 
 Baseline corrected data from Matlab and Ciphergen Express give similarly 
large coefficient of variations. 
 The Ciphergen software was found to be good for quick, initial screening of 
data so that decisions could be made on which datasets to export to Matlab. 
 Matlab will be used in the next chapter because it provides the freedom to 
try many different data visualisation techniques. 
Protein mass spectrometry for bioprocess development & monitoring 
 
140 
 
CHAPTER 7 MASS SPECTROMETRY TO DESCRIBE PRODUCT AND 
CONTAMINANT RELATIONSHIPS FOR BIOPROCESS DEVELOPMENT 
 
7.1 Introduction 
 
Traditionally, biopharmaceutical process development starts without full 
characterization of the material produced from fermentation. It would be 
particularly advantageous to determine the proteins that have similar 
physicochemical properties to the product prior to purification. In upstream 
operation, cell lines and the conditions they are grown under could be changed or 
the host’s genetic information modified to alter the properties of protein 
contaminants similar to the product, relieving some of the burden on later 
purification stages (Humphreys et al. 2004). For the downstream processing 
sequence, the physicochemical information of near neighbour contaminants could 
be used to select the best purification strategy. 
Current methods for full physicochemical property characterisation are very 
time consuming, labour intensive and carry with them many unfavourable 
assumptions and could fall on the  process development critical path, something 
which will always be avoided. This lack of a rapid method for full characterisation 
leads to reduced flexibility in the process due to laborious, time consuming 
experimentation with every process change.  
Conditions for the removal of cellular debris have been found previously in 
chapter four to avoid fouling of the chromatography column. The focus of this 
chapter is to use SELDI-MS adsorption data generated during chapter five and 
treated in chapter six for detecting retained compounds with shared 
physicochemical properties in order to rapidly characterize feed materials 
(Merchant and Weinberger,2000). Patterns in the differential adsorption of 
proteins to ProteinChip surfaces have been investigated as a route to address this. 
Similarities between proteins are then deduced and hence impurity proteins that 
are hardest to separate from the product identified. 
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Summary of chapter aims: 
 Incorporate peak normalisation, where peaks are compared against one 
another within a spectrum to reduce variability. 
 Develop a physicochemical map to compare proteins within a given process 
material. 
 Determine nearest neighbours to target protein. 
 Commence investigation into the conditions that may be promising for 
separating the target protein from nearest neighbours. 
 
7.2 Materials & Methods 
 
Unless specified otherwise the materials & methods are unchanged from 
section 5.2. 
 
7.2.1 Protein samples 
 
A stock solution of 2mg/mL ovalbumin in 50mM Tris, pH 7 was created. A 
hen egg white (HEW) solution was made following protocol in section 2.2. The 
process materials used in this study came from an E. coli process generating ApoA-
IM (Figure 3.1) and was provided by the Pfizer Global Biologics group (Chesterfield, 
MO, U.S.A.). 
 
7.2.2 Mass spectrometry 
 
7.2.2.1 Data treatment 
 
SELDI-MS spectra were analysed using functions written within Matlab using 
settings as defined in section 3.2 (Coombes et al. 2005). Peaks were manually 
selected based on a signal/noise ratio > 5 and from prior SELDI-MS analysis of the 
samples. SELDI-MS results were recorded by summing signal intensities between 
+/- 0.3% of peak m/z. The value of 0.3% was decided from previous work, 
discussions with Bio-Rad Inc. (Hercules, CA, U.S.A.) and its frequent use in the 
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literature as a parameter for SELDI-MS peak detection (Brozkova et al. 
2008;Panicker et al. 2009). Baseline correction was not used for star plots, 
dendrograms or adsorption maps due to the treatment incurring decreased peak 
signal reproducibility as shown in the previous chapter. 
 
7.2.3 Chromatography 
 
 Chromatography was performed with a HiTrap column (7mm i.d. x 250mm 
height, 1mL) on an AKTA Explorer 100 system. These were supplied by GE 
Healthcare (Uppsala, Sweden). 
The column was delivered pre-packed with a Q Sepharose fast flow sorbent. 
The buffer condition used was; equilibration, wash with 50mM Tris, pH 8, 100mM 
NaCl and elution with 50mM Tris, pH 8, 400mM NaCl. 
Chromatography separations were accomplished at a flowrate of 1mL/min 
equivalent to a linear velocity of 0.04cm/s. Absorbance of column effluents was 
recorded at 280nm. 
The column was equilibrated with 10 CV (column volumes) of equilibration 
buffer. The sample was diluted to 1 mg/mL and adjusted to column equilibration 
conditions before direct loading of 10mL onto the column. The non-adsorbed 
proteins were washed out with 5 CV of equilibration buffer. The column was eluted 
with 10 CV of elution buffer before being cleaned with 10 CV of equilibration buffer 
with 2M NaCl. The column was stored in 1M sodium hydroxide. 
Fractions of 1mL each were collected throughout and diluted 1in100 with 
50mM Tris, pH 8.0, 0mM NaCl before being analysed directly on an anion exchange 
(Q10) ProteinChip as described in section 6.2. This buffer was chosen because it 
showed favourable binding of many proteins in the ApoA-IM post centrifuge 
supernatant including ApoA-IM and its nearest neighbour impurities. Fractions 
were also analysed using RP-HPLC following the protocol in section 3.2 to confirm 
that Q10 ProteinChips are able to produce quantitative data. 
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7.2.4 Data visualisation techniques 
 
7.2.4.1 Star plots 
 
Star plots (Figure 7.1) consist of equiangular spokes around an origin. Each 
spoke represents a variable and its length represents a normalised response. 
Normalisation is based on the maximum response observed for that variable across 
all the data. The data values for each spoke are connected by a line. 
 
Figure 7.1 A star plot example from The Mathworks Inc. (Natick, MA, U.S.A.) 
This example shows how different cars can be compared, with each spoke 
representing a different property e.g. engine size. 
 
7.2.4.2 Dendrograms 
 
There are two main steps before dendrogram creation; calculating a 
distance between observations and then linking these observations by clustering. 
There are many distance metrics available such as Mahalanobis, Manhattan and 
Chebyshev but the most commonly used distance metric and the one used for this 
work was Euclidean distance (Bonet et al. 2008). This was used to measure 
differences in peak intensities over the range of adsorption conditions used. For 
three identified peaks, A, B & C we have (Equation 7.1); 
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𝐴𝐵    =    𝑎𝑖 − 𝑏𝑖 2
𝑛
𝑖=1
 
𝐴𝐶    =    𝑎𝑖 − 𝑐𝑖 2
𝑛
𝑖=1
 
𝐵𝐶    =    𝑏𝑖 − 𝑐𝑖 2
𝑛
𝑖=1
 
Equation 7.1 Euclidean distance 
where a, b and c are peak intensities for peak masses A, B and C respectively. 
Subscript i refers to individual adsorption conditions; and the number of conditions 
studied in this case was 93. 𝐴𝐵    , 𝐴𝐶     and 𝐵𝐶     are the Euclidean distances between 
peak masses A, B and C. 
 
For the average linkage method, otherwise known as the unweighted pair 
group method with arithmetic mean (UPGMA), the two proteins with the smallest 
value from Equation 7.1, for instance A & B, are joined at a node connected by two 
branches to start the formation of a dendrogram. The combined height of both 
branches represents the differences in peak intensities between them. The 
difference in peak intensities between the new cluster (AB) and another peak mass 
(C) is then an average of the difference in peak intensities of A from C and of B from 
C (Equation 7.2).  
 
(𝐴𝐵    )𝐶 =
1
2
 𝐴𝐶    + 𝐵𝐶      
Equation 7.2 Calculating the new distance from cluster AB to peak mass C using 
UPGMA. 
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Figure 7.2 Dendrogram formation 
 
Once the new distances are calculated the next nearest observations would 
be joined (Figure 7.2). In this simplified example, this could only be C since it is the 
only peak mass left but in reality it could be any of the peak masses chosen at the 
start of the algorithm. The algorithm would continue until a dendrogram is formed. 
 
7.3 Results 
 
7.3.1 Measurement of contaminants during purification 
 
Figure 7.3 shows chromatography samples analysed from the ApoA-IM 
process. It reveals that two chromatography steps are necessary to remove the 26.2 
and 27.2kDa/e proteins. All the other product related impurities (deduced from 
their m/z values) were not removed even after three chromatography steps 
although it could be argued that dimers at 54.6 and 57.5kDa/e may no longer be 
present after two steps. The most distantly related impurities in mass terms are 
removed after one chromatography step, particularly proteins less than 14.6kDa/e. 
The hardest proteins to separate from the product are the 28.6 and 29.1kDa/e 
proteins which are shown to remain with our product even after three 
chromatography steps. The peak at ~14kDa/e could be a double charged form of 
the product. The analysis reflects what is seen in many other separations e.g. 
monoclonal antibodies, where product related forms are the most challenging to 
separate.  
 
  
A B C 
AB 
2 
(AB)C 
2 
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Figure 7.3 Mass spectra for process chromatography samples. 
As in Figure 3.3; (E) post centrifuge supernatant; (G) Capture pool; (H) IEX pool; (J) 
UF/DF 2, after HIC. Analysis was carried out on an NP20 ProteinChip. The low m/z 
(1-30 kDa/e) and high m/z (5-90 kDa/e) regions were acquired at 1750 and 3000nJ 
respectively. The y-axis scale used for each mass to charge range is shown in the top 
spectra. The same scale is used for all samples.  
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The hypothesis was to investigate the possibility of predicting the observed 
separation difficulty of the feed material components based upon adsorption 
behaviour (physicochemical properties) using SELDI-MS. The ability to determine 
the extent of the separation challenge presented by near neighbour proteins for 
any given process feed materials could be used to determine manufacturability e.g. 
based on the cell line or upstream processing strategy. 
 
7.3.2 Generating basic physicochemical properties using mass spectrometry 
 
A physicochemical property of proteins is the isoelectric point (pI). The 
theoretical pI of a protein is the pH at which the net electrical charge of all the 
constituent amino acids is zero. The product protein sequence will most likely be 
known but this is not necessarily the case for contaminants. For proteins with 
unknown amino acid sequences an empirical method such as two-dimensional 
electrophoresis is necessary to find their pI values. A downside to this approach 
however is the amount of time necessary for optimising the method for each new 
sample. 
Using the isoelectric point to find conditions to separate a protein of 
interest from contaminants also has its drawbacks. It is usually assumed that when 
the net charge of a protein is zero it will not adsorb to an ion-exchange column. 
However, the isoelectric point gives no information on charge distributions and 
there may be localised patches of charge on its surface allowing adsorption to 
occur.  
A direct method is needed to find conditions where proteins adsorb to a 
sorbent. It was considered that SELDI-MS could be used to get this information by 
using cation and anion exchange ProteinChips. Figure 7.4 and Figure 7.5 
respectively show how this can be done using a single protein and a complex 
mixture as examples. As can be seen, there is some correlation between the neutral 
adsorption point and the isoelectric points of the proteins in HEW, with the rank 
order of the adsorption point pH following the rank order of the isoelectric points 
for the proteins (Table 1.7).  
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Figure 7.4 Non-competitive adsorption of ovalbumin to electrostatically charged 
surfaces. 
A solution of 2mg/mL ovalbumin in 50mM Tris, pH 7 was diluted ten-fold in buffers 
with pH from 4.4 to 8.6 pH (Table 5.2) before incubation with: a cation exchange 
(CM10) ProteinChip (top spectrum) & an anion exchange (Q10) ProteinChip (bottom 
spectrum). Subtracting the summed peak intensity from the two spectra gives an 
approximation of the neutral adsorption point of a protein. This can be carried out 
for any protein present. The pH at which the neutral adsorption point is equal to 
zero can sometimes be similar to the pI but as this figure shows this is not always 
the case. A laser strength of 1000nJ was used during acquisition and the spectra 
were processed using Matlab as described in section 7.2. For ease of visualisation, 
baseline correction was applied to the spectra in the top half of the figure but this 
was not used when calculating net summed intensities.  
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Figure 7.5 Competitive adsorption of hen egg white proteins to electrostatically 
charged surfaces. 
Adsorption of lysozyme, lys (●), ovalbumin, ova (∆) and conalbumin, con (○) onto 
cation- exchange (CM10) & anion-exchange (Q10) ProteinChips at pH 4.5 to 9. A 
laser strength of 1000nJ was used during acquisition and the spectra were 
processed using Matlab as described in section 7.2. 
 
7.3.3 Visualising nearest neighbour contaminants using mass spectrometry 
data 
 
To find more physicochemical properties, the next step involved incubating 
the feed material to four surface chemistries representative of those applied in 
process chromatography using an array of buffers of varying pH and salt 
concentration. The level of adsorption of each protein for each of these conditions 
is then detected by laser desorption/ionisation mass spectrometry.  
Star plots were used to represent the differences between proteins based 
on their binding to these surfaces under the various conditions investigated. The 
star plots were created by observing the binding of each protein under all the 
conditions chosen (Figure 5.7) and normalising against the maximum response 
observed for that protein. As well as producing star plots that are readily 
ova con 
lys 
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comparable to one another, this normalisation also improved reproducibility. 
Plotting the data equiangular around a single origin produced a star plot for each 
protein. These plots were created in Matlab using the “glyphplot” function. There 
were 93 conditions analysed (Figure 5.7), which meant peak intensities plotted on 
the glyphplot every 3.87 degrees (360 degrees/93).  
Figure 7.6 shows how the star plots were plotted including how the 
conditions were placed around the origin. Star plots were created for thirty proteins 
selected in the post centrifuge supernatant (Figure 7.6). The star plots highlight that 
proteins are shown to be distinct while a significant portion are very similar to one 
another. 
 The next step was to create a method to quantify and visualise these 
relationships. This was achieved by creating dendrograms. Dendrograms are 
commonly used to visualise large amounts of multi-dimensional data and are 
commonly used to cluster genes in computational biology. This technique allows 
visual comparison between the data represented in Figure 7.6. Star plots were 
compared to produce a dendrogram showing the relationship between their 
adsorption characteristics. Those proteins linked by small branches are closely 
related and those with long branches between them are most likely distinct 
proteins with little if any similarities. 
 Three distinct clusters are formed (Figure 7.7). Cluster 1, are proteins 
distantly related to the product (28.1kDa/e). Based on their m/z values this group of 
proteins doesn’t seem to include any product related species and with the 
exception of the 35.2kDa/e protein are all fairly small (<14.6kDa/e). Cluster 2, are a 
group of closely related proteins. This group includes the product. All of these 
proteins have m/z values that suggest they may be product related. These proteins 
could possibly be truncations (27.2, 28.6 and 29.1kDa/e), dimers (54.6, 56.3, 
57.5kDa/e), and a trimer form (84.2kDa/e). The final major group is cluster 3. Apart 
from the 26.2kDa/e protein none of these proteins were believed to be product 
related. Within this group are a sub-group of proteins that have m/z values from 
40.1 to 48.6kDa/e. These proteins have near identical physicochemical properties.   
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The method identifies the near neighbour contaminants hardest to separate 
from the product. In this case these impurities are shown to be product related 
proteins, particularly the 29.1 and 28.6kDa/e proteins. This correlates well with the 
observations of the pilot scale downstream processing (Figure 7.3).  
This technique also allows the possibility of weighting impurities prior to 
dendrogram formation to bias the removal of some impurities over others. For 
example, this could be particularly useful if there was a desire to remove particular 
proteases early that maybe known to be damaging to the product protein. 
 
 
 
Figure 7.6 Star plots for thirty proteins contained within post centrifuge 
supernatant. 
Each spoke of a star represents one of ninety three different binding conditions 
shown in Figure 5.7. Proteins are identified based on their m/z ratio shown 
1
10
5
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underneath each star. The star plot highlighted with a red box is the product at 28.1 
kDa/e. Stars give a qualitative indication of how proteins are related in terms of 
physicochemical properties. 
 
 
Figure 7.7 Dendrogram to show relationships between post centrifuge 
supernatant proteins. 
The dendrogram is based on adsorption characteristics from SELDI-MS and shows 
how major proteins in the post centrifuge supernatant are related. Proteins with 
relatively short branch lengths between them are closely related and those with 
relatively long branch lengths are distantly related.  The product (28.1kDa/e protein) 
is indicated by red branches. The dendrogram was created using Euclidean distance 
and the average linkage method (UPGMA) for clustering. 
 
7.3.4 Identifying conditions for separating nearest neighbour contaminants 
using mass spectrometry 
 
After predicting which proteins are problematic to remove (product related 
species) it is necessary to find ways to separate them from the product. As 
mentioned previously, it is unlikely that ProteinChips fully represent the subtleties 
of surface interactions for the wide range of chromatography resin available but 
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they should however give insight into where to start scouting experiments in order 
to find conditions to separate the nearest neighbour contaminant from the 
product. 
Figure 7.8 shows adsorption maps for the product, a closely related protein 
(29.1kDa/e) and distantly related protein (12.7kDa/e) on the different ProteinChips 
under varying pH (x-axis) and salt concentration (y-axis). Red regions indicate high 
protein adsorption and blue regions indicate low protein adsorption. As expected, 
Figure 7.8 shows that the product has very different adsorption characteristics to 
the distantly related contaminants and displays very similar behaviour on both 
cation exchange and hydrophobic surfaces.  
It was found that there were some slight differences between adsorption on 
the anion exchange ProteinChip particularly near the edges of the binding region 
for the product and nearest neighbours while being in the low adsorption region for 
the distantly related proteins (Figure 7.8). These were conditions at high pH (>=8) 
and with the addition of sodium chloride (>=0.1M). 
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Figure 7.8 Selectivity maps for product and nearest neighbour contaminants.  
Post centrifuge supernatant was incubated with a cation (CM10), anion (Q10) & 
hydrophobic (H50) ProteinChip using the conditions Figure 5.7. Red regions 
correspond to high protein adsorption while blue corresponds to low protein 
adsorption. A laser strength of 1750nJ & 3000nJ was used respectively for the low 
and high m/z regions. The white circle indicates the selected pH 8, 100mM NaCl 
condition used for the equilibrium, load and wash for the Q Sepharose FF 
chromatogram in Figure 7.9.  
 
7.3.5 Nearest neighbour removal analysis 
 
The chromatography condition chosen to test the separation on a column 
was a Q Sepharose FF resin with 50mM Tris, pH 8, 100mM NaCl buffer for 
equilibration, loading and washing (indicated by white circle in Figure 7.8). Figure 
7.9 shows the chromatogram generated for the Q column using 50mM Tris, pH 8, 
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100mM NaCl buffer for equilibration, loading and washing. Elution fractions from 
this chromatogram were pooled and analysed for product using Q10 ProteinChips 
with 50mM Tris, pH 8.0 and RP-HPLC to confirm results. The anion exchange 
condition was selected to provide good adsorption of product related species to 
improve analytical sensitivity. The representative impurities selected were: (a) very 
distantly related to the product (9.3 and 12.7kDa/e proteins), (b) a protein that was 
moderately related to the product (35.2kDa/e) and (c) some nearest neighbours to 
the product (28.6, 29.1, and 56.3). 
Figure 7.9 shows that conditions chosen seemed to separate the product 
from distantly related proteins (9.3 and 12.7kDa/e) but not the 35.2kDa/e proteins 
or the nearest neighbour contaminants (28.6, 29.1, and 56.3). This illustrates the 
difficulty of separating such closely related proteins in a single step, a fact borne out 
in the previously developed process (Figure 7.3) which requires four 
chromatography steps (Berrill et al. 2009). 
 
 
 
 
 
 
Protein mass spectrometry for bioprocess development & monitoring 
 
156 
 
 
Figure 7.9 Impurity removal analysis from chromatography elution fractions. 
The column used was a 1mL Q Sepharose FF HiTrap column using 50mM Tris, pH 8, 
100mM NaCl for equilibration, load and washing. For elution 50mM Tris, pH 8, 
400mM NaCl was used. Pooled elution fractions are shown by shaded region. 
Analysis was carried out on a Q10 ProteinChip with 50mM Tris, pH 8.0, 0mM NaCl. 
Proteins chosen for study were either very distantly related to the product (9.3 and 
12.7kDa/e proteins), moderately related to the product (35.2kDa/e) or nearest 
neighbours to the product (28.6, 29.1, and 56.3). Bar charts are normalised based 
on the total summed peak intensity for all seven peaks for each sample. 
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7.4 Summary 
 
Review of chapter aims: 
 Incorporate peak normalisation, where peaks are compared against one 
another within a spectrum to reduce variability. 
 Star plots and dendrograms incorporate normalisation by comparing 
responses between peaks. 
 
 Develop a physicochemical map to compare proteins within a given process 
material. 
 Using dendrograms, a visualisation tool usually used in taxonomy for 
grouping species or genes it was possible to compare proteins based on 
their physicochemical properties for bioprocess development. 
 
 Determine nearest neighbours to target protein. 
 SELDI-MS was used to gather the data required for this analysis in a matter 
of days enabling identification of impurities that are hard to separate from 
the product.  
 Impurities that were observed to be difficult to remove in a previously 
developed bioprocess were predicted correctly by this approach. 
 Impurities that were predicted to be hard to remove were most likely 
product related. 
 
 Commence investigation into the conditions that may be promising for 
separating the target protein from nearest neighbours. 
 Conditions for the separation of the product from these nearest neighbours 
were found to be challenging, on the basis of simple hydrophobic and 
electrostatic adsorption chemistries. 
 Although conditions for separation of ApoA-IM monomer from its nearest 
neighbours were not found, separation from very distantly related proteins 
was observed.  
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 The ProteinChips could give some clues on the conditions to focus on in 
future sorbent scouting experiments. 
 The method gives a rapid indication of the separation challenge for a 
particular product and contaminant profile using minimal material. This is an 
important metric to determine the resources required for process 
development. 
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CHAPTER 8 CONCLUSIONS & RECOMMENDATIONS FOR FUTURE 
WORK
 
8.1 Review of project objectives 
 
8.1.1 Objective 1: Develop the use of a mass spectrometry technology for 
bioprocess materials 
 
This EngD project has generated Matlab code (appendix) for the easy upload 
and treatment of SELDI-MS data for further applications. This significantly benefited 
this project but could also be beneficial for researchers who do not want to be 
confined to a platform limited to a graphical user interface. 
 
8.1.2 Objective 2: Application of the approach to an industrial process in 
conjunction with a USD device 
 
During this project I was fortunate enough to observe the ApoA-IM process 
at Pfizer. This gave me an excellent opportunity to test the capabilities of SELDI-MS 
as a process monitoring tool against other more conventional approaches. Although 
SELDI-MS would require a large amount of optimisation to allow absolute 
quantification, it did demonstrate some key advantages over other techniques. This 
included its ability to handle very crude feed streams, even those near the start of a 
process. This meant that unlike other approaches, SELDI-MS could be used at every 
stage of protein production. SELDI-MS could also provide information that would 
usually require all three conventional analytical approaches. 
It was also possible to incorporate an ultra scale-down shear device study 
with the aim of improving the flocculation/centrifugation stage of the ApoA-IM 
process.  
This work which was an extension on previous work at UCL showed that the 
flocculation/centrifugation could be improved by adding more flocculating agent at 
a slower rate. This also showed the benefit at pilot scale that the ultra-scale down 
predicted.  
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This improvement could have been due to the slower flow rate allowing an 
increased mixing time for the flocculating agent and therefore increased aging of 
the flocs. If flocs had a longer time to form their mechanical strength could have 
greatly increased. Adding more flocculant would also ensure complete flocculation 
of the material which would also improve clarification. 
The material generated from the flocculation/centrifugation stage was used 
for later purification development work. 
 
8.1.3 Objective 3: Develop novel approaches for acquisition and analysis of 
mass spectra to expedite bioprocess development and monitoring 
 
Aware of the limitations of using SELDI-MS for chromatography sorbent 
screening meant the need to apply a different approach. SELDI-MS could be used to 
examine the relationship between proteins present in process streams and reveal 
which impurities maybe hardest to remove down-stream. This may then suggest 
which impurities should be knocked out of the process during fermentation by 
changing or modifying the host or the conditions it is grown under. This technique 
could also propose initial purification conditions for impurity removal. 
 
8.2 Publications 
 
The above objectives provide a summary of the original aspects of the work 
presented in this thesis, of which a significant portion has been published, or 
accepted for publication in a peer reviewed journal. Selections of this work have 
also been presented in poster and oral form. 
 
Peer reviewed publications: 
 
Berrill A, Ho SV, Bracewell DG. Ultra scale-down to define and improve the 
relationship between Flocculation and disc-stack centrifugation. Biotechnology 
Progress 2008; 24:426-431. 
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Berrill A, Ho SV, Bracewell DG. Product and Contaminant Measurement in 
Bioprocess Development by SELDI-MS. Biotechnology Progress. In press. 
 
Conference presentations: 
 
Berrill A, Ho SV, Bracewell DG. Ultra scale-down to define and improve the 
relationship between flocculation and disc-stack centrifugation. American Institute 
of Chemical Engineers. 1st Annual Meeting for the Society of Biological Engineering, 
San Diego, CA, US, March 19-23, 2007. (Poster) 
 
Berrill A, Ho SV, Bracewell DG. Ultra scale down to improve the flocculation disc 
stack centrifuge interaction. American Institute of Chemical Engineers. Annual 
Meeting, Salt Lake City, UT, US, Nov 4-9, 2007. (Oral) 
 
Berrill A, Ho SV, Bracewell DG. Accelerated physicochemical characterization of 
protein mixtures to aid purification sequence selection. American Institute of 
Chemical Engineers. Annual Meeting, Salt Lake City, UT, US, Nov 4-9, 2007. (Oral) 
 
8.3 Final comments and future work 
 
This section will evaluate the three objectives of this thesis, in terms of their 
future potential, highlighting those ones of greatest importance.  
 
8.3.1 Related to objective 1: Develop the use of a mass spectrometry 
technology for bioprocess materials 
 
Key developments to this objective: 
 
1) Analysis of data treatment routines, particularly baseline correction and 
absolute quantification. 
It is widely known that obtaining quality SELDI-MS data is difficult and more 
research in treating this data is required. A surprising result in this thesis was that 
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baseline correction actually reduced reproducibility. Further investigation is 
required to identify where these sources of variation occur. Once this is clearer 
better suited data treatment algorithms can be chosen to reduce this variation. One 
of the major downsides of the TOF-MS approach is the increased signal intensities 
for peaks at lower m/z. This makes absolute quantification without standards for 
each protein currently impossible. A data treatment technique needs to be 
developed to correct for the expansion in the ion clouds that are known to cause 
this phenomenon.  One way to do this may involve bridging the proteins of interest 
with protein standards. If the protein standards are quantifiable then it may also be 
possible to relate changes in the peak signals between the standards to known 
quantities.  
 
8.3.2 Related to objective 2: Application of the approach to an industrial 
process in conjunction with a USD device 
 
Key developments to this objective: 
 
1) Varying additional variables for the flocculation and centrifugation. 
Only one type of flocculating agent was used in the ApoA-IM process but it 
would be of interest to investigate the use of other flocculating agents. Increasing 
the number of flocculating agent concentrations and the levels added would also be 
beneficial.  
In terms of analysis, further particle size measurements could be implemented 
to examine further how particle morphology changes with different flocculation 
conditions. In this work, microscope images were taken but further analysis using 
equipment such as light scattering would also provide useful information. 
  
8.3.3 Related to objective 3: Develop novel approaches for acquisition and 
analysis of mass spectra to expedite bioprocess development and 
monitoring 
 
Key developments to this objective: 
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1) Investigate ability of SELDI-MS to give further information on HCPs and 
other impurities such as nucleic acids and endotoxins. 
To gather detailed information on HCPs present in feed materials is to isolate 
them prior to their peptide mapping to confirm their identities with existing protein 
databases. A far less labour intensive and timely method maybe possible if HCP 
standards are available such as those used for ELISA. These standards could be run 
either individually or in a mixture on a non-selective ProteinChip to confirm their 
m/z values. A mixture of these HCPs could then be profiled under the same array of 
adsorption conditions as those used for the feed material. Provided there is 
minimal competition between proteins, an HCP that is present in the HCP standard 
as well as the feed material should have a similar adsorption pattern. The closer the 
masses of the two proteins and the more similar the adsorption pattern the greater 
the likelihood they are indeed the same protein. 
    At present there is very little literature on the use of SELDI-MS to detect 
nucleic acids and endotoxins but this is also an area where it may be possible to 
expand the SELDI-MS technique. 
 
2) Identify nearest neighbours in other feed materials and confirm the 
difficulty of their removal and define how close an impurity has to be to the product 
in order for it to become problematic to remove. 
By analysing other feed materials with SELDI-MS and using existing 
knowledge of the difficulties of purifying certain components it should be possible 
to build up a database of how close impurities have to be on a dendrogram to 
become difficult to separate from one another. This could result in defining a cut-
off (annotated by C in Figure 8.1) for any new material examined. The cut-off would 
group those impurities that co-elute with the target protein under the majority of 
separation conditions (e.g. cluster 2 in Figure 8.1). It may then mean that more 
novel separation techniques such as mixed-mode chromatography would need to 
be adopted to separate these nearest neighbours.  
This work may also allow a cost for removal to be assigned to each impurity 
which is linked to the difficulty of their separation from the target protein. The 
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closer the nearest neighbour, the more costly purification will be. If there are many 
near neighbours, column capacities may also be lower for the target protein due to 
nearest neighbours competing for adsorption sites.  
 
 
Figure 8.1 Defining cut-off to cluster hard to remove proteins 
The cut-off is defined by C and could move depending on further analysis of how 
hard these impurities are to remove using conventional process purification 
techniques. 
 
3) Inform cell biologists of ways of cell engineering to help enhance 
recovery/purification performance.  
If impurities are found that are close enough to the target protein that the cost 
of separating them downstream is greater than the cost of engineering the host so 
they are no longer expressed, then perhaps cell engineering is the preferred option. 
For cell engineering these impurities would need to be identified using an advanced 
LC-MS system combined with a database search. The cell biologist would then be 
able to decipher which genes produced them and how they should be knocked out 
of the hosts DNA to prevent their expression. 
 Without these nearest neighbours being produced, downstream processing 
would be greatly simplified and less resource intensive. 
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4) Investigation the adsorption characteristics of the ProteinChips relate to 
chromatography column formats. 
In order to develop chromatography operations based on ProteinChip results 
further understanding of the correlation between the two is required. This thesis 
shows it is possible to define which proteins are likely to be problematic to 
separate. Further dendrograms can be created to show the relationship between 
nearest neighbours and product on the individual SELDI surface chemistries 
available. What remains to be defined is what this establishes in terms of the 
chromatographic operation considering the variety of materials and surface 
chemistries available as adsorbents. 
 
5) Design of chromatographic sequences. 
As further correlations between adsorption on ProteinChips and modes of 
chromatographic resins are made there is increased likelihood that SELDI-MS data 
could be used to design chromatography sequences. This could involve selecting 
the first chromatography chemistry in a chromatography sequence to be the one 
that shows the greatest distance between the target protein and the overall 
nearest neighbour when all chemistries are considered. There are many other 
elements that could be considered in the complex algorithms that would need to be 
generated for this work. For instance, a ranking system could be introduced based 
on the removal of some proteins early on. For example, if a protease is present this 
may need to be weighted heavily so that the distances in the dendrogram for this 
impurity are reduced making it more of a concern to remove this impurity early on. 
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CHAPTER 9 VALIDATION OF BIOPROCESSES: IMPLICATION OF SCALE-
DOWN METHODOLOGIES 
 
9.1 Process validation 
 
Biopharmaceutical products need to be efficacious and economically viable 
to produce while satisfying regulatory requirements on their safety. Since they are 
biologically derived these medicines usually have to be purified from very complex 
mixtures of DNA, lipids and other proteins including those with similar properties to 
the protein of interest. 
Since the protein produced is defined by the process that produces it, it is 
the process needs to be validated. Throughout production, data must be collected 
that gives assurances that the process implies product quality. The process must 
consistently meet these specifications. This includes a robust and well characterised 
process that can withstand inevitable variance in operating conditions including 
operating error. 
 
9.2 Scale-down models 
 
At pilot scale and larger it is rarely economically feasible to test a wide range 
of operating conditions. This is due in part to the large amount of resources that 
would need to be employed. Also, this stage is likely to be on the critical path of 
process development and time spent here will ultimately delay product launch and 
hence the recuperation of the capital invested along with any expected profit. 
Technologies that can generate the data required with minimal resource 
expenditure while running in parallel with large scale development are in high 
demand. These technologies include scale down mimics of the large scale 
operations.  An ideal scale down device will use minimal material while having high 
throughput and minimal burden on timely analytical assays. 
The scale down mimic must match the larger scale in terms of key process 
parameters with an equivalent set of operating parameters. Any change in the 
operating parameters at either scale should result in comparative outputs. If this is 
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achievable then this scale-down device would be suitable to be used for process 
validation of the larger scale operation.  
Scale-down models have been used for a number of large scale unit 
operations including; centrifugation, filtration, hydrophobic interaction 
chromatography, expanded bed chromatography, and bioreactors (Boychyn et al. 
2004;Boychyn et al. 2000;Neal et al. 2003;Reynolds et al. 2003;Willoughby et al. 
2004). 
 
9.2.1 Process validation scenario: Effect of contaminant properties on 
purification 
 
The initial concept behind the ProteinChip experiments used in this project 
were to simulate the adsorption at ultra scale-down to that experienced during 
large scale chromatography. Due to the complexity of the mechanisms and 
different operation factors of the two scales it is very hard to precisely mimic the 
chromatography using ProteinChip technology. 
After continued efforts the decision was made to concentrate on using 
SELDI-MS as an analytical technique to provide wide arrays of information about 
our process material in a minimal amount of time. 
Using SELDI-MS in this way allows the user to identify impurities that maybe 
particularly difficult to remove and adjust their host organism or fermentation 
conditions to reduce these or concentrate on the unit operations that will be the 
most effective in removing these problem proteins. Once an initial process is 
developed around this framework SELDI-MS can then be used to validate the 
process by analysing different feed streams shown in chapter three. 
  
9.2.2 Process validation scenario: A new protein candidate for a process 
development team 
 
Imagining the scenario of a biopharmaceutical company discovering a 
protein or wanting to acquire or buy the license for a protein that displays clinical 
benefit. How does the company evaluate early on if producing this protein will be 
economically feasible to produce at industrial scale? The methodology outlined 
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could be a useful way to do this before many resources have committed that may 
have been better spent on more viable alternatives.  
Figure 9.1 gives an outline of the types of steps that may occur when a new 
protein candidate is presented to process development team. 
 
 
 
Figure 9.1 Theoretical framework for the rapid evaluation of protein candidates at 
early stage process development. 
The steps are based on product titres, product efficacy and expected cost of 
removing nearest neighbour impurities to satisfy regulatory requirements. 
 
Define product peak 
 
Identify nearest neighbour(s) using 
star plots and dendrograms 
Upload & treat SELDI-MS data within 
Matlab environment 
Profile with SELDI-MS using an array of 
adsorption conditions 
New protein candidate with likely impurities 
Go ahead with the development 
Is it feasible to increase product titres or remove nearest 
neighbour(s) in the fermentation? e.g. a change of host; the 
genetic modification of the present host; the product being 
produced extracellularly instead of intracellularly; the removal of 
nearest neighbour(s) from the genetic code 
Calculate expected profit based on product titer, product efficacy 
and cost to remove nearest neighbours to satisfy regulatory 
requirements 
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ABBREVIATIONS 
 
2D-PAGE:  Two Dimensional-PolyAcrylamide Gel Electrophoresis 
ABS:   Aqueous Biphasic Systems 
ACN:   Acetonitrile 
ADH:   Alcohol Dehydrogenase 
ADI:   ApoA-IM Dimer Intermediate 
ApoA-IM:  ApolipoproteinA-IM 
BSA:   Bovine Serum Albumin 
CM:   Carboxy Methyl 
CV:   Coefficient of Variation 
DEAE:   Diethylaminoethane 
DRT:   Dimensionless Retention Time 
DTT:    Dithiothreitol   
EAM:   Energy Absorbing Molecule 
EBA:   Expanded Bed Adsorption 
E.coli:   Escherichia coli 
ELISA:   Enzyme-linked immuno sorbent assay 
ESI-TOF-MS: ElectroSpray Ionisation-Time of Flight-Mass Spectroscopy 
Fab:   Antibody Fragment 
FDA:   Food and Drug Administration 
HCP:   Host Cell Protein 
HEW:   Hen Egg White 
HIC:   Hydrophobic Interaction Chromatography 
HPLC:   High Performance Liquid Chromatography 
IEX:   Ion-Exchange 
IMAC:   Immobilised Metal Affinity Chromatography 
kDa:   kiloDalton 
MALDI-TOF-MS:  Matrix Assisted Laser Desorption/Ionisation-Time of Flight- 
   Mass Spectrometry 
MS:   Mass Spectrometry 
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MW:    Molecular Weight 
NP:   Normal Phase 
PAT:   Process Analytical Technology 
PBS:   Phosphate Buffered Saline 
pI:    Isoelectric point 
Q:   Quaternary amine  
QbD:   Quality by Design 
QSPR:   Quantitative Structure Property Relationships 
RP:   Reverse Phase 
SDS-PAGE:   Sodium Dodecyl Sulphate-PolyAcrylamide Gel Electrophoresis 
SE:   Size Exclusion 
SEAC:   Surface Enhance Affinity Capture 
SELDI-TOF-MS:  Surface Enhanced Laser Desorption/Ionisation-Time of Flight -
Mass Spectroscopy 
SP:   Sulfopropyl 
SPA:   Sinapinic Acid 
TFA:   Trifluoroacetic acid 
TMB:   Tetramethylbenzidine 
UDWT:   Undecimated Discrete Wavelet Transform 
UF/DF:   Ultrafiltration/Diafiltration 
UPGMA:  Unweighted Pair Group Method with Arithmetic mean 
USD:   Ultra-Scale Down 
UV:   Ultra Violet 
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NOMENCLATURE
 
Symbol Description Unit 
g Acceleration due to gravity m.s-2 
Фsurface Average surface hydrophobicity value - 
φ Cellular solids fraction - 
z Charge e 
Ci Concentration of protein i mol.L
-1 
c 
Correction factor to account for non-ideal fluid flow 
patterns, the value of which depends on centrifuge design 
- 
DRT Dimensionless retention time - 
∑ds Equivalent settling area of the disc-stack centrifuge m
2 
∑lab Equivalent settling area of the laboratory centrifuge m
2 
Q Flow rate m3.s-1 
θ Half disc angle in disk stack centrifuge degrees 
h Hindered settling correction factor - 
φaai Hydrophobicity value for amino acid ‘i’ - 
r1 Inner disc radius in disk stack centrifuge m 
Ri 
Inner radius, the distance between the centre of rotation 
and the top of the liquid in USD centrifuge 
m 
M Mass of protein kDa 
ODf Optical density of the feed nm 
ODr Optical density of the reference nm 
ODs Optical density of the supernatant nm 
r2 Outer disc radius in disk stack centrifuge m 
Ro 
Outer radius, the distance between the centre of rotation 
and the bottom of the liquid in USD centrifuge 
m 
nd Number of active discs in industrial scale centrifuge - 
Ki Partition coefficient - 
%C Percentage Clarification - 
Tlab Residence time in the laboratory centrifuge s 
ω Rotational speed rad.s-1 
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N Rotational speed, rps s-1 
saai Solvent accessible area occupied by amino acid ‘i’ - 
tf Time corresponding to the end of the elution gradient s 
tr 
Time corresponding to the retention time of the target 
protein 
s 
t0 Time corresponding to the start of the elution gradient s 
tt Time of flight s 
sp Total solvent accessible area of the protein - 
Vlab Volume of process material in laboratory centrifuge tube m
3 
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APPENDIX - MATLAB CODE
 
Reading spectra data 
 
%Enter directory where the data is located 
 
clear all  
 
path=cd; 
 
directory=find(path=='\'); 
 
currentfile=path(directory(end-1)+1:end); 
 
currentfile(currentfile=='.')='_'; 
currentfile(currentfile=='\')='_'; 
 
%Read Data 
 
cd([cd '\' 'Processed']); 
 
[MZ SELDIProcessed,Metapropnames,Metapropvalues,filenames]=readProcessed; 
 
cd .. 
 
cd([cd '\' 'Raw']); 
 
[Raw]=readRaw(filenames); 
 
%Remove redundant data from Processed & Raw 
[u numcols]=size(MZ); 
 
for i=1:numcols; 
    b(:,i)=min(find(isnan(MZ(:,i))==1)); 
end 
 
clearInd=max(b); 
 
MZ(clearInd:end,:)=[]; 
SELDIProcessed(clearInd:end,:)=[]; 
Raw(clearInd:end,:)=[]; 
 
% Process Raw Data 
[Raw,Smoothed]=basecorr2(Raw, MZ, 6, 10, 6); 
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%Mass=MZ; 
 
clear b 
 
AverageMass1=[]; 
AverageMass2=[]; 
 
clear e 
 
for i=1:numel(filenames); 
     
    %remove csv 
    a=strmatch(filenames{i}(:,end-3:end),'.csv'); 
         
    if a==1; 
       filenames{i}=filenames{i}(:,1:end-4); 
    end 
    
    %remove _1 
    b=strmatch(filenames{i}(:,end-1:end),'_1'); 
     
    if b==1; 
       filenames{i}=filenames{i}(:,1:end-2); 
    end 
     
end 
      
for i=1:numel(filenames); 
     
    f=numel(strmatch(filenames{i},filenames)); 
     
    e(i,1:f)=strmatch(filenames{i},filenames)'; 
     
end 
     
[l m n]=unique(e,'rows'); 
 
variablenames=[]; 
variables=[]; 
variablelevels=repmat(NaN,numel(filenames),1); 
 
%Sorting Variables 
if  numel(filenames(Karpievitch et al. 2007))==10 & numel(filenames{end})==10; 
    [variablenames variables variablelevels]=datasorting2(filenames,MZ); 
end 
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MinCutOff=5000; 
MidCutOff=22500; 
MaxCutOff=90000; 
     
lowStepSize=200; 
highStepSize=200; 
 
lowWindowSize=900; 
highWindowSize=1800; 
 
%if numel(f)>=2; 
 
newMass=repmat(NaN,25000,numel(m)); 
newSELDIProcessed=repmat(NaN,25000,numel(m)); 
newRaw=repmat(NaN,25000,numel(m)); 
newBaselineCorrected=repmat(NaN,25000,numel(m)); 
newSmoothed=repmat(NaN,25000,numel(m)); 
 
%if numel(m)<numel(l); 
  
%Merging of low & high mass spectra 
if  m(1)==2; 
        
    for i=1:numel(m); 
            
        o=min(MZ(:,l(i,1))); 
        p=max(MZ(:,l(i,1))); 
        AverageMass1=(o+p)/2; 
             
        x=min(MZ(:,l(i,2))); 
        y=max(MZ(:,l(i,2))); 
        AverageMass2=(x+y)/2; 
             
        if  AverageMass1<AverageMass2; 
            
            %Process low and high mass data 
            lowMass=MZ(:,l(i,1)); 
            highMass=MZ(:,l(i,2)); 
            lowSmoothed=Smoothed(:,l(i,1)); 
            highSmoothed=Smoothed(:,l(i,2)); 
            
            lowMass(isnan(lowMass))=[]; 
            highMass(isnan(highMass))=[]; 
            lowSmoothed(isnan(lowSmoothed))=[]; 
            highSmoothed(isnan(highSmoothed))=[]; 
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baselineCorrectedlow=msbackadj(lowMass,lowSmoothed,'WindowSize',low
WindowSize,'StepSize',lowStepSize,'QuantileValue',0.1);  
            
baselineCorrectedhigh=msbackadj(highMass,highSmoothed,'WindowSize',hi
ghWindowSize,'StepSize',highStepSize,'QuantileValue',0.1);  
             
            %Splice treated data together             
            a=max(find(MZ(:,l(i,1))<MinCutOff)); 
            b=max(find(MZ(:,l(i,1))<MidCutOff)); 
            
            c=max(find(MZ(:,l(i,2))<MidCutOff)); 
            d=max(find(MZ(:,l(i,2))<MaxCutOff)); 
            
            if  isempty(a); 
                [u a]=min(MZ(:,l(i,1))); 
            end 
             
            if  isempty(b)||isempty(c) ;  
                [u b]=max(MZ(:,l(i,1)));  %some NaN so can not have numel, need max 
                c=max(find(MZ(:,l(i,2))<=max(MZ(:,l(i,1))))); 
            end 
                                
            if  isempty(d); 
                [u d]=max(MZ(:,l(i,2))); 
            end 
                          
            k=length([MZ(a:b,l(i,1));MZ(c:d,l(i,2))]); 
        
            newMass(1:k,i)=[MZ(a:b,l(i,1));MZ(c:d,l(i,2))]; 
            
newSELDIProcessed(1:k,i)=[SELDIProcessed(a:b,l(i,1));SELDIProcessed(c:d,l(i,
2))]; 
            newMetapropvalues(:,i)=[Metapropvalues(:,l(i,1));Metapropvalues(:,l(i,2))];  
            newRaw(1:k,i)=[Raw(a:b,l(i,1));Raw(c:d,l(i,2))]; 
            
newBaselineCorrected(1:k,i)=[baselineCorrectedlow(a:b,:);baselineCorrecte
dhigh(c:d,:)]; 
            newSmoothed(1:k,i)=[Smoothed(a:b,l(i,1));Smoothed(c:d,l(i,2))]; 
            V(i,:)=variablelevels(l(i,1),:);          
            
        end 
 
        if  AverageMass1>AverageMass2; 
         
            % Process low and high mass data 
            lowMass=MZ(:,l(i,2)); 
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            highMass=MZ(:,l(i,1)); 
            lowSmoothed=Smoothed(:,l(i,2)); 
            highSmoothed=Smoothed(:,l(i,1)); 
            
            lowMass(isnan(lowMass))=[]; 
            highMass(isnan(highMass))=[]; 
            lowSmoothed(isnan(lowSmoothed))=[]; 
            highSmoothed(isnan(highSmoothed))=[]; 
                       
baselineCorrectedlow=msbackadj(lowMass,lowSmoothed,'WindowSize',low
WindowSize,'StepSize',lowStepSize,'QuantileValue',0.1);  
            
baselineCorrectedhigh=msbackadj(highMass,highSmoothed,'WindowSize',hi
ghWindowSize,'StepSize',highStepSize,'QuantileValue',0.1);  
             
            %Splice treated data together 
            a=max(find(MZ(:,l(i,2))<=MinCutOff)); 
            b=max(find(MZ(:,l(i,2))<=MidCutOff)); 
            
            c=max(find(MZ(:,l(i,1))<=MidCutOff)); 
            d=max(find(MZ(:,l(i,1))<=MaxCutOff)); 
            
             if  isempty(a); 
                [u a]=min(MZ(:,l(i,2))); 
            end 
             
            if  isempty(b)||isempty(c) ;  
                [u b]=max(MZ(:,l(i,2))); %some NaN so can not have numel, need max 
                c=max(find(MZ(:,l(i,1))<=max(MZ(:,l(i,2))))); 
            end 
                                
            if  isempty(d); 
                [u d]=max(MZ(:,l(i,1))); 
            end 
                          
            k=length([MZ(a:b,l(i,2));MZ(c:d,l(i,1))]); 
        
            newMass(1:k,i)=[MZ(a:b,l(i,2));MZ(c:d,l(i,1))]; 
          
newSELDIProcessed(1:k,i)=[SELDIProcessed(a:b,l(i,2));SELDIProcessed(c:d,l(i,
1))]; 
             newMetapropvalues(:,i)=[Metapropvalues(:,l(i,2));Metapropvalues(:,l(i,1))]; 
           newRaw(1:k,i)=[Raw(a:b,l(i,2));Raw(c:d,l(i,1))]; 
            
newBaselineCorrected(1:k,i)=[baselineCorrectedlow(a:b,:);baselineCorrecte
dhigh(c:d,:)]; 
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             newSmoothed(1:k,i)=[Smoothed(a:b,l(i,2));Smoothed(c:d,l(i,1))]; 
           V(i,:)=variablelevels(l(i,1),:);          
        
        end 
    end 
    
% if one spectrum per condition no splicing necessary 
else 
    for i=1:numel(variablelevels(:,1)); 
                                          
         a=max(find(MZ(:,i)<=MinCutOff)); 
         b=max(find(MZ(:,i)<=MidCutOff)); 
         d=max(find(MZ(:,i)<=MaxCutOff)); 
            
         if isempty(a); 
            [u a]=min(MZ(:,i)); 
         end 
          
         if isempty(b); 
            b=(a+d)/2; 
         end 
              
         if isempty(d); 
            [u d]=max(MZ(:,i)); 
         end 
                          
         k=length([MZ(a:d,i)]); 
        
         newSELDIProcessed(1:k,i)=[SELDIProcessed(a:d,i)]; 
         newMetapropvalues(:,i)=[Metapropvalues(:,i)]; 
               
         lowMass=MZ(a:b,i); 
         highMass=MZ(b+1:d,i); 
         lowSmoothed=Smoothed(a:b,i); 
         highSmoothed=Smoothed(b+1:d,i); 
            
         lowMass(isnan(lowMass))=[]; 
         highMass(isnan(highMass))=[]; 
         lowSmoothed(isnan(lowSmoothed))=[]; 
         highSmoothed(isnan(highSmoothed))=[]; 
            
         
baselineCorrectedlow=msbackadj(lowMass,lowSmoothed,'WindowSize',low
WindowSize,'StepSize',lowStepSize,'QuantileValue',0.1);  
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baselineCorrectedhigh=msbackadj(highMass,highSmoothed,'WindowSize',hi
ghWindowSize,'StepSize',highStepSize,'QuantileValue',0.1);  
           
         newMass(1:k,i)=[lowMass;highMass]; 
         newRaw(1:k,i)=[Raw(a:b,i);Raw(b+1:d,i)]; 
         newBaselineCorrected(1:k,i)=[baselineCorrectedlow;baselineCorrectedhigh]; 
         newSmoothed(1:k,i)=[lowSmoothed;highSmoothed]; 
         V(i,:)=variablelevels(i,:);         
    end 
end 
   
%End of Sorting Masses function 
  
%clear a 
clear variablevels; 
clear Metapropvalues; 
clear Mass; 
clear SELDIProcessed; 
clear Raw; 
clear BaselineCorrected; 
clear Smoothed; 
     
variablelevels=V; 
Metapropvalues=newMetapropvalues; 
Mass=newMass; 
SELDIProcessed=newSELDIProcessed; 
Raw=newRaw; 
BaselineCorrected=newBaselineCorrected; 
Smoothed=newSmoothed; 
 
%crop data at max mass 
[z clearInd]=max(Mass(:,1)); 
 
Mass(clearInd+1:end,:)=[]; 
SELDIProcessed(clearInd+1:end,:)=[]; 
Raw(clearInd+1:end,:)=[]; 
BaselineCorrected(clearInd+1:end,:)=[]; 
Smoothed(clearInd+1:end,:)=[]; 
 
Mass=Mass/1000; 
%Mass(Mass==0)=NaN; 
 
Noise=Raw-Smoothed; 
Baseline=Smoothed-BaselineCorrected; 
     
cd .. 
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save([currentfile 
'Spectra'],'Mass','SELDIProcessed','Raw','Noise','Smoothed','Baseline','BaselineCorr
ected')%,'AUCMass','AUCSELDIProcessed','AUCRaw','AUCSmoothed','AUCBaselineC
orrected'); 
save([currentfile 
'MetaData'],'Metapropnames','Metapropvalues','filenames','variablenames','variabl
es','variablelevels'); 
 
[nummasses numcols]=size(Mass); 
 
%stop it crashing from too much data 
if  numcols<=32; 
 
    load([currentfile 'Spectra']); 
 
    xlswrite([currentfile 'Raw'],[Mass Raw]);  
    xlswrite([currentfile 'SELDIProcessed'],[Mass  SELDIProcessed]); 
    xlswrite([currentfile 'Noise'],[Mass Noise]); 
    xlswrite([currentfile 'Smoothed'],[Mass Smoothed]); 
    xlswrite([currentfile 'Baseline'],[Mass Baseline]); 
    xlswrite([currentfile 'BaselineCorrected'],[Mass BaselineCorrected]); 
   
    load([currentfile 'MetaData']); 
 
    if  AverageMass1~=AverageMass2; 
        xlswrite([currentfile 'MetaData'],[repmat(Metapropnames,2,1) 
Metapropvalues]); 
    else 
        xlswrite([currentfile 'MetaData'],[Metapropnames Metapropvalues]);   
    end 
 
end 
 
Reading processed data 
 
%Read data 
 
%Enter directory files are in and run 
 
function [MZ,Processed,propertyname,propval,csvfiles]=readProcessed 
 
%Upload data and get conditions 
 
%function 
[operatingparameters,MZ,Int,datafilenames]=uploadSELDInp20data(fullpath); 
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%fullpath=['c:\My Documents\Matlab\Functions & Data\Data\' sample '\' 'SELDI' '\' 
experiment '\' intensity '\' datatreatment '\' 'Raw' '\']; 
Int=[]; 
%cd(fullpath); 
 
[stat,mess]=fileattrib('*'); 
 
[r numfiles]=size(mess); 
 
for i=1:numfiles; 
datafullpath{i}=mess(i).Name; 
end 
 
[pathrows pathcols]=size(cd); 
 
for i=1:numfiles; 
datafilenames{i}=datafullpath{i}(:,pathcols+2:end); 
end 
 
datafilenames=datafilenames'; 
 
chardatafilenames=char(datafilenames); 
 
for i=1:numfiles; 
    a=char(datafilenames(i,:)); 
    [numletters]=length(deblank(a)); 
    x=strmatch(a(:,numletters-2:numletters),'csv','exact'); 
    if x==1; 
        j(i)=i; 
    end     
end 
 
csvfiles=datafilenames(nonzeros(j),:)'; 
 
[numfiles]=length(csvfiles); 
 
%csvfiles 
 
[MZ, Processed, propertyname, propval]=GetSpectraData(csvfiles); 
 
Reading raw data 
 
%Read data 
 
%Enter directory files are in and run 
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function [Raw]=readRaw(csvfiles) 
 
%path=['c:\My Documents\Matlab\Data\' sample '\' samplenumber '\' equipment 
'\' experiment '\' intensity '\' datatreatment '\']; 
 
%Upload data and get conditions 
 
%function 
[operatingparameters,MZ,Int,datafilenames]=uploadSELDInp20data(fullpath); 
 
 [numfiles]=length(csvfiles); 
Raw=repmat(NaN,150000,numfiles); 
 
for i=1:numfiles; 
[propertyname propertyvalue]=textread(csvfiles{i},'%s 
%s','delimiter','=','emptyvalue',NaN); 
 
%propertyname 
 
%Take mass spec data from propertyname 
[a]=size(str2num(char(propertyvalue))); 
 
TOFmultiplier=str2num(char(propertyvalue(a(1)-1))); 
TOFdata=str2num(char(propertyname(a(1)+2:end,:))); 
 
size(TOFmultiplier); 
lenTOFdata=length(TOFdata); 
 
Raw(1:lenTOFdata,i)=TOFdata*TOFmultiplier; 
end 
 
Retrieve spectra data 
 
function [lowcatMZ, lowcatInt, propertyname, propval]=GetSpectraData(csvfiles); 
 
numcsvfiles=numel(csvfiles); 
 
lowcatMZ=repmat(NaN,150000,numcsvfiles); 
lowcatInt=repmat(NaN,150000,numcsvfiles); 
propertyname=[]; 
 
propval=cell(130,numcsvfiles); 
 
for i=1:numcsvfiles; 
[propertyname propertyvalue]=textread(csvfiles{i},'%s %s','delimiter','='); 
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a=strmatch(char('M/Z, Intensity'),char(propertyname)); 
 
%a 
%propertyname 
 
%Take mass spec data from propertyname 
[massspecdata]=str2num(char(propertyname(a+1:end))); 
 
MZ=massspecdata(:,1); 
Int=massspecdata(:,2); 
     
lowcatMZ(1:numel(MZ),i)=MZ; 
lowcatInt(1:numel(Int),i)=Int; 
 
%Clear mass spec data at end  
 
propertyvalue(a:end,:)=[]; 
 
%size(propval) 
t(:,i)=a; 
 
propval(1:a-1,i)=propertyvalue; 
end 
 
maxt=max(t); 
 
propval(maxt:end,:)=[]; 
propertyname(maxt:end,:)=[]; 
 
Sort data 
 
function [variablenames variables variablelevels]=datasorting2(filenames,Mass); 
 
variablelevels=[]; 
variables=[]; 
 
charcsvfiles=char(filenames); 
 
[Chip]=charcsvfiles(:,1); 
ChipInd=repmat(NaN,numel(Chip),1); 
pHInd=repmat(NaN,numel(Chip),1); 
SaltInd=repmat(NaN,numel(Chip),1); 
SaltConcInd=repmat(NaN,numel(Chip),1); 
 
%ChipType 
cm=strmatch('c',Chip); 
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qu=strmatch('q',Chip); 
hyd=strmatch('h',Chip); 
nor=strmatch('n',Chip); 
ima=strmatch('i',Chip); 
dea=strmatch('d',Chip); 
 
ChipInd(cm,:)=1; 
ChipInd(qu,:)=2; 
ChipInd(hyd,:)=3; 
ChipInd(nor,:)=4; 
ChipInd(ima,:)=5; 
ChipInd(dea,:)=6; 
 
%Mass 
[Mass b MassInd]=unique(min(Mass)); 
 
%pH 
[pH b pHInd]=unique(str2num(charcsvfiles(:,2:5))); 
pH=pH/100; 
 
%SaltType 
[Salt]=charcsvfiles(:,6); 
 
sod=strmatch('s',Salt); 
amm=strmatch('a',Salt); 
imi=strmatch('i',Salt); 
 
SaltInd(sod,:)=1; 
SaltInd(amm,:)=2; 
SaltInd(imi,:)=3; 
 
%Salt Conc 
[SaltConc b SaltConcInd]=unique(str2num(charcsvfiles(:,7:10))); 
 
variables(Karpievitch et al. 2007)={'c';'q';'h';'n';'i';'d'}; 
variables(Karpievitch et al. 2007;Merchant and Weinberger,2000)=Mass; 
variables(Coombes et al. 2005;Karpievitch et al. 2007)=pH; 
variables(Karpievitch et al. 2007;Xu and Lenhoff,2008)={'s';'a';'i'}; 
variables(Chen et al. 2008;Karpievitch et al. 2007)=SaltConc; 
size(ChipInd) 
size(MassInd) 
 
variablelevels(:,1)=ChipInd; 
variablelevels(:,2)=MassInd'; 
variablelevels(:,3)=pHInd; 
variablelevels(:,4)=SaltInd; 
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variablelevels(:,5)=SaltConcInd; 
%FractionInd 
%variablelevels(:,6)=FractionInd; 
%variablelevels(:,7)=SpotInd; 
%variablelevels(:,8)=PartitionInd; 
 
Raw data treatment 
 
The code in this section is from the UT M.D. Anderson Cancer Center and follows 
these conditions: 
 
CONDITIONS FOR USE: 
Copyright (c) 2003, 2004 UT M.D. Anderson Cancer Center. All rights reserved. 
 
This software is distributed and licensed to you on a non-exclusive  
basis, free-of-charge. Redistribution and use in source and binary forms,  
with or without modification, are permitted provided that the following  
conditions are met: 
 
1. Redistribution of source code must retain the above copyright notice,  
   this list of conditions and the following disclaimer. 
2. Redistribution in binary form must reproduce the above copyright notice,  
   this list of conditions and the following disclaimer in the  
   documentation and/or other materials provided with the distribution. 
3. All advertising materials mentioning features or use of this software  
   must display the following acknowledgment: This product includes  
   software developed by the University of Texas M.D. Anderson Cancer 
   Center, Houston, Texas and its contributors. 
4. Neither the name of the University nor the names of its contributors  
   may be used to endorse or promote products derived from this software  
   without specific prior written permission. 
 
THIS SOFTWARE IS PROVIDED BY UNIVERSITY OF TEXAS M.D. ANDERSON CANCER 
PROTEIN MASS SPECTROMETRY FOR BIOPROCESS DEVELOPMENT & MONITORING 
 
186 
 
CENTER, HOUSTON, TEXAS, AND CONTRIBUTORS AS IS AND ANY EXPRESS OR 
IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED 
WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE 
ARE 
DISCLAIMED. IN NO EVENT SHALL M.D. ANDERSON OR CONTRIBUTORS BE 
LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR 
CONSEQUENTIAL DAMAGES (INCLUDING, BUT NOT LIMITED TO, PROCUREMENT OF 
SUBSTITUTE GOODS OR SERVICES; LOSS OF USE, DATA, OR PROFITS; OR 
BUSINESS INTERRUPTIONS) HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, 
WHETHER IN CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE 
OR OTHERWISE), PRODUCT LIABILITY, OR OTHERWISE ARISING IN ANY WAY OUT 
OF THE USE OF THIS SOFTWARE, EVEN IF ADVISED OF THE POSSIBILITY OF 
SUCH DAMAGE. 
 
Applicable code: 
function [RawEnd, sm]= basecorr2(raw, rawMass, M, L, thld) 
 
w = size(raw);   % how much data are we handling? 
n = floor(w(1)/2^L);  % number of length 2^L pieces available 
 
echo on 
status = 'start baseline correction' 
tic 
echo off 
 
midmass=22500; 
 
bc = repmat(NaN, [w(1) w(2)]); 
sm = repmat(NaN, [w(1) w(2)]); 
RawEnd = repmat(NaN, [w(1) w(2)]); 
for i = 1:w(2), 
          
    Mass=rawMass(:,i); 
    RawInt=raw(:,i); 
    
    Mass(isnan(Mass))=[]; 
    RawInt(isnan(RawInt))=[]; 
     
    [s] = waveletSmoothAndBaselineCorrect(Mass,RawInt, thld, M, L, midmass); 
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    c=length(Mass); 
     
    RawEnd(1:c,i)=RawInt; 
    sm(1:c,i)=s; 
    
end 
echo on 
toc 
status = 'end baseline correction' 
echo off 
 
Peak selection 
 
%Enter directory where the data is located 
clear all 
 
path=cd; 
 
directory=find(path=='\'); 
 
currentfile=path(directory(end-1)+1:end); 
 
currentfile(currentfile=='.')='_'; 
currentfile(currentfile=='\')='_'; 
 
load([currentfile 'Spectra']); 
load([currentfile 'MetaData']); 
 
PeakMass=[6.855;9.277;11.16;12.22;12.41;12.66;13.06;13.28;14.03;14.6;26.2;27.18
;28.15;28.62;29.05;31.75;35.19;36.88;38.09;40.13;41.18;42.06;43.18;46.57;48.59;5
2.18;54.62;55.95;57.48;84.23]; 
 
[a b]=size(PeakMass); 
 
[peakindexrange peakindexmid]=mspeakfindman(Mass(:,1),PeakMass); 
 
RawPeakHeight=Raw(peakindexmid,:); 
BcPeakHeight=BaselineCorrected(peakindexmid,:); 
CiphergenPeakHeight=SELDIProcessed(peakindexmid,:); 
 
for i=1:a; 
    %SELDIInt(i,:)=sum(NormSELDIAUC(peakindexrange(i,1):peakindexrange(i,2),:),1); 
          
BcPeakArea(i,:)=sum(BaselineCorrected(peakindexrange(i,1):peakindexrange(i,2),:),
1); 
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CiphergenPeakArea(i,:)=sum(SELDIProcessed(peakindexrange(i,1):peakindexrange(i,
2),:),1); 
             
 [a b]=size(BcPeakArea); 
 
maxBcPeakArea=max(BcPeakArea,[],2); 
maxBcPeakArea=repmat(maxBcPeakArea,[1 b]); 
normBcPeakArea=BcPeakArea./maxBcPeakArea; 
 
xlswrite([currentfile 'RawPeakHeight'],[PeakMass RawPeakHeight]); 
xlswrite([currentfile 'CiphergenPeakHeight'],[PeakMass CiphergenPeakHeight]); 
xlswrite([currentfile 'CiphergenPeakArea'],[PeakMass CiphergenPeakArea]); 
xlswrite([currentfile 'BcPeakHeight'],[PeakMass BcPeakHeight]); 
xlswrite([currentfile 'BcPeakArea'],[PeakMass BcPeakArea]); 
xlswrite([currentfile 'normBcPeakArea'],[PeakMass normBcPeakArea]); 
 
save([currentfile 
'Peaks'],'Mass','PeakMass','RawPeakHeight','CiphergenPeakHeight','BcPeakHeight','
CiphergenPeakArea','BcPeakArea','normBcPeakArea'); 
    
Nearest neighbour predictor 
 
%Enter directory where the data is located 
 
path=cd; 
 
directory=find(path=='\'); 
 
currentfile=path(directory(end-1)+1:end); 
 
currentfile(currentfile=='.')='_'; 
currentfile(currentfile=='\')='_'; 
 
load([currentfile 'Peaks']); 
load([currentfile 'MetaData']); 
   
MassString=char(num2str(PeakMass,'%.1f')); 
 figure 
h=glyphplot(normBcPeakArea,'Obslabels',MassString); 
set(h(:,3),'FontSize',16); 
  
Y = pdist(normBcPeakArea); 
Z = linkage(Y); 
 
figure 
[H,T] = dendrogram(Z,'colorthreshold', 0,'labels',MassString,'orientation','right'); 
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set(gca,'FontSize',14); 
set(H,'LineWidth',2); 
xlabel('Relationship (\muA)','FontSize',16) 
ylabel('Protein ID (kDa/e)','FontSize',16) 
 
TargetInd=13; 
 
SquareDist=squareform(Y); 
TargetDist=SquareDist(TargetInd,:); 
TargetDist(TargetDist==0)=NaN; 
 
[a NearestNeighbourInd]=min(TargetDist); 
NearestNeighbour=PeakMass(NearestNeighbourInd) 
 
ph=variables(Coombes et al. 2005)(variablelevels(:,3)); 
conc=variables(Chen et al. 2008)(variablelevels(:,5))/1000; 
 
[a]=find(variablelevels(:,1)==1);     
[b]=find(variablelevels(:,1)==2);     
[c]=find(variablelevels(:,1)==3); 
 
%Cation Exchange 
if size(a)>0; 
    
    figure 
    subplot(1,2,1); 
    [XI,YI] = meshgrid(unique(ph(a)),unique(conc(a))) 
    [catph,catconc,catpeakarea] = 
griddata(ph(a),conc(a),normBcPeakArea(TargetInd,a),XI,YI,'v4'); 
        
    contourf(catph,catconc,catpeakarea,500,'EdgeColor','none') 
    
    view(0,90) 
    axis tight 
     
    subplot(1,2,2); 
    [XI,YI] = meshgrid(unique(ph(a)),unique(conc(a))) 
    [catph,catconc,catpeakarea] = 
griddata(ph(a),conc(a),normBcPeakArea(NearestNeighbourInd,a),XI,YI,'v4'); 
    
        contourf(catph,catconc,catpeakarea,500,'EdgeColor','none') 
     
    view(0,90) 
    axis tight 
end 
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if  size(b)>0; 
    
    figure 
    subplot(1,2,1); 
    [XI,YI] = meshgrid(unique(ph(b)),unique(conc(b))) 
    [catph,catconc,catpeakarea] = 
griddata(ph(b),conc(b),normBcPeakArea(TargetInd,b),XI,YI,'v4'); 
    
    contourf(catph,catconc,catpeakarea,500,'EdgeColor','none') 
    
    view(0,90) 
    axis tight 
     
    subplot(1,2,2); 
    [XI,YI] = meshgrid(unique(ph(b)),unique(conc(b))) 
    [catph,catconc,catpeakarea] = 
griddata(ph(b),conc(b),normBcPeakArea(NearestNeighbourInd,b),XI,YI,'v4'); 
    
    %colormap('default') 
    contourf(catph,catconc,catpeakarea,500,'EdgeColor','none') 
     
    view(0,90) 
    axis tight 
end 
 
if  size(c)>0; 
    
    figure 
    subplot(1,2,1); 
    [XI,YI] = meshgrid(unique(ph(c)),unique(conc(c))) 
    [catph,catconc,catpeakarea] = 
griddata(ph(c),conc(c),normBcPeakArea(TargetInd,c),XI,YI,'v4'); 
    
    contourf(catph,catconc,catpeakarea,500,'EdgeColor','none') 
       
    view(0,90) 
    axis tight 
     subplot(1,2,2); 
    [XI,YI] = meshgrid(unique(ph(c)),unique(conc(c))) 
    [catph,catconc,catpeakarea] = 
griddata(ph(c),conc(c),normBcPeakArea(NearestNeighbourInd,c),XI,YI,'v4'); 
    
    contourf(catph,catconc,catpeakarea,500,'EdgeColor','none') 
     
    view(0,90) 
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    axis tight 
end
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